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ABSTRACT 
Development of a Biomimetic Hydrogel Scaffold as an Artificial 
Niche to Investigate and Direct Neural Stem Cell Behavior 
by 
Christy Lynn Franco 
The mature central nervous system has a very limited capacity for self-renewal and 
repair following injury. Neural stem cells (NSCs), however, provide a promising new 
therapeutic option and can be readily expanded in vitro. Towards the development of 
an effective therapy, greater understanding and control is needed over the mechanisms 
regulating the differentiation of these cells into function-restoring neurons. In vivo, the 
neural stem cell niche plays a critical role in directing stem cell self-renewal and 
differentiation. By understanding and harnessing the power of this niche, a tissue 
engineered system with encapsulated neural stem cells could be designed to encourage 
neuronal differentiation and ultimately regeneration of damaged neural tissue. 
Poly(ethylene glycol)-based hydrogels were used here as a platform for isolating and 
investigating the response of neural stem cells to various matrix, soluble, and cellular 
components of the niche. When covalently modified with a cyclic RGD peptide, the 
synthetic scaffold was demonstrated to support attachment and proliferation of a 
human NSC line under conditions permissive to cell growth. Under differentiating 
conditions, the scaffold maintained appropriate lineage potential of the cells by 
permitting the development of both neuronal and glial populations. Expansion and 
differentiation of NSCs was also observed in a more biomimetic, three dimensional 
environment following encapsulation within a degradable hydrogel material. To 
simulate the soluble signals in the niche, fibroblast growth factor and nerve growth 
factor were tethered to the hydrogel and shown to direct NSC proliferation and 
neuronal differentiation respectively. Finally, as an example of the cell-cell interactions 
in the niche, the pro-angiogenic capacity of encapsulated neural stem cells was 
evaluated both in vitro and in vivo. Ideally, the optimal scaffold design will be applied to 
guide NSCs in a therapeutic application. Toward this goal, a novel method was 
developed for encapsulation of the cells within injectable hydrogel microspheres. This 
technique was optimized for high cell viability and microsphere yield and was 
demonstrated with successful microencapsulation and delivery of neural stem cells in 
rodent model of ischemic stroke. 
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1 Introduction and Background 
Cerebrovascular disease is the third leading cause of death and the leading cause of serious, 
long term disability.1 In addition, neurodegenerative diseases such as Alzheimer's and Multiple 
Sclerosis collectively affect over 6 million people.1 For all of these conditions, a lack of intrinsic 
repair mechanisms and scarcity of clinical treatments beyond physical therapy leaves few 
options for affected individuals. Recent research has shown, however, that stem and progenitor 
cells may be a source for repairing and regenerating those tissues of the body that are incapable 
of doing so on their own. 
1.1 Stem Cells in the Central Nervous System 
The basic definition of a stem cell requires two key characteristics to be present: the ability to 
self-renew, and the ability to differentiate into more specialized cell types.2 Stem cells can be 
further classified based on their potential. Totipotent stem cells have the capacity to completely 
regenerate a whole organism if introduced into the uterus.3 A pluripotent stem cell, also known 
as an embryonic stem (ES) cell, is capable of producing all tissue types except that of the 
placenta.3-5 As an organism develops, the cells become more restricted to the specific tissue that 
they make up. Nearly all stem cells found in an adult organism are classified as multipotent, or 
able to differentiate along a few, but not all, lineages.3 Although the hematopoietic stem cell of 
the bone marrow was the first to be discovered and studied, it is now known that many adult 
tissues harbor their own stem cell populations.2 For example, crypt stem cells are found within 
pits in the intestinal lining, and epidermal stem cells can be found near the base of the hair 
folicules.4'5 Owing to their significant regenerative potential, each of these cell populations 
presents new possibilities for repairing and engineering tissues. 
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1.1.1 Neural Progenitors 
For many centuries it was believed that neurogenesis did not occur in the fully developed 
central nervous system.3'6'7 In 1983, however, Goldman and Nottebohm proved that active 
replacement of neurons occurred in the brains of adult canaries as they learned new songs.8 By 
the 1990's several researchers showed that neural stem cells exist in the mammalian brain and 
can proliferate and migrate to replenish olfactory bulb neurons in rodents.3•6•9 Further evidence 
of a neural stem cell was provided when Reynolds and Weiss showed that cells isolated from 
highly proliferative zones in the adult mammalian brain could be cultured in vitro as non-
adherent cell clusters termed neurospheres, and could be induced to differentiate along both 
neural and glial lineages.2•5•10 The neurosphere assay has since become a common tool for the 
characterization of neural stem cells in vitro.11 
1.1.2 Neural Stem Cell Lineage 
Identification and characterization of neural stem cell populations in vivo has proven to be 
significantly more challenging. The transcription factor SOX2 as well as the intermediary 
filament nestin are common antigenic markers used in the literature to identify NSC 
populations.7'12'13 Additional characterization methods must be used, however, since neither 
marker is entirely unique to NSCs.3'4'11 For example, nestin in particular has been reported in a 
wide variety of healthy and injured adult tissues.14 In addition to immunostaining, the use of S-
phase labeling and in vitro neurosphere-forming assays have been the primary methods used to 
identify NSCs since they allow observation of the two key traits: self-renewal and 
differentiation.3•9•10'15 The exact nature of these tests, however, may vary widely between labs in 
everything from the harvesting technique to the cell culture methods, leading to changes in the 
resulting cell populations being studied.2'3 Additional differences in harvested stem cell 
2 
characteristics have been reported based on the age of the animal and the location in the brain 
from which they are derived.2'16 As a result of all these complications, the precise nature and 
origin of the neural stem cell has yet to be determined and is widely debated in the literature.3 
For example Johansson et a/. showed evidence that ependymal cells lining the ventricle walls 
have some stem cell characteristics.3'7'17 Other researchers have identified a population of cells 
with an astrocyte phenotype that were capable of self-renewal and differentiation into both 
neurons and glia.3'7' 18 A comprehensive theory to explain the variety of NSCs was presented by 
Alvarez-Bullya eta/. in 2001 and 2006 and is diagramed in Figure 1.19'20 This theory proposes that 
neuroepithelial cells give rise to radial glia and then astrocyte stem cells, all of which have the 
capacity to form neurons and glia.19'20 In the adult brain, the astrocyte stem cell is the quiescent 
population which upon stimulation can give rise to transit amplifying cells that then become 
lineage restricted progenitors and ultimately mature neurons or glial cells.18-20 The ependymal 
cells themselves are also suggested to be derived from the radial glia of this lineage, explaining 
some of their stem cell-like features.20 Within only the last few years, a significant body of 
research has been published providing further support and clarification of this theory.21 For 
example, adult astrocyte stem cells are now known to extend a single primary cilium into the 
ventricular space on one end, and alternately long processes which connect with the pial 
microvasculature on the other.22'23 This morphology is strikingly similar to that of their proposed 
precursors, the radial glia, which stretch between the ventricular and pial surfaces of the 
embryo.22"24 Lineage mapping of labeled radial glia has provided additional validation that they 
give rise to stem and non-stem astrocytes as well as the ependymal cell layer in the adult.25 
Overall, generating an accurate picture of NSC development allows a better understanding of 
their ultimate potential to regenerate the cells and tissues of the central nervous system. 
3 
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Figure 1. Unified theory on the origin of the adult neural stem cell.20 Neuroepithelial cells (blue) line the 
pial surface of the neural tube (a). In the embryonic brain (b), neuro-epithelial cells become radial glia 
(blue), which line the walls of the forming ventricles. In the neonatal brain (c) the radial glia transition into 
the mature, ciliated ependymal cells lining the ventricle walls (tan). A few of these radial glia retain stem 
cell characteristics in the adult brain (d) as astrocyte stem cells (blue) which extend a single cilia into the 
ventricular space. When stimulated, the astrocyte stem cells proliferate as transit amplifying cells (green) 
and differentiate into neurons and glia.2° Figure from Merkle eta/. 2005. 
1.1.3 Potential for Cell-Based Therapies 
Due to their regenerative capacity, neural stem cells are promising candidates for the treatment 
of a wide variety of neurological diseases and injuries.10'26'27 Activation of the endogenous niche 
through delivery of neurotrophic factors as well as implantation of allogenic or autologous cells 
have both been investigated as therapeutic strategies (Figure 2).21'28 Since they are already 
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somewhat restricted, NSCs do 
not carry the same risk for the 
formation of teratoma, a 
scrambled mass of tissue 
types generated by 
uncontrolled proliferation and 
differentiation of implanted 
embryonic stem cells. 26' 27'29 
Several central nervous 
system impairments have 
already shown promise as 
targets for stem cell therapy. 
These fall into two main 
categories: acute injury such 
Embryonic 
stem cells 
a 
Blastocyst 
Transplantation 
of stem cells 
Neural stem cells Other tissue stem cells 
marrow Umbilical cord 
Recruitment of 
endogenous stem cells 
Figure 2. Approaches for neural stem cell -based therapies. 27 
Exogenous stem cell sources could be expanded and/or 
differentiated in vitro towards the desired phenotype prior to 
delivery. Alternatively, a therapy could focus on recruiting 
endogenous neural stem cells .27 Figure from Lindvall et at. 2006. 
as from stroke or spinal cord damage, or more gradual onset resulting from progressive, 
neurodegenerative disease.27'30'31 In the case of Parkinson's disease, the gradual loss of 
dopaminergic neurons is the primary pathology.27'32 Transplanted neurons from fetal tissue have 
been shown to engraft and provide some improvement in clinical trials, however there are 
serious moral concerns and a limited a supply of fetal tissue to use this as common treatment 
modality.27'32 A more recent trial for Parkinson's treatment avoids this controversy since 
autologous cells were harvested from patient biopsies and expanded in vitro prior to 
implantation.33 Another solution for cell sourcing is through the development of a bank of 
neural stem cells that have been validated for stable karyotype and phenotype.34 In one 
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example, a fetal-derived NSC line has been expanded and conditionally immortalized for use in 
h I. · 1 t · 1 · h · k 33 3s uman c m1ca na s to treat 1sc em1c stro e. · Other indications currently undergoing clinical 
trials include spinal cord injury, ALS (Lou Gehrig's Disease), and lysozomal storage disorders such 
as Batten's Disease.33'36'37 Preclinical studies are additionally investigating treatment of multiple 
sclerosis, Alzheimer's disease, Huntington's disease, and traumatic brain injury to name a 
few. 21,27,32,37-39 
Despite the growing body of research and a surge in clinical trials in recent years, a continued 
challenge to improving the therapeutic outcome is the largely unknown mode-of-action for 
many of these cell-based therapies.40 Tracking of cell fate following NSC implantation in animal 
models has shown rapid clearance and minimal engraftment with host tissue, supporting a 
hypothesis of neuro- or immunoprotective effects rather than cell or tissue regeneration.27•40.41 
Low persistence times may be one factor behind marginal patient improvements thus far 
observed in human trials.33 In the case of stroke, the implant environment can be characterized 
by necrosis, hypoxia, and glial scar formation, all of which may contribute to low transplant 
survival.32 Direct cell delivery to the site of tissue damage may not be necessary, however. Using 
a stroke model in the rat brain, neural stem cells engrafted in the parenchyma were shown by 
Modo et a/. to migrate to the infarct region and provide improved functional recovery in the 
animals based on behavioral testing.27.42.43 Additional strategies to enhance survival and 
neuronal differentiation of engrafted cells may be one approach to further improve results and 
patient outcomes.27'31 
Recently, the highly motile property of implanted NSCs has also been utilized in cancer therapy. 
Transfection of NSCs with oncolytic-genes coupled with their intrinsic capacity to home in on 
cancerous cells in the brain has shown to reduce tumor volume in rodent models.30'39 Due to the 
6 
highly invasive nature and lack of treatment options for malignant brain tumors such as 
glioblastoma, finding a targeted therapy to "search and destroy" rogue tumor cells could prove 
to be a promising approach.39.42.44 
1.2 The Neural Stem Cell Niche 
To maintain self-renewal and prevent nonspecific differentiation, stem cells in the body require 
a complex combination of signals and interactions.5'30.45-47 Within their respective tissue, 
therefore, the adult stem cell is restricted to specific regions which provide the necessary 
microenvironment to maintain stemness.5'6'48 These regions have been termed in the literature 
as the stem cell niche, and are unique for each type of multipotent stem cell.5•30.47 Figure 3 
shows the different forms of interactions which may be present in the niche and play a role 
in controlling stem cell 
behavior.48 Such interactions 
can be classified as physical 
signals from the extracellu lar 
matrix, soluble signals such as 
growth factors and cytokines, 
and direct interaction with 
neighboring cells.49 Evidence 
has shown that signals from 
the surrounding environment 
may play an even greater role 
in defining stem cell behavior 
Physical signals 
• Fibronectin 
• Vitronectin 
• Laminin 
• Collagen 
• Fibrillin 
• GAGs. PGs 
Cell late 
processes 
1 Replication 
2 Differentiation 
3 Migration 
4 Apoptosis 
Soluble signals 
• Growth factors 
• Cytokines 
• Chemokines 
Figure 3. Niche interactions affecting NSC fate.49 These can include 
physical signals from adhesion to the matrix, interaction with soluble 
signals, and direct contact with neighboring cells. All can lead to 
changes in gene expression and therefore cell response.49 Figure from 
Lutolf eta/. 2005. 
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and fate than its origin.3' 6 For example, in vitro protocols have been developed that use soluble 
signals added to the media to coax mesenchymal stem cells to differentiate along neuronal 
lineages. 5° 
Since their discovery it has been determined that NSCs are concentrated in two distinct niches in 
the rodent and human CNS.3'5'15.48 The subventricular or subependymal zone (SEZ) defines a 
region of stem cells directly adjacent to the ependymal cells that line the lateral ventricle 
wallsY8•48 Alternatively, the subgranular zone (SGZ) involves a region of the hippocampus with a 
high concentration of cells shown to proliferate and form new neurons in the dentate gyrus.3•7•48 
In both regions, the stem cells are shown to be of an astrocyte phenotype based on morphology 
and antigen presentation.18'19.48 This evidence supports one theory that glial lineages are the 
default differentiation pathway for neural stem cells.18.48 Some researchers even hypothesize 
that populations of astrocytes outside the niche, which were typically regarded as merely 
support cells, retain the capacity for neurogenesis.18.48 Of the two characterized niches, the SEZ 
has been the focus of greater study since the NSCs in this region appear to be less committed 
and have a wider range of potential.19 Although there is some debate, SGZ stem cells show signs 
of being restricted to the formation of new granular neurons.5'19'48 
Histological analysis of the adult rodent SEZ has revealed several distinguishing characteristics 
which are summarized in Figure 4.48'51 Slowly dividing, astrocyte stem cells, termed Type B cells, 
are located directly adjacent to ciliated ependymal cells lining the ventricle walls.20•22•23•48 These 
stem cells give rise to transient amplifying cells which divide rapidly and progress on to 
committed neural or glial progenitors.20 The principal function of the SEZ in mammals is the 
generation of new neurons to replenish those in the olfactory bulb.23 As such, the transit 
8 
Figure 4. The subependymal neural stem cell niche.23 Slow-dividing astrocyte-like neural stem cells (Type 
B cells) are localized at the center of pinwheel arrangements of ciliated ependymal cells (Type E cells). 
These type B stem cells interact with and receive signals from multiple aspects of the niche including fast-
dividing transit amplifying cells (Type C cells), neuroblasts (Type A cells), specialized basal lamina and 
extracellula r matrix (grey), microglia (Mg), and endothelial cells of the microvasculature (Bv). 23 Figure 
f rom lhrie eta/. 2011. 
amplifying cells largely differentiate into highly motile neuroblasts which travel en masse and 
parallel to the SEZ to ultimately form the rostral migratory stream.48 
Due to its complexity and variety of cellular components, the overarching spatial organization of 
the SEZ had for some time remained ambiguous. In 2008, however, Mirzadeh eta/. employed a 
unique method for whole-mount, en face dissection of the lateral ventricle wall and 
subependymal tissue of the rodent brain.22 This perspective of the intact ventricular surface and 
underlying niche revealed that type B NSCs were localized at the center of pinwheel-shaped 
arrangements of ciliated ependymal cells as shown in Figure 5. They additionally found that the 
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type B cells extended a single, non-functioning cilia into the ventricular space and retained a 
long basal process with specialized endfeet terminating directly on blood vessels. Subsequently, 
these highly extended cells may be capable of receiving information directly from both the 
cerebral spinal fluid and microvasculature.22 
Figure 5. Pinwheel organization on the lateral ventricle surface. 22 lmmunostaining (A) shows 13-catenin at 
the cell borders and punctate y-tubulin at the basal bodies of the cilia . Type B neural stem cells are 
distinguished by the astrocyte marker, glial f ibrillary acidic protein (GFAP). Graphical representation of the 
same field of view (B) in which pinwheel arrangements are highlighted by color-coded ependymal cells 
and Type B stem cells are identified in blue.22 Scale bar, 10 J.lm. Figure from Mirzadeh eta/. 2008. 
Observation of physical proximity provides minimal insight into the functional relationships 
between the various elements of the NSC microenvironment. In fact, all of the components of 
the niche including soluble factors, extracellular matrix, and surrounding cell types may play a 
role in controlling the behavior of the primitive neural stem cell .5.48 In vivo investigations of 
which components are the primary regulators can provide some mechanistic insight. One 
common approach has been infusion of a particular factor of interest into the CSF of the 
ventricles where it is likely to diffuse directly into the subependymal zone. 23 EGF and FGF 
infusion, for example, both lead to an increase in type B cells and reduction of neurogenesis, 
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supporting their role in promoting NSC self-renewal. 52 Knocking down the expression of a 
particular component is another way to study its particular role in the niche. Tenascin C (TNC) is 
an extracellular matrix protein observed at high concentrations in the NSC niche.53 Investigation 
of TNC null mice found that the absence of this glycoprotein lead to delayed expression of EGF 
receptor during development and a shift in NSC differentiation towards the neuronal linage. 53 To 
accurately interpret th is result, however, in vitro stud ies are required since gene knockdown 
rarely affects a singular component of t he complex living system. 
1.3 Approaches in Neural Tissue Engineering 
A method to isolate and individually study cell response to particular components of the niche in 
vitro can significantly aid in understanding the regulators of neural stem cell fate. Ideally, such a 
system would present low intrinsic bioactivity to avoid confounding influence from substrate 
bioactivity. Furthermore it should allow a wide range of modifications in order to mimic the 
physical, soluble, and cellular signals found in vivo. A biomaterial that is additionally suitable for 
implantation would be preferred. Potentially, once in vitro studies have defined the optimal 
scaffold properties, this matrix could be utilized as a delivery mechanism to support implanted 
NSCs for therapeutic applications. 
1.3.1 Biomaterials for Tissue Engineering 
In vitro systems are an ideal way to scale down the complexity of this niche so that the 
significance of individual interactions can be determined.54 Within the literature there are 
several examples where a specific aspect of the niche such as an ECM molecule or soluble factor 
was introduced to NSCs under controlled conditions. 54 These experiments often involve a 
biomaterial substrate in place of t issue culture polystyrene (TCPS), since it can be more easily 
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modified to simulate the natural microenvironment.49 The materials used for in vitro 
experiments may or may not be applicable subsequent, in vivo work. 54 
Biomaterials fall into two basic classes: natural and synthetic.49 Often, natural biomaterials are 
composed of whole ECM proteins isolated from animal tissues.55 These materials can closely 
recreate the complex environment that cells experience within normal tissue, and they are 
typically degradable by cellular proteases allowing cell migration and remodeling.49•54 Common 
examples used in tissue engineering include collagen, Matrigel (reconstituted basement 
membrane), laminin, and fibronectin. 56 Due to difficulties in isolation and purification, however, 
naturally derived materials are frequently expensive and can experience batch to batch 
variability, making results more complicated to interpret.49 The alternative approach attempts 
to incorporate features of the native ECM proteins into a man-made, polymeric constructs.49 
Examples include poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(caprolactone), and 
poly(ethylene glycol).56 With these synthetic materials, the polymer chemistry and mechanical 
properties can be finely tuned and regulated, improving consistency.49 The ECM structures 
presented to the cells can also be more highly controlled, for example a specific cell adhesion 
site can be used instead of the entire fibronectin protein chain.49 A number of methods have 
been developed for the incorporation of bioactivity and are specific to the material being used. 
A final consideration is whether the system will eventually be tested in vivo. If so, 
immunocompatibility and mechanisms for degradation should be essential features. 49'54 
1.3.2 Hydrogel Scaffolds for Neural Tissue Engineering 
Poly(ethylene glycol) or PEG, is a hydrophilic material that may be particularly useful for neural 
tissue engineering both in vitro and in vivo.49'57 When combined with an photoinitiator and 
activating light source, acrylated PEG molecules can be cross-linked into a solid, hydrogel matrix. 
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This process can be controlled such that it is sufficiently mild to allow encapsulation of cells into 
the bulk of the material for three dimensional studies. 58 Fully hydrated, the cross-linked polymer 
is composed primarily of water and has diffusional and mechanical properties close to that of 
soft tissue in the body.59 The material is also FDA approved, highly biocompatible even following 
implantation into the brain57, and a strong inhibitor of nonspecific protein adsorption. 5° 
Well developed chemistries have been established to incorporate bioactivity into PEG 
materials.61'62 A common strategy involves attachment of a bifunctional PEG spacer molecule to 
the free amine or carboxyl group of the peptide or protein to be investigated.61 The other end of 
the PEG spacer is then covalently attached to the surface or throughout the bulk of a PEG 
hydrogel. Figure 6 shows the possibilities for bioactive modification of PEG-based scaffolds. 
---...___., 
PEG diacrylate 
Cell adhesive peptide 
-----
+ photoin itiator 
and activating light 
Growth Factor 
protease-sensitive peptide 
Figure 6. Bioactive modificat ion of poly(ethylene glycol)-based hydrogels. When combined with a 
photoinitiator and activating light, several bioactive molecules can be incorporated in the hydrogel matrix. 
The gelation process is mild such that cells can additionally be included in the liquid polymer solution and 
encapsulated in the bulk of the material. 
In the simplest application of this method, bioactive oligopeptides (sequences known to interact 
with cell surface receptors) are attached to the hydrogel and the response of surface seeded 
cells is evaluated.63 Examples of peptides that have been studied in this way include RGDS, 
YIGSR, and IKVAV.63-65 The chemistry used to attach the PEG spacer can also be performed in 
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aqueous solutions so that proteins can be incorporated without altering their folded 
structure. 61'62 Previous studies have demonstrated immobilization of epidermal growth factor, 
vascular endothelial growth factor, and fibroblast growth factor.66. 68 Since attachment is often 
initiated by exposure to light, these bioactive components can additionally be patterned with a 
photomask into gradients or distinct regions to spatially control cell behavior. 67 
For encapsulated cell studies and in vivo applications, any scaffold used should be able to 
degrade and allow cell migration and organization. One type of degradable hydrogel reported in 
the literature employed a block co-polymer of PEG and hydrolytically sensitive PLA. Primary 
neural tissue was observed to proliferate and migrate when encapsulated within this material as 
shown in Figure 7.58 
A Cell Expansion 
800 
~CS' 600 t:~ 8"t\ 
~~ 400 
~ ~ 200 ~..._ 
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I 
20 
Time (Days) 
Figure 7. NSC culture in three dimensional PEG-PLA hydrogels.58 Proliferation (A) is observed for an 
encapsulation of primary neural tissue. Morphology of the encapsulated cell clusters at 10 days (B) and 14 
days (C) post-encapsulation show spreading and migration of the cells within the synthetic scaffold .58 
Scale ba r, 20 jlm. Figure from Mahoney eta/. 2006. 
A similar chemistry as used for the tethering of adhesive peptides can be adapted to embed a 
peptide sequence in the center of the polymer backbone.69 By specifically selecting sequences 
that are known substrates for cellular proteases, the hydrogel material can be tuned to degrade 
by secreted cellular enzymes such as plasmin or collagenase.69'70 In one published study, it was 
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found that a collagenase sensitive hydrogel modified with the RGD adhesive peptide supported 
self-organization of an angiogenic co-culture {Figure 8).71 Over a period of six days, the co-
encapsulated mural and endothelial cells developed into a primitive vascular plexus with similar 
characteristics as the in vivo microvasculature.71 
Figure 8. Cell-adhesive and collagenase-degradable hydrogel supports organization of co-encapsulated 
smooth muscle progenitors (SMa-actin positive) and endothelial cells (CD31 positive) into a primitive 
vascular network.71 lmmunostaining at day 1 (A) and day 6 (B) shows progression of cellular 
reorganization. Encapsulated cells also secrete extracellular matrix proteins such as laminin (C) within the 
synthetic microenvironment.71 Scale bar, 50 11m. Figure from Moon eta/. 2010. 
Overall the PEG-based hydrogel system is extremely customizable for a variety of applications. 
High biocompatibility coupled with the capacity for precise control over the physical and 
chemical characteristics of the cellular microenvironment make the material valuable for both in 
vitro and in vivo applications. As such, PEG hydrogels have been chosen as the core substrate for 
the research presented herein. 
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1.4 Overview of Thesis 
The neural stem cell niche is a unique environment, specialized for maintaining neural stem cells 
and capable of directing their differentiation. In this thesis work, a modified poly(ethylene 
glycol) hydrogel with specific matrix, soluble, and cellular niche components independently 
incorporated was studied in vitro to determine the influence of these factors on cell fate under 
permissive (growth) as well as differentiating media conditions. This artificial niche was 
furthermore synthesized in the form of injectable hydrogel microspheres and demonstrated to 
support therapeutic delivery of encapsulated NSCs in a rodent model of ischemic stroke. 
Influence of the ECM: It has been reported that a unique arrangement of basal lamina exists in 
the subependymal zone and may play a role in controlling stem cell behavior. To investigate this 
hypothesis, cell-adhesive peptides from fibronectin were studied within a PEG hydrogel system 
for their effect on the behavior of a human neural stem cell line. Specifically, the ability of the 
material to support attachment, spreading, and proliferation of undifferentiated neural stem 
cells was first demonstrated and found to be comparable to standard culture on laminin coated 
TCPS. The influence of the synthetic matrix on NSC lineage commitment was additionally 
evaluated under differentiating conditions by flow cytometry of the resulting cell populations. 
Finally, both growth and differentiated cell phenotype was characterized within the 3D hydrogel 
microenvironment. 
Influence of Soluble Factors: Growth factors are well known to influence stem cell behavior 
and are commonly used in the isolation and expansion of primary neural stem cells. The 
hydrogel environment was demonstrated here as a platform for presenting immobilized growth 
factors to surface seeded NSCs. Two factors in particular, FGF-2 and NGF, were chosen for their 
contrasting effects on proliferation and differentiation. Successful PEG conjugation was 
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determined for both factors by western blot analysis and the effect of the PEG linkage on 
bioactivity was assessed. Finally, the PEG-FGF and PEG-NGF conjugates were shown to influence 
NSC proliferation and neuronal differentiation respectively when immobilized within the bulk of 
a hydrogel matrix. 
Influence on the Microvasculature: In vivo, neural stem cells directly contact the 
microvasculature though the specialized endfeet on their extended basal process. It is theorized 
that signaling between NSCs and endothelial cells coordinates both angiogenesis and 
neurogenesis within the niche. The bioactive hydrogel was used as a platform to observe the 
angiogenic potential of neural stem cells in an in vivo cornea micropocket assay as well as in 
vitro through co-culture with brain microvascular endothelial cells. Cells were observed to 
stimulate an angiogenic response in vivo, and furthermore promoted close interaction and self-
organization within an endothelial co-culture system. 
Microencapsulation and In Vivo Delivery: Neural stem cell delivery to treat brain injury or 
neurodegenerative disease is a promising new therapeutic approach that has already 
progressed into clinical trials. Significant room for improvement still exists, however, as cell 
survival following implantation is often poor. It is theorized that encapsulation of the cell 
therapy within a protective and supportive matrix will improve cell viability, persistence, and 
ultimately the therapeutic effect. A novel method was developed to synthesize hydrogels in an 
injectable microsphere form. Several parameters of this technique were optimized to improve 
particle gelation, yield, and size distribution and to maintain compatibility of the 
microencapsulation protocol across multiple cell lines. Finally, the constructs were 
demonstrated to support long-term in vitro culture as well as successful in vivo delivery of 
encapsulated neural stem cells. 
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2 ECM Mimetic Scaffold for Investigation of NSC Behavior In Vitro 
2.1 Introduction 
2.1.1 Extracellular Matrix Interactions in the NSC Niche 
The extracellular matrix {ECM) most notably forms a structural scaffold to physically support the 
cells that make up a tissue.72 These molecules, however, also provide attachment points for 
cells, sequester growth factors and cytokines, and transmit mechanical signals.48•72 Cellular 
attachment to the ECM often occurs through integrin binding.48'73 Far from a passive 
attachment, these integrins are connected to the cytoskeleton within the cell and can trigger 
intercellular signaling cascades leading to changes in cell behavior such as promotion of cell 
survival or increased proliferation.48'73 lntegrins are dimeric transmembrane proteins formed 
from a combination of alpha and beta subunits.73 As shown in Figure 9, different ECM molecules 
can have binding sites that are specific for particular subunit pairs, and can lead to unique 
downstream signaling 
effects within the cell.73 
The composition and 
arrangement of ECM in 
a region of tissue could 
therefore play a direct 
role in influencing cell 
behavior.48'72.73 
FIBRONECTIN MATRIX 
Figure 9. lntegrin adhesion to the extracellular matrix.73 Cell attachment to ECM 
molecules such as laminin or fibronectin occurs through integrins. Specificity of 
cell attachment and response is achieved by unique binding site affinity for 
different integrin subunit pairings.73 Figure adapted from Yamada eta/. 2001. 
Within the SEZ of both humans and rodents, a particularly unique arrangement of the ECM has 
been observed to be intimately associated with the neural stem cells.48'72'74 In most tissues, the 
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basal lamina is a thin, two dimensional sheet of specialized ECM that wraps around blood 
vessels or lines the back of epithelial cell layers. 51 Basement membranes are known to play a key 
role during development by affecting cell proliferation, polarization, and morphogenesis.72 In 
contrast to the normal arrangement, the basal lamina of the SEZ microvasculature extends out 
past the capillary tips, ending in clusters just beneath the ependymal cell layer.48•51 Referred to 
as a fractone, this extravascular basal lamina has a highly branched, three dimensional structure 
and therefore connects between many different cell types in the vicinity.51'74 Figure 10 provides 
a graphical representation of the typical fractone arrangement in the SEZ.51 
A single fractone starts from a perivascular macrophage and may interact with several NSCs, 
transit amplifying cells, and macrophages before reaching the ependymal layer.51 It is made up 
of many classic basal lamina components such as laminin ~1 and y1, collagen I and IV, nidogen, 
and perlecan.51'74 A more unusual ECM 
component associated with some of the 
fractones is N-sulfate heparin su lfate 
proteoglycan (N-sulfate HSPG), which was 
shown by Kerever et a/. to sequester and 
activate growth factors, in particular basic 
f ibroblast growth factor, or FGF-2.74 Taken 
together, observations of the unique 
composition and arrangement of the ECM in 
the niche as well as the close association of 
the NSCs with these structures suggest a key 
role for ECM in directing NSC behavior.48•51 
perivascular 
macrophages 
• fibroblasts 
capillary 
SEZ 
Figure 10. Fractone structure in the NSC niche.51 Basa l 
lamina in the subependymal zone is arranged in a 
unique branching structure referred to as a fractone 
(shown in purple).51 Figure from Mercier eta/. 2002. 
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2.1.2 Investigating ECM Interactions In Hydrogel Scaffolds 
Both synthetic and natural biomaterials have been used in conjunction with neural stem cells.54 
Thornhoff et a/. investigated multiple commercially available products including Matrigel and 
PuraMatrix (peptide-based hydrogel), and found that they had different effects on NSC 
proliferation, migration, and differentiation.55 A more specialized collagen/hyaluronan matrix 
was shown by Brannville et a/. to allow thermoresponsive encapsulation and 3D culture of 
NSCs.75 Recently, a laminin-functionalized PuraMatrix was shown to allow improved 3D growth 
and differentiation of a human neural progenitor line.76 All of these materials, however, can be 
relatively expensive to generate. These studies are also difficult to interpret due to intrinsic and 
variable bioactivity from the scaffold proteins.49 
Within the literature the use of synthetic materials appears to be more common and to provide 
greater versatility. One study compared common polymers used for tissue engineering including 
poly(lactic-co-glycolic acid), poly(L-Iactide-co-E-caprolactone), and poly(L-Iactic acid) and 
concluded that there were significant differences in proliferation and neuronal differentiation of 
an embryonic rat hippocampal stem cell line, designated HiB5.77 The variation in cell response 
was attributed to differences in protein adsorption on the surface of the three scaffolds.77 In a 
separate study, a unique synthetic material developed primarily for in vitro work involved a 
biomimetic, interfacial interpenetrating network of polymers (IPN).78 The interpenetrating 
network was used to immobilize peptides containing known, cell-adhesive sequences (RGD 
sequence from fibronectin or IKVAV sequence from laminin) at varying concentrations. Their 
results showed that only RGD supported attachment and survival of primary adult hippocampal 
neural stem cells.78 Other groups, in contrast, have shown that laminin derived peptides such as 
IKVAV can actually promote neuronal attachment and differentiation, for example when 
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covalently linked to a PEG hydrogel surface (Figure 11}.65•79 For this work by Ranieri et at., 
however, a more committed neural progenitor 
line, PC-12, was used. The conflicting data on NSC 
adhesion to these materials indicates that we are 
only beginning to understand the interactions 
between NSCs and their physical environment. 
Significant work remains to identify appropriate 
platforms for studying the cellular response 
across a variety of experimental conditions. 
Figure 11. Neural progenitor cell adhesion to IKVAV-
modified hydrogels.65 Phase contrast image shows 
attachment and neurite extension of PC-12 cells. 
Figure from Gunn eta/. 2005. 
In some cases, conflicting cell behavior may be caused by differences in the cell type or cell line 
used in the research . Primary cells can be particularly variable due to the lack of standard 
harvesting techniques. Cell lines can provide greater homogeneity, however may not be as 
representative of in vivo cell behavior. The human neural stem cell line CTXOE03, was developed 
for therapeutic implantation to treat ischemic stroke in humans.80 As such, this cell line is 
clinically relevant, provides a readily expandable and homogeneous source for in vitro studies, 
and has no known tendencies for tumor formation in vivo. 35 Furthermore, the cell line is 
conditionally immortalized with the c-mycERTAM transgene to allow undifferentiated expansion 
in the presence of the synthetic drug, 4-hydroxy-tamoxifen (4-0HT} and rapid activation of 
differentiation pathways on implantat ion or removal of 4-0HT from the media.80 The 
combination of clinical relevance and standard expansion I differentiation protocols make the 
CTXOE03 cell line an excellent model to study the mechanisms regulating neural stem cell 
proliferation and differentiation. For these reasons, CTXOE03 has been chosen as the primary 
cell line for developing and testing the synthetic hydrogel scaffold presented herein. 
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2.3 Materials and Methods 
All materials were purchased from Sigma unless otherwise noted. 
2.3.1 Cell Culture 
Conditionally immortalized human cortical neural stem cells (CTXOE03 line, passage 10 to 
)80 86 87 f . 20 · · were generously donated rom the lab of Dr. Jack Pnce. The cells were cultured on 
laminin coated TCPS flasks, which were prepared by applying 0.07 ml per cm2 of a 20 ~ml 
solution of laminin in Hank's balanced salt solution (HBSS, Invitrogen) to the surface for 4 h at 
room temperature (RT). Cells were cultured a 1:1 mixture of Dulbecco's Modified Eagle's 
Medium and Ham's F12 (DMEM/F12, Invitrogen) supplemented with 0.03% human albumin 
(SeraCare), 100 ~ml ape-transferrin, 16.2 ~ml putrescine dihydrochloride, 5 jlg/ml 
recombinant human insulin, 60 ng/ml progesterone, 2 mM L-Giutamine, 40 ng/ml sodium 
selenite, 10 ng/ml human basic fibroblast growth factor (FGF, Peprotech), 20 ng/ml epidermal 
growth factor (EGF, Peprotech), and 100 nM 4-hydroxy-tamoxifen (4-0HT). The cells were 
incubated at 37 oc in a 5% C02 environment and passaged 1: 8 every 5 to 7 days with Accutase 
solution. For select studies, spontaneous differentiation along neural and glial lineages was 
induced by culturing cells in media lacking FGF, EGF, and 4-0HT. 
2.3.2 Characterization of Cellular lntegrin Expression 
lntegrin expression by the neural stem cells was evaluated with an a/~ lntegrin-Mediated Cell 
Adhesion Array Kit (Millipore) using manufacturer's protocol. Briefly, microwell strips from the 
alpha integrin array plate (containing immobilized antibodies against a 1, a2, a 3, ~. a 5, av, and 
av~3) and from the beta integrin array plate (containing immobilized antibodies against ~11 ~2, ~3, 
~4, ~6, av~5, and a5~1) were soaked in HBSS at RT for 1 h to rehydrate. CTXOE03 cells were 
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Although the CTXOE03 cell line is expanded on laminin coated surfaces, previous investigations 
of laminin derived peptide sequences such as YIGSR and IKVAV have reported inconsistent 
responses from the different neural progenitor sources.65•78'79 Only the fibronectin-derived RGD 
peptide sequence has been found to consistently promote neural stem cell adhesion on 
synthetic substrates.65'78'81'82 The RGD motif is arguably one of the most ubiquitous and well 
characterized adhesive peptide sequences and may be bound by a number of integrin pairs 
including avl33, avl3s, and a 5j31.83 For this work a linear RGD- containing peptide, RGDS, was 
investigated in addition to a cyclicized RGD peptide, c(RGDfK), which has been reported to 
present a more natural conformation, have greater integrin binding strength and specificity, 
and to be more resistant to proteolysis (30-fold more stable at pH 7.0).84•85 
2.2 Objectives 
Current platforms for investigation of neural stem cells have primarily been limited to 2D studies 
on modified surfaces such as TCPS, or 3D studies within complex and difficult to control 
naturally-derived matrices. In order to begin to isolate the effects of the physical environment 
on stem cell fate, a highly controlled substrate with potential for both 2D and 3D investigations 
is needed. For this work, a tunable PEG-based scaffold is proposed as a superior platform for 
studying CTXOE03 cell behavior in vitro. Cell adhesion and spreading on the scaffold was 
evaluated for hydrogels modified with the well characterized RGD motif in both a linear and 
cyclic form. Furthermore, cell behavior under growth and differentiating conditions was 
compared between laminin-coated TCPS and the synthetic scaffold. Finally, these investigations 
were repeated under more biomimetic, 3D encapsulation conditions using a matrix 
metalloproteinase (MMP)-degradable polymer scaffold. 
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passaged with Versene chelating solution (Invitrogen) and seeded at 2x105 cells/cm2 on the 
assay plate. After 16 h incubation, the cells were rinsed with phosphate buffered saline (PBS, 
Cellgro) and stained with the provided crystal violet cell stain solution for 10 min at RT. After 
two additional PBS rinses, wells were allowed to air dry before addition of 100 Ill/well of the 
provided extraction buffer. Gentle rocking of the samples at RT in the extraction buffer was 
conducted for 10 minutes to allow complete disruption of the cells and dissolut,ion of the crystal 
violet stain. Sample absorbance was read at 570 nm on a microplate reader (Bio-Tek Elx800) 
and compared to negative control wells with immobilized anti-mouse lgG. 
2.3.3 Synthesis of Poly( ethylene glycol) Diacrylate 
Poly(ethylene glycol) diacrylate (PEGDA) was synthesized by reacting 10 kDa PEG with 3 molar 
excess of acryloyl chloride and 1 molar excess triethylamine (TEA) in anhydrous 
dichloromethane (DCM) under argon overnight. The reacted mixture was transferred to a 
separatory funnel where 2 M K2C03 was added at a 5 molar excess to the PEG (Figure 12). After 
mixing well, the solution was allowed to separate and the organic phase was collected, dried 
with magnesium sulfate and filtered. The final, clear liquid was precipitated in cold diethyl ether, 
filtered, and dried under vacuum. 
0 
+2 II 1.TEA. DCM 
Cl~ 2.K~C03 
PEG Acryloyl Chloride PEGDA 
Figure 12. Chemical synthesis of poly( ethylene glycol) diacrylate by reaction of poly( ethylene glycol) with 
acryloyl chloride in DCM. Acrylate end groups permit crosslinking of a liquid PEGDA solution of into a solid 
hydrogel matrix in the presence of photoinitiator and activating light. 
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2.3.4 Synthesis of PEG-peptide Conjugates 
Monoacrylate PEG-peptide conjugates were synthesized by reacting acrylate-PEG-succinimidyl 
carboxymethyl (acrylate-PEG-SCM MW 3400 Da, laysan Bio) with a 0.2 molar excess of peptide 
and a 1 molar excess N,N-diisopropylethylamine (DIPEA) in anhydrous dimethyl sulfoxide 
(DMSO) on a rocker plate at RT overnight. The reacted mixture was then dialyzed to remove 
unreacted peptide, lyophilized, and characterized by gel permeation chromatography (GPC, 
Varian Inc.). Peptide sequences investigated here include linear RGDS (American Peptide), a 
lysine-containing, cyclic form of RGD (c(RGDfK), Creative Peptide), and a tryptophan containing 
RGD peptide, GGGWGGRGDS (referred to as WRGDS), which was synthesized by Melissa McHale 
with a solid phase peptide synthesizer (Aapptec) using standard Fmoc chemistry. See Figure 13 
for a diagram of the reaction scheme. 
NH2 I 
c(RGDfK)-COOH 
or 
NHrRGDS-COOH 
vr 
Monoacrylate-PEG-succinimidyl 
carboxymethyl (SCM) 
r•H2-GGGWGGRGDS-cooH 
peptide 
~peptide 
Figure 13. Chemical synthesis of PEG-peptide conjugates. Reaction of PEG-SCM with the primary amine of 
a cell adhesive peptide forms an acryi-PEG-peptide conjugate that can be covalently linked to the 
hydrogel matrix. Cyclic, linear, and tryptophan-containing RGD motifs were prepared for investigation 
within the hydrogel. 
2.3.5 Synthesis of Degradable PEG-PQ-PEG 
The MMP-sensitive peptide GGGPQGIWGQGK (abbreviated as PQ)68'71'88 was similarly 
synthesized with a solid phase peptide synthesizer (Aapptec) using standard Fmoc chemistry. 
The product was analyzed with matrix-assisted laser desorption ionization time-of-flight mass 
spectrometry (MAlDI-ToF, Bruker Daltonics). Enzyme degradable PEG-PQ-PEG was synthesized 
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by reacting PQ peptide with a 1 molar excess of acrylate-PEG-SCM and a 3 molar excess DIPEA in 
anhydrous DMSO on a rocker plate at RT overnight. The product was then dialyzed, lyophilized, 
and characterized by GPC to determine coupling efficiency. 
2.3.6 Characterization of PEG-PQ-PEG Enzymatic Degradation 
Sensitivity of the PEG-PQ-PEG hydrogel material to enzyme-mediated degradation was 
determined by exposing cross-linked gels to a collagenase containing buffer. Since the PQ 
peptide contains a tryptophan in the sequence, the degradation of a hydrogel can be monitored 
by measuring the tryptophan absorbance peak (280 nm) in the surrounding solution over time.71 
To produce the gels, a hydrogel precursor solution was formed by mixing 10% by weight PEG-
PQ-PEG or 10 kDa PEGDA in 10 mM HEPES buffered saline (HBS, pH 8.5) containing 3.4 lll/ml N-
vinylpyrrolidone (NVP), 10 llM eosin Y photoinitiator, and 1.5% v/v triethanolamine (TEOA, Fluka 
BioChemika). The polymer solution was then sterilized via filtration through a 0.2 j..lm membrane 
(Whatman). Droplets of this precursor solution (5 Ill volume) were pipetted into the bottom of 
ethanol sterilized 200 Ill cuvettes, cross-linked by exposure to 60 s of white light (Fiber-Lite, 
Dolan Jenner), and then incubated in 200 Ill sterile degradation buffer (PBS containing 3.6 mM 
CaCh and 0.2 mg/ml NaN3, pH 7.4) overnight. The solution was then exchanged with 200 Ill fresh 
degradation buffer with or without 100 j..lg/ml collagenase (~125 CDU/mg, Type IV from 
Clostridium histolyticum) and absorbance measurements at 280 nm were taken between 0 and 
72 h with a UV spectrophotometer (Carey 5000, Varian). Degradation buffer without collagenase 
or hydrogel was used as reference blank. 
2.3.7 Formation of Coverglass-lmmobilized hydrogels 
Hydrogels were formed as disks immobilized against acrylated glass coverslips to improve 
handling of the constructs and to stabilize the gel at the bottom of the well plate during surface 
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seeding of cells. First, 12 mm diameter glass coverslips (TedPella) were cleaned with piranha 
solution (3:1 ratio of sulfuric acid and hydrogen peroxide, 30% soln.) for 2 hat RT. The glass was 
rinsed with MilliQ H20 and then incubated for 3 days in acrylating solution (2% w/v 
trimethylsilylpropyl acrylate (TMPSA) in 95% Ethanol, pH 4.5) on a rocker at RT. Finally the slides 
were cleaned with 95% ethanol and baked overnight at 100 oc. To produce the gel disks, a 
hydrogel precursor solution was formed by mixing 10% by weight PEGDA in 10 mM HBS 
containing 3.4 ~1/ml NVP, 10 ~M eosin Y photoinitiator, and 1.5% v/v TEOA. A 10 ~I volume of 
precursor solution was placed between an acrylated coverslip and clean glass slide separated by 
380 ~m thick polydimethylsiloxane (PDMS) spacers before crosslinking by exposure to white 
light (Fiber-lite 180 Illuminator) for 1 min. Handling only the coverglass portion with tweezers, 
the immobilized gels were transferred to a 24 well plate and soaked in 1 ml HBSS for a minimum 
of 24 h prior to cell seeding. A complete diagram of this process is provided in Figure 14. 
Acrylated glass coverslip 
380 ~1111 PDMS spacer ..{). light 
Glass Slide 
~ 
S-10 pl dt Oi>let 
Figure 14. Technique for generating coverglass-immobilized hydrogels. Droplet of polymer precursor 
solution is sandwiched between acrylated coverslip and glass slide before crosslinking as a hydrogel disk. 
2.3.8 Characterization of PEG-peptide Incorporation 
The tryptophan-containing peptide, WRGDS, was used to evaluate incorporation efficiency in 
crosslinked hydrogels. Sterile 10% hydrogel precursor solution (10% 10 kDa PEGDA in HBS with 
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1.5% TEOA, 3.4 Jll/ml NVP, and 10 JlM eosin Y) was prepared both with and without 3 mM PEG-
WRGDS. The UV absorbance at 280 nm was evaluated for these solutions and compared to a 
serial dilution of PEG-WRGDS (0.0156 to 0.5 mM in HBS with 1.5% TEOA). Disk-shaped hydrogels 
(10 Jll volume) were then formed with 35 s or 1 min exposure as described in section 2.3.7 with 
the exception that a non-acrylated coverslip was used. The gels were transferred to a 24 well 
plate and soaked in HBSS with 1.5% TEOA for 48 h. At 24 and 48 h, 500 Jll of soak solution was 
temporarily removed and absorbance read at 280 nm with a UV spectrophotometer. 
Additionally at the 48 h time point, the gels were removed, dried of excess moisture, and placed 
on a quartz coverglass (TedPella) for direct measurement of 280 nm absorbance in the UV 
spectrophotometer. Finally, each gel was manually sectioned and imaged on a dissecting scope 
affixed with a ProgRes C5 CCD camera to determine thickness and final volume. 
2.3.9 Investigation of NSC Adhesion and Spreading 
Neural stem cell adhesion to the hydrogel matrix was investigated by seeding cells on the 
surface of immobilized hydrogel disks. Polymer precursor solution was prepared as 10% 10 kDa 
PEGDA in HBS with 1.5% TEOA, 3.4 Jll/ml NVP, and 10 JlM eosin Y. Linear PEG-RGDS or cyclic 
PEG-c(RGDfK) were added to separate aliquots of the precursor solution and serially diluted to 
create a range of concentrations from 0.375 to 6 mM. The solutions were filter-sterilized and 
used to prepare immobilized 380 Jlm thick, 10 Jll volume disk gels with three gels per test 
condition as described in section 2.3.7. Coverglass with attached hydrogel was placed in a 24-
well plate and soaked at RT for 24 h in 1 ml of HBSS. CTXOE03 cells were then passaged with 
Accutase and seeded at 10,000 cells/cm2 in complete growth media. After 16 h incubation, 
samples were visualized with nuclear and actin staining. Briefly, the cells were fixed for 1 h in 4% 
paraformaldehyde (PFA), permeabilized for 15 min with 0.5% Triton X-100, blocked overnight at 
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4 oc with 5% bovine serum albumin (BSA), and finally stained for 2 h in PBS with 5 U/ml 
rhodamine-phalloidin (Invitrogen) and 2 J.lM DAPI to label actin and nuclei respectively. All steps 
were performed at RT (unless otherwise noted) with reagents diluted in PBS and three PBS 
rinses following each step. Finally, the samples were imaged by phase contrast and fluorescence 
microscopy (Zeiss Axiovert 135) and analyzed in lmageJ (NIH) to quantify cell adhesion (count of 
DAPI positive nuclei per cm2) and cell spreading (actin signal area divided by cell number based 
on DAPI count). To identify the lower limit of cell adhesion and spreading on the cyclic RGD 
modified surface, the study was repeated in a similar manner with 0.003 to 0.3 mM PEG-
c(RGDfK) and with an incubation time of 3 h. 
A final study was performed to identify the integrins primarily involved in NSC interaction with 
the c(RGDfK) modified hydrogel. Immobilized hydrogel disks (10% 10 kDa PEGDA with 0.3 mM 
PEG-c(RGDfK)) were prepared as described in section 2.3.7. Cells were passaged with Versene to 
preserve surface integrins and resuspended in media at approximately 5x104 cells/mi. Cells were 
then incubated for 40 min at RT with either av~3 integrin blocking antibody (1:100, Millipore), ~1 
integrin blocking antibody (1:100, Millipore), or no blocking antibody and seeded onto the 
hydrogels at 20,000 cells/cm2• After 4 h, all samples were fixed and stained with DAPI and 
rhodamine-phalloidin. 
2.3.10 Hydrogel substrates for Expansion of NSCs 
CyQyuant Proliferation Assay: Neural stem cell behavior was first compared between the 
hydrogel and laminin-coated TCPS under non-differentiating culture conditions. To assay rate of 
proliferation, hydrogel disks containing 0.3 mM PEG-c(RGDfK) were prepared as described in 
section 2.3.7 with non-acrylated coverglass. After swelling for 24 h in HBSS, 6 mm diameter 
punches were made from the disks and transferred to the wells of a 96 well plate. Other wells 
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for TCPS conditions and standard curve generation were coated with laminin as described in 
section 2.3.1. Cells were passaged and seeded at 10,000 cells/cm2 for test conditions or at o to 
100,000 cells/cm2 for a standard curve. After allowing cells to adhere for 12 h, the 0 time point 
(with standard curve) was acquired by aspirating the media and storing the dry samples at -80 
°C. Remaining samples were similarly collected at 24, 48, and 72 h time points with a minimum 
of 4 samples per condition and per time point. After all samples had been collected, cell number 
was determined with the CyQuant Cell Proliferation Assay (Invitrogen) according to 
manufacturer's instructions. In this assay, the CyQuant GR dye becomes highly fluorescent upon 
binding to cellular DNA. Briefly, the provided cell-lysis buffer stock solution was diluted 20-fold 
in MilliQ water and supplemented with CyQuant GR dye at 400-fold dilution to produce 1X 
working solution. To each well of the thawed samples, 200 Jll of working solution was added and 
allowed to incubate for 10 min with gentle rocking protected from light. Finally, 180 J.J.I from 
each well was transferred to a black-bottom 96-well plate and read on a fluorescent microplate 
reader (SPEX Fluorolog-3 Spectrofluorometer) with excitation set at 480 nm and emission set at 
520 nm. 
Ki-67 Expression Analysis: Proliferative response to growth conditions was also assayed via 
immunohistochemical staining of cellular markers. Cells were seeded at 10,000 cells/cm2 on 
immobilized hydrogel disks or laminin-coated TCPS and cultured for 3 days. A standard protocol 
for immunostaining was used for all samples. The cells were fixed for 1 h in 4% PFA, 
permeabilized for 15 min with 0.5% Triton X-100, and blocked overnight at 4°C with 5% BSA. 
Primary antibodies were added in PBS containing 0.5% BSA and incubated overnight at 4 oc 
followed by 4, 1 h PBS rinses at RT. Secondary antibodies (Alexa Fluor conjugated, Invitrogen) 
were all used at 1:500 dilution and incubated on the sample at 4°C overnight in PBS with 0.5% 
30 
BSA. Finally, samples were rinsed with PBS and stained for 1 h at RT in 2 ~M DAPI working 
solution. To quantify actively proliferating cells, samples were stained according to protocol with 
rabbit anti Ki-67 primary antibody (1:200, Vector Labs) and donkey anti-rabbit AlexaFiuor 488 
secondary antibody. Images were quantified in lmageJ by determining percent of total DAPI 
positive nuclei that were positive for the Ki-67 marker. 
Undifferentiated NSC Marker Analysis: Recognized markers for undifferentiated neural stem 
cells (nestin and SOX2) were also assessed to determine if the hydrogel-cultured cells retained 
their proper NSC phenotype. Samples were stained with rabbit anti-nestin (1:200, Sigma) and 
mouse anti-SOX2 (1:200, R&D Systems) primary antibodies in combination with donkey anti-
rabbit Alexa Fluor 488 and donkey anti-mouse Alexa Fluor SSS secondary antibodies (1:SOO, 
Invitrogen). Images were acquired by fluorescence microscopy (Zeiss Axiovert 13S) or confocal 
microscopy (Zeiss LiveS DuoScan) and analyzed in lmageJ to determine percent of nestin and 
SOX2 positive cells relative to DAPI positive nuclei count. 
2.3.11 Hydrogel Substrates for the Study of NSC Differentiation 
To determine if the substrate on which the CTXOE03 cells were cultured would affect lineage 
specification, cells were seeded at 40,000 cells/cm2 on 0.3 mM PEG-c(RGDfK) modified hydrogel 
disks or laminin-coated TCPS controls in differentiating media lacking EGF, bFGF, and 4-0HT. 
After 2 weeks in culture, the cells were fixed and immunostained for lineage markers according 
to the protocol in section 2.3.10. Rabbit anti-~111 Tubulin (1:1000, Abeam) and mouse anti-GFAP 
(1:200, Invitrogen) primary antibodies were used to label neuronal and glial lineage committed 
cells respectively. Secondary antibodies used included donkey anti-rabbit Alexa Fluor 488 and 
anti-mouse Alexa Fluor SSS. Samples were imaged by fluorescence (Zeiss Axiovert 13S) and 
confocal (Zeiss LiveS DuoScan) microscopy. 
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2.3.12 Analysis of Encapsulated Cell Viability 
In preparation for 3D encapsulation studies, the effect of encapsulation conditions on neural 
stem cell viability was determined. First, a hydrogel precursor solution was prepared as 5% 10 
kDa PEGDA in HBS with 1.5% TEOA, 3.4 ~1/ml NVP, and 10 ~M eosin Y and filter-sterilized 
through a 0.2 ~m filter. CTXOE03 cells were passaged, counted by hemacytometer, pelleted at 
600 xg, and resuspended in the polymer solution at 10x106 cells/mi. Cells were encapsulated 
within immobilized hydrogel disks of 10 ~I volume with 35, 45, or 60 s exposure to crosslinking 
light. A control group of cells that had been resuspended in polymer solution but not crosslinked 
was also generated. Gels and control cells were transferred to a 24 well plate and incubated at 
37 oc in 1 ml growth media for 2 h prior to staining. To observe viability and distribution of 
encapsulated cells, samples were incubated for 30 min at RT in PBS containing 2 ~M calcein AM 
and 4 ~M ethidium homodimer (Live/Dead Kit, Invitrogen) and imaged by fluorescence 
microscopy (Zeiss Axiovert 135). Calcein AM exhibits green fluorescence when metabolized 
within living cells. Ethidium homodimer penetrates the compromised cell membrane of dead 
cells and fluoresces red upon binding to cellular DNA. Three gels were generated for each set of 
conditions and images were analyzed in lmageJ to quantify viable cells as a percent of total. 
2.3.13 NSC Encapsulation and Three Dimensional Culture 
Neural stem cell response to growth and differentiating conditions was additionally evaluated 
for three dimensional encapsulated cultures. Polymer solution was prepared with degradable 
PEG-PQ-PEG in place of PEGDA (5% PEG-PQ-PEG in HBS with 0.3 mM PEG-c(RGDfK), 1.5% TEOA, 
3.4 ~1/ml NVP, and 5 ~M eosin Y) and filter-sterilized through a 0.2 ~m filter. CTXOE03 cells were 
passaged, counted by hemacytometer, pelleted at 600 xg, and resuspended in the polymer 
solution at 30x106 cells/mi. Immobilized hydrogels with the encapsulated cells (5 ~I volume 
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each) were prepared as described in section 2.3.7 with a 60s exposure to white light. Gels were 
transferred to a 24 well plate and incubated in 1 ml growth or differentiation media. After 1 
week for growth or 2 weeks for differentiating conditions, gels were fixed for 1 h in 4% PFA and 
immunostained against phenotypic markers: SOX2 and nestin for growth condition gels or 13111 
Tubulin and GFAP for differentiated samples) according to the same protocol as described for 
surface seeded cultures (section 2.3.10). Samples were then imaged by confocal microscopy 
(Zeiss LiveS DuoScan). 
2.3.14 Flow Cytometry for Analysis of Cellular Populations 
Flow cytometry was used to characterize cell populations under growth, differentiating, and 
encapsulated conditions. For growth conditions on TCPS, CTXOE03 cells were seeded at 20,000 
cells/cm2 and grown for 1 week on laminin-coated TCPS with complete growth media. For 
differentiating conditions on TCPS, cells were seeded at 40,000 cells/cm2 and cultured for 2 
weeks on laminin-coated TCPS with differentiation media lacking FGF, EGF, and 4-0HT. For 
surface-seeded samples, 25 mm diameter hydrogel disks were prepared from sterile-filtered 
polymer precursor solution (10% 10 kDa PEGDA in HBS with 0.3 mM PEG-c(RGDfK), 1.5% TEOA, 
3.4 lll/ml NVP, and 10 11M eosin Y) using a slightly modified protocol from section 2.3.7 in which 
25 mm diameter coverglass and a 200 Ill volume per gel disk was used in place of 12 mm 
diameter coverglass and 10 Ill volume. Similar to the TCPS samples, cells were seeded at 20,000 
cells/cm2 for growth conditions or 40,000 cells/cm2 for differentiating conditions on the gels in 
6-well plates and cultured for either 1 week in growth media or 2 weeks in differentiating 
media. For encapsulated cultures, cells were resuspended at 30x106 cells/ml in 5% PEG-PQ-PEG 
with 0.3 mM PEG-c(RGDfK), encapsulated in immobilized hydrogels (protocol in section 2.3.7), 
and cultured for either 1 week in growth media or 2 weeks in differentiating media. To collect 
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samples for flow cytometry, cells were dissociated in Accutase solution (supplemented with 0.25 
j.!g/ml proteinase K for encapsulated samples) for 30 min at 37 oc, rinsed two times with sterile 
PBS, fixed for 20 min at RT in 4% PFA, rinsed twice with sterile PBS, and finally resuspended at 
106 cells/ml in ice cold 90% MeOH for storage at -20 °C. On the day of FACS analysis, samples 
were rinsed two times in staining buffer (sterile-filtered PBS with 1% BSA and 0.1% sodium 
azide) and labeled for 1 h at RT in staining buffer with 1:20 dilution of fluorescently-tagged 
primary antibiodies (mouse anti-class Ill 13 Tubulin - Alexa Fluor 488, mouse anti-nestin - PE, 
mouse anti-SOX2 - PerCP-Cy5.5, mouse anti-GFAP - Alexa Fluor 647; BO Biosciences). Finally, 
samples were rinsed twice in staining buffer and analyzed with a BO FACSCanto II Flow 
Cytometer with compensation controls established using BO Anti-Mouse lgG CompBeads (BO 
Biosciences) according to manufacturer's protocol and voltage gating established with unstained 
cell controls. All analysis of flow cytometry data was performed using FlowJo software. 
2.3.15 Statistical Analysis 
Significance was determined via unpaired, two-tailed t-test when p < 0.05. Error bars in figures 
depict standard deviations for the data sets. 
2.4 Results and Discussion 
In the field of neural tissue engineering, there exists a need for a universal platform to 
investigate the regulation of neural stem cell fate in vitro. The CTXOE03 human neural stem cell 
line is utilized here to demonstrate the versatility of the bioactive, PEG-based hydrogel scaffold. 
Cell interaction with the matrix was evaluated both in surface seeded, 20 cultures and with 
encapsulated cultures to study behavior in a 30 microenvironment. 
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2.4.1 lntegrin Presentation by Human Neural Stem Cells 
As described above, cells form adhesions with the surrounding extracellular matrix primarily via 
integrin binding to specific ligand sites. By identifying which integrins are highly expressed by a 
cell population, one could potentially predict which substrates will promote adhesion and 
therefore should be considered in the design of an artificial culture environment. An initial 
characterization of integrin expression by the human neural stem cell line, CTXOE03, was 
performed through the use of a commercially available integrin profiling assay. For this 
technique, the cells were first dissociated with a non-enzymatic chelating solution to preserve 
intact integrins on the cell surface. The cell suspension was seeded into hydrated microwells 
containing immobilized antibodies against specific integrin subunits or integrin pairs. After 
allowing cells to settle and interact with the antibody-coated surface, unbound cells were 
washed away and the remaining quantified in an absorbance-based assay. In contrast to 
western blot or PCR based techniques, this approach provides rapid screening of integrins that 
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Although a comprehensive analysis of neural stem cell integrins has not been reported in the 
literature, several studies have evaluated mRNA or protein expression for particular integrins of 
interest. A review of the literature found that the results presented here generally agree with 
published findings. In particular, primary human neural stem cells have been characterized by 
low a11 l33, and 13s integrin expression, and positive expression of integrins a 2, a3, as, aw 134, and 
13s.89'90 High expression of 131 integrin has been repeatedly observed for neural stem cell 
populations and even been used as a marker to sort neural progenitors from primary brain 
tissue.89'91.94 One contradiction between the integrin array data and published findings, 
however, was the presence of ~ and 132 integrins.89 It is possible that the conditionally 
immortalized cell line differs from primary neural stem cells in this respect. 
From these results, one can see that the CTXOE03 line displays a variety of surface integrins and 
may be capable of adhering to a wide array of substrates. Although the cell line is expanded on 
laminin-coated TCPS, the well characterized RGD motif was chosen for initial development of an 
artificial scaffold. An RGD presenting matrix should enable binding by avl33, avl3s, and asl31 
integrin pairs83 that were shown here to be present on the CTXOE03 cell surface.83 
2.4.2 Characterization of Peptide Modified Hydrogels 
PEG Conjugation Efficiency: Multiple peptides were conjugated to an acrylate-PEG linker via 
succinimide chemistry. These included a linear and cyclic form of RGD, a tryptophan-containing 
RGD peptide, and finally a collagenase-degradable peptide, abbreviated as PQ which was 
reacted in a 2:1 ratio with the PEG linker. Since the presence of unconjugated acryi-PEG could 
36 
disrupt the polymer network, the efficiency for all these reactions was determined using gel 
permeation chromatography. In th is technique, the reaction products are separated by size and 
quantified by an evaporative light scattering (ELS) detector. As shown in Figure 16, the larger, 
conjugated product (black trace) will move more quickly through the column and present as a 
left-shifted peak when compared to the unmodified PEG-SCM (red trace) . Based on the absence 
of a measurable peak at the location of t he unmodified SCM, it was determined that near 100% 
conjugation occurred for all of the reactions. 
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Figure 16. GPC analysis of PEG-peptide conjugates. Unmodified acryi-PEG-SCM sample is provided as a 
reference trace in red, and the product of t he PEG-peptide conjugation reaction is shown in black. Near 
100% conjugation efficiency was observed for all reactions. 
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For the PEG-WRGDS reaction, the presence 
of the tryptophan amino acid in the 
conjugated product should result in a 
characteristic absorbance peak at 280 nm. 
During GPC analysis, UV absorption can be 
monitored on the size-separated components 
in addition to the ELS signal. As shown in 
Figure 17, a peak in the UV absorbance signal 
was observed to coincide with the ELS signal 
from the PEG-WRGDS confirming successful 
conjugation. 
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Figure 17. GPC ana lysis of PEG-WRGDS showing 
tryptophan absorbance peak. ELS (black) and UV 
absorbance (red) signal are shown. Characteristic 
UV absorbance from the tryptophan-containing 
PEG-WRGDS confirms conjugation was successful. 
Enzymatic degradation: Enzymatic degradation of PEG-PQ-PEG hydrogel was characterized 
in a controlled study prior to cell experiments. The release of tryptophan-containing peptide 
fragments provides a simple measure of hydrogel degradation over time and was therefore used 
to characterize the protease-sensitive polymer. Figure 18 shows the degradation profile of the 
PEG-PQ-PEG scaffold in the presence of 100 j..lg/ml compared to two controls: degradable gel in 
buffer without collagenase and nondegradable PEGDA gel in collagenase solution. Solution 
absorbance increased only when degradable gel was incubated in the presence of protease, 
indicating that hydrogel degradation is mediated by enzymatic cleavage and not a hydrolytic 
process. Visual inspection after 72 h incubation confirmed that the PEG-PQ-PEG hydrogels fully 
degraded when in collagenase solution while degradable samples without collagenase and 
nondegradable PEGDA gels remained intact. It is important to note that a high collagenase 
concentration was chosen to allow observation of degradation within a reasonable time frame. 
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Figure 18. Collagenase degradation of PEG-PQ-PEG hydrogel. Degradation profile is shown for hydrogel 
scaffolds in buffer with or without 100 ~g/ml collagenase. Degradation can be observed as increasing 
absorbance over time due to the cleavage and release of tryptophan-containing peptides into solution . 
Analysis of PEG-Peptide Incorporation: The hydrogel scaffold is formed from a liquid polymer 
precursor solution by addition of photoinitiator and exposure to an activating light source. 
Addition of acryi-PEG-peptides to the precursor solution allows these components to be 
covalently linked into the scaffold for presentation to the seeded cells. In order to determine the 
efficiency of the incorporation of PEG-peptides into the matrix, a model RGD peptide containing 
tryptophan was used. The ring structure of tryptophan results in a characteristic absorbance 
peak at 280 nm that is linearly proportional to the concentration of the amino acid in solution. 
To measure incorporation, hydrogel disks were synthesized with a known concentration of PEG-
WRGDS and placed in buffer solution to soak. The absorbance of the soak solution was 
measured over time and used to determine the percent of uncrosslinked PEG-peptide that 
diffused from the hydrogel. As shown in Figure 19, after 48 h approximately 61% of the starting 
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amount of PEG-WRGDS remained in the hydrogels that were exposed to crosslinking light for 1 
min. For hydrogels that were exposed for 35 seconds, only 46% remained in the gels at the same 
time point. Direct measurement of the gel absorbance at the final time point found that at a 
minimum, 95% of the starting moles of WRGDS were fully accounted for (data not shown) . 
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Figure 19. Incorporation of PEG-WRGDS. Quantification of incorporated PEG-WRGDS in the hydrogel 
matrix is based on soak solution absorbance at 280 nm. Hydrogels exposed for 1 min to the crossl inking 
light source showed improved retention of the PEG-WRGDS at both time points compared to a 35 s 
exposure indicating that more complete gelation of the hydrogel occurred . * p < 0.05 
There was no significant difference observed between 24 and 48 h time points for either 
exposure group. These observations indicate that the hydrogel is more completely crosslinked 
following the longer exposure time, and therefore future experiments were conducted with a 1 
min exposure unless otherwise indicated. It is proposed that the incorporation efficiency of PEG-
WRGDS is representative of the other PEG-peptides used in this work. Therefore for all 
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subsequent experiments, the concentration of ligand presented to the cells can be 
approximated as 60% of the starting concentration reported for the polymer precursor solution. 
2.4.3 Investigation of NSC Adhesion and Spreading 
Initial cell studies evaluated the ability of the CTXOE03 line to adhere and spread on the hydrogel 
surface. Both linear and cyclic forms of RGD were tested at a range of concentrations from 0 to 6 
mM and compared to a control group of cells seeded onto laminin-coated TCPS {Figure 20). Cell 
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Figure 20. Quantification of CTXOE03 adhesion (A) and spreading (B) on the surface of hydrogel scaffolds 
modified with varying concentrations of PEG-RGDS or PEG-c(RGDfK) as compared to controls with 0 mM 
PEG-peptide or laminin-coated TCPS. The cyclic form of the RGD peptide promoted significantly greater 
cell adhesion and spreading as compared to linear RGD for all concentrations tested . p < 0.05 
response was evaluated by staining the nuclei and actin of the fixed cell samples with DAPI and 
rhodamine-phalloidin, respectively. It was observed that cell adhesion to linear RGDS increased 
with increasing PEG-peptide concentration, however even at the highest tested concentration of 
6 mM, the modified hydrogel substrate promoted significantly less adhesion when compared to 
laminin-coated TCPS. In addition, the linear RGD supported only minimal spreading of the 
adherent cells. In contrast, cyclic RGD peptide promoted equivalent cell adhesion when 
compared to laminin-coated TCPS for all concentrations tested . The PEG-c(RGDfK) modified 
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surfaces did support spreading of the seeded cells, however even at the highest concentration, 
there was still a significant difference between the hydrogel and TCPS control. Representative 
images from the laminin-coated TCPS and c(RGDfK) modified hydrogel groups are shown in 
Figure 21. One can see that a possible explanation for the measured difference in the area cell 
could be the difference in cell morphology between the two surfaces. On laminin-coated TCPS, 
the majority of the cell edges were characterized by wide, lamellipodia-like extensions, while on 
the PEG-c(RGDfK) hydrogel surface the t his feature was not observed. This distinction indicates 
that the cells may be responding differently to the c{RGDfK) motif compared to laminin adhesive 
sites, however further studies are required to rule out confounding factors such as differences in 
the substrate stiffness. 
Laminin-coated TCPS 
Figure 21. Representative images of cells spreading on laminin-coated TCPS or c(RGDfK) hydrogels that 
have been stained with DAPI (blue, nucleus) and phalloidin (false-colored yellow, actin). White arrow 
highlights the difference in the spread morphology observed between the two surfaces. 
An additional evaluation of cell response to the low range of c(RGDfK) concentrations {Figure 
22) found that cell adhesion to the hydrogel begins to drop at a ligand concentration of 0.03 
mM, however cell spreading was not affected until a concentration of 0.003 mM was reached . 
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Figure 22. Quantification of NSC adhesion (A) and spreading (B) on hydrogels modified with a lower range 
of PEG-c(RGDfK) concentrations. Cell adhesion is significantly decreased when the peptide concentration 
drops from 0.3 to 0.03 mM while cell spreading is not impacted until a concentration of 0.003 mM PEG-
c(RGDfK) is reached. * p < 0.05 for the noted comparisons 
Since it has been shown in the literature that too much adhesive ligand can negatively impact 
cell response in some cases70, the min imum effective concentration of PEG-c(RGDfK), or 0.3 
mM, was chosen for subsequent experiments. Based on these results, the cyclic-RGDfK peptide 
was found to be over 1000-fold more effective at promoting neural stem cell adhesion 
compared to linear RGDS. Previous reports in the literature have found that the cyclic form of 
RGD-containing peptides were 20 to 100 times more effective as an inhibitor of cell adhesion 
than their linear counterparts when in solution.95•96 It has additionally been reported that an 
immobilized cyclic RGD has even higher affinity for the integrin receptors than its soluble form.97 
Such a dramatic improvement in cell adhesion and spreading as shown here, however, has not 
been previously observed . 
Both RGDS and c(RGDfK) are known to be able to bind av~3 and a5~1 integrin pairs, however the 
cyclic peptide is reported to have a higher specificity for av~3 . 96'98'99 A final study was performed 
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to attempt to identify if one of the two integrin pairs plays a larger role in promoting CTXOE03 
interaction with the c{RGDfK)-modified hydrogel surface. As shown in Figure 23, neural stem cell 
adhesion was significantly impacted when cells were incubated with blocking antibodies against 
either the avl33 integrin pair or the 131 integrin subunit prior to seeding. Only the l31 integrin 
blocking antibody, however, caused a significant decrease in cell spreading compared to a 
positive control. From this data one can conclude that both sets of integrins were utilized by the 
NSCs when binding to synthetic substrate. It is recommended for future studies that a more 
comprehensive evaluation of the possible integrins involved be conducted. 
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Figure 23. Quantification of NSC adhesion (A) and spreading (B) on 0.3 mM PEG-c(RGDfK)-modified 
hydrogels after incubation with blocking antibodies against a..~3 or ~ 1 integrins. Both blocking antibodies 
caused significant decrease in cell adhesion to the hydrogel surface, however only the ~ 1 blocking 
antibody caused a measurable decrease in cell spreading. * p < 0.05 compared to control without blocking 
antibody 
2.4.4 Expansion of NSCs on Hydrogel Substrates 
The optimal hydrogel composition containing 0.3 mM PEG-c{RGDfK) was next evaluated with 
the neural stem cells under proliferative conditions to determine if the synthetic matrix can 
support expansion of the cell line in vitro. 
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Proliferation Analysis: To determine if the growth rate of the cells varied between laminin-
coated TCPS and the c(RGDfK)-presenting hydrogel surface, cells were seeded on both 
substrates and cell number quantified at multiple time points with the fluorescent-based 
CyQuant Assay. Fluorescence intensity f rom the CyQuant reagent was linearly proportional to 
the cell count (standard curve not shown), allowing accurate quantification of the cell number at 
each t ime point. Analysis of cell proliferation (Figure 24)found that the laminin-coated TCPS and 
c(RGDfK) hydrogel permitted an equivalent rate of cell expansion with a calculated doubling 
time of approximately 42 h by exponent ial regression fit.100 This measured population doubling 
t ime was in perfect agreement with the published value of 36 to 48 h for the CTXOE03 cellline .80 
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Figure 24. Analysis of NSC prol iferation using the CyQuant Proliferation Assay. Comparison of CTXOE03 cell 
proliferation between laminin-coated TCPS and the PEG-c(RGDfK) hydrogels showed both su rfaces 
support an equ ivalent rate of cell proliferation with a calculated doubling time of approximately 42 h. 
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An alternative method for characte rization of cell proliferation is to stain for markers of actively 
dividing cells. The Ki-67 antigen is commonly used via immunostaining to label the nuclei of non-
quiescent cells. It was thus used in this work to compare the proliferative phenotype between 
the hydrogel and TCPS culture surface. CTXOE03 cells cultured on laminin-coated TCPS or PEG-
c(RGDfK) hydrogels were stained for DAPI and the Ki-67 marker and analyzed with lmageJ 
software as shown in Figure 25. Quantification of the percent of Ki-67 positive nuclei is shown in 
DAPIImage Smooth and Threshold Watershed 
Figure 25. Process flow demonstrating the method developed to evaluate the percent of Ki-67 positive 
cells using lmageJ software. Stain intensity was measured within regions of interest (ROis) defined by 
DAPI positive nuclei . 
Figure 26 along with representative images of the labeled cells on the two substrates. Briefly, 
cell nuclei were defined by the DAPI signal and used to generate regions of interest (ROis). 
These ROis were applied to the corresponding Ki-67 image and used to measure the 
fluorescence intensity. A cutoff value for identification of positive cells was chosen as twice the 
measured background fluo rescence. As with the proliferation curve, no significant difference 
was observed for CTXOE03 cells cultured on laminin-coated TCPS vs. the bioactive hydrogel. This 
further indicates that the hydrogel provides an equivalent surface for the expansion of the 
neural stem cell line. 
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Figure 26. Quantification of Ki-67 immunostaining and representative images of CTXOE03 cells on laminin-
coated TCPS or the c(RGDfK) modified hydrogel surface with Ki-67 positive nuclei labeled in red. No 
significant difference in Ki-67 expression was observed between the two culture surfaces for p < 0.05. 
Maintenance of Undifferentiated Phenotype: In addition to assessing the rate of proliferation, 
it is important to confirm that the expanding cell population maintains the proper 
undifferentiated phenotype when cultured on the hydrogel su rface. This parameter was 
assessed by immunostain ing for two conserved markers of undifferentiated NSCs: the 
transcription factor, SOX2, and the intermediary filament, nestin. 12 lmageJ software was used to 
analyze the stained cell cultures on both laminin-coated TCPS and the c(RGDfK) hydrogel in a 
similar technique as for Ki-67 quantification. In Figure 27, representative images of the cultured 
cells as well as quantified marker expression are presented. One can see from this data that on 
both substrates approximately 95% of t he cells were positive for SOX2 and similarly 95% were 
nestin positive. No significant difference was observed for marker expression between the two 
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Figure 27. Quantification of NSC marker expression and representative images of CTXOE03 cells cultured 
on laminin-coated TCPS vs. PEG-c(RGDfK) modified hydrogels. No significant difference in expression of 
SOX2 or nestin was observed indicating that the proper NSC phenotype is maintained for the cells on 
either surface for p < 0.05. 
culture substrates confirming that the hydrogel material does not promote differentiation of the 
neural stem cells and is therefore a suitable material for the study of NSC behavior in vitro. 
2.4.5 Hydrogel Substrate for the Study of NSC Differentiation 
The ultimate goal of the synthetic scaffold is to provide a platform on which to investigate 
factors that regulate NSC behavior and fate specification. It has been shown above that the 
hydrogel can support undifferentiated neural stem cell expansion. The next objective is 
therefore to show that the material preserves the differentiation potential of the CTXOE03 cell 
line by supporting development of both neuronal and glial lineages. The human NSC line used in 
this work has been conditionally immortalized such that cells will divide indefinitely in the 
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presence of FGF, EGF, and the synthetic drug, 4-0HT. Withdrawal ofthese components from the 
media is reported to trigger spontaneous differentiation along glial and neuronal lineages.80 
These lineages can be identified by specific markers such as the neuron-specific cytoskeletal 
component class Ill (3 tubulin or the astrocyte-specific glial fibrilliary acidic protein (GFAP). It has 
been previously published and subsequently confirmed here that the cell line will differentiate 
along both expected lineages when cultured for a period of 2 weeks on the laminin-coated TCPS 
surface.8° Figure 28 shows a low (A) and high (B) magnification view of the typical differentiated 
phenotype at this 2 week time point. The cells were observed to become elongated and extend 
multiple long projections that formed a tightly interwoven mesh across the surface of the 
substrate. The majority of cells were found to express the glial, GFAP marker, while (3111 Tubulin 
positive cells were more sporadic or found in clusters at sites of high cell density as depicted by 
DAPI staining. CTXOE03 cells, which were similarly cultured for 2 weeks in differentiating media 
on the surface of the PEG-c(RGDfK) hydrogels, are shown in low (A) and high (B) magnification in 
Figure 29. It was noted that the overall morphology and marker expression is highly reminiscent 
of the laminin-coated TCPS cultured cells. Again sporadic neuronal populations were found at 
regions of high cell density and were surrounded by a meshwork of interwoven GFAP positive 
cellular processes. It was not possible to accurately quantify the differentiated lineages from 
these immunostained samples due to the high cell density and the development of the dense, 
interwoven network. It can be concluded, however, that the c(RGDfK) modified hydrogel 
provided a suitable substrate for the support of CTXOE03 differentiation in a similar capacity as 
the traditional, laminin-coated TCPS substrate. For all of these studies a 10% by weight PEGDA 
hydrogel with 0.3 mM PEG-c(RGDfK) was used, however one distinct advantage that this system 
provides over TCPS is the ability to test a wide range of substrate stiffness and ligand density. 
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Figure 28. CTXOE03 differentiation on laminin-coated TCPS: ~Ill Tubulin positive neuronal cells and GFAP 
posit ive gl ial committed cells are identified after 2 weeks culture in differentiating media . Low (180X, A) 
and high (340X, B) magnification views are presented . 
Figure 29. CTXOE03 differentiation on c(RGDfK) modified hydrogels: ~Ill Tubulin positive neuronal cells 
and GFAP positive glial committed cells are observed after 2 weeks culture in differentiating media on the 
synthetic matrix. Low (160X, A) and high (380X, B) magnification views are presented. 
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2.4.6 Analysis of Encapsulated Cell Viability 
Another distinct advantage of the bioactive hydrogel scaffold presented here over typical 
cu lture substrates is its ability to support 3 dimensional encapsulation and culture of the neural 
stem cells. In vivo, these cells reside in a complex 3D environment surrounded by a framework 
of extracellular matrix and supporting cell types. For the first step in recapitulating this 
microenvironment in the hydrogel, sensitivity of the CTXOE03 cell line to the microencapsulation 
conditions was evaluated. Specifically, the effect of the photoinitiator alone was compared to 
photoinitiated encapsulation in the PEGDA hydrogel for a range of light exposure times between 
35 s and 1 min. These exposure times are relevant, as it was shown above that hydrogels were 
not fully crosslinked after only a 35 s exposure, thus causing diffusion of uncrosslinked ligand 
(represented by WRGDS) and depletion of adhesive sites from the matrix over time. It was 
important to confirm that the preferred 1 min exposure did not negatively affect cell viability. As 
shown in Figure 30-A, CTXOE03 cells that were passaged and exposed to hydrogel precursor 
solution containing Eosin Y photoinitiator but without exposure to light retained 
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Figure 30. CTXOE03 viability analysis following encapsulation in the hydrogel matrix. A decrease in viability 
was observed upon encapsu lation as compared to unencapsulated control, however no significant 
difference in viability was observed between the three exposure times tested for encapsulation (A). 
Fluorescent image (B) and brightfield overlay (C) shows even distribution of live (calcein AM, green) and 
dead (ethidium homodimer, red) CTXOE03 cells encapsulated for 1 min in the hydrogel scaffold . * p < 0.05 
compared to encapsulated samples. 
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a viability of 93%. Figure 30-A shows that cell viability was slightly reduced to approximately 
89% following encapsulation in the hydrogel regardless of the amount of time they were 
exposed to the crosslinking white light source. Representative fluorescent and brightfield 
overlay of live (green) and dead (red) cells in a 1 min crosslinked hydrogel is also included 
(Figure 30-B,C) to show the even distribution of the encapsulated cells. From this data, one can 
conclude that the 1 min exposure time, which provides improved hydrogel crosslinking as 
determined in section 2.4.2, does not cause a measurable reduction in cell viability as compared 
to the shorter exposure times tested here. For subsequent studies of encapsulated cells, an 
exposure time of 1 min was therefore used unless otherwise noted. 
2.4.7 Demonstration of Three Dimensional NSC Culture 
For long-term studies of encapsulated cell behavior, the hydrogel matrix must be capable of 
degrading to permit natural cell functions such as spreading and migration. To this end, the 
nondegradable PEGDA hydrogel backbone was replaced with a collagenase sensitive polymer, 
PEG-PQ-PEG. This material is generated with an MMP-2 and 9 sensitive peptide sequence 
embedded in the polymer chain allowing cell-secreted enzymes to locally degrade the 
crosslinked hydrogel scaffold. For all of the following encapsulated cell studies, polymer weight 
percent was reduced to 5% as the 10% hydrogel was observed to be too densely crosslinked to 
permit NSC spreading and organization (data not shown). Adhesive ligand concentration was 
maintained at 0.3 mM PEG-c(RGDfK). 
Initial demonstration of the 30 scaffold was performed with NSCs encapsulated and cultured 
under growth conditions for 1 week. lmmunostaining was used to evaluate cell morphology and 
expression of the undifferentiated NSC markers, nestin and SOX2. As shown in the following DIC 
image (Figure 31-A), the cells spread to form interconnected networks in the synthetic matrix. 
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Figure 31-B again shows the cell organization in a z-projection from a 75 11m thick confocal 
image stack of an immunostained sample. Although accurate quantification of marker 
expression was not feasible from these images, the vast majority of cells were observed to be 
positive for both nestin and SOX2 expression. 
Figure 31. Encapsulated CTCOE03 cells after 7 days in culture under growth conditions. DIC image (A) 
shows morphology of the interconnected network of cells wh ich has formed in the scaffold . 75 ~m thick Z 
projection (B) shows nestin and SOX2 expression by the encapsulated cells . 
The next step in demonstrating the utility of the hydrogel scaffold for 30 culture was to 
investigate CTXOE03 differentiation following encapsulation. Equivalent lineage markers as for 
surface seeded cells were used to characterize neurona l ([3111 tubulin) or glial (GFAP) committed 
cells after 2 weeks in the hydrogel matrix. In Figure 32, low (A) and high (B) magnification z-
projections allow observation of the cellular organization and marker expression. Additionally, 
for Figure 32-A, the z projection includes the plane of cells growing on the surface of the 
scaffold. These cells can be seen to form dense, island- like clusters with a relatively high 
proportion of [3111 tubulin positive cells. These cell clusters were interconnected via a branching 
network of long, GFAP positive projections. Figure 32-B provides a higher magnification image 
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Figure 32. lmmunostaining of encapsu lated CTXOE03 cells showing neuronal (Bill Tubulin, green) and glial 
(GFAP, red) differentiated cells along with DAPI positive nuclei (blue). Cells were observed to form dense 
clusters on the surface of the gel (A) and extensive networks in the bulk of the hydrogel matrix (B). 
of the cell network that formed deeper in the scaffold. Again the cells were elongated and 
characterized by long, thin projections. Both glial and neuronally differentiated cells were clearly 
distinguishable by exclusive marker expression. An additional observation is that the neuronal 
cells appear adjacent to and extend along the larger network of GFAP projections. A higher 
magnification example of this is shown in Figure 33. Although time-lapse imaging would be 
required to confirm, this organization suggests that the neural cells are utilizing the astrocyte 
network as a path for migration through the scaffold. Glial guided neuronal migration is a well-
documented phenomenon both in vivo and in vitro. 101 Observation of a natural process such as 
this within the artificial matrix is a strong indication that the material is highly mimetic of the 
native ECM. 
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Figure 33. High magnification (700X) confocal image showing 13111 tubulin positive cells (green) extending 
along GFAP positive projections (red) with nuclei labeled in blue. 
Based on these results, the hydrogel scaffold was found to be an excellent matrix for 
encapsulation and in vitro study of neural stem cells in a 30 microenvironment. The cells 
expressed appropriate markers when cultured under growth or differentiating conditions and 
were capable of adhering to and remodeling the matrix as evidenced by the reorganization of 
encapsulated cells to form complex, branching networks. Although only the PEG-c(RGDfK) 
adhesive ligand was demonstrated here, the degradable scaffold could potentially be modified 
with a wide array of bioactive components in a precise manner that is not achievable with 
naturally derived scaffolds. It is therefore proposed as a significant improvement over the 
previously reported materials investigated for 30 culture of neural stem cells. 
2.4.8 Flow Cytometry for NSC Population Analysis 
lmmunostaining provides an excellent means to evaluate the morphology and structural 
organization of both surface seeded and encapsulated cells. Due to the complexity of the dense 
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cell networks formed by the CTXOE03 cell line in culture and especially during differentiation, 
however, this approach does not permit quantitative analysis of the resulting cell populations. 
Flow cytometry was therefore utilized in order to more rigorously characterize the resulting cell 
populations on laminin-coated TCPS compared the c(RGDfK)-presenting hydrogel scaffold. 
CTXOE03 cells were cultured under both growth and differentiating conditions on the hydrogel 
and TCPS surfaces. At the final time point (1 week for growth or 2 weeks for differentiating 
conditions), cells were passaged and stained with fluorescently labeled primary antibodies 
against the same antigens used for immunocyotchemistry. Although information on the spatial 
organization of cell populations is lost with this technique, multi-color flow cytometry provides 
significant advantages in that up to six fluorescent markers, as well as forward scattering (size), 
and side scattering (granularity) characteristics can be evaluated simultaneously for each 
individual cell. Data acquired on tens of thousands of cells per sample are compiled to generate 
a comprehensive survey of the various cell populations. 
In Figure 34 and Figure 35, representative flow cytometry scatter-plots are presented for cells 
cultured on laminin-coated TCPS or PEG-c(RGDfK) modified hydrogels under growth and 
differentiating conditions. Quad-gating of undifferentiated NSC markers was used to determine 
the percent of nestin and SOX2 positive cells (Q2) under growth conditions for each sample. 
Neuronal and glial lineage markers were defined with box gates to allow comparison of lineage 
specification between culture conditions for differentiated samples. It can be additionally seen 
that the differentiated cell populations have a distinct scatter profile as compared to 
undifferentiated cells. A direct comparison of the growth and differentiated samples on laminin-
coated TCPS is shown in Figure 36 to highlight these differences. 
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Figure 34. Representative f low cytometry results for cells cultured on laminin-coated TCPS showing 
scatter profile, undifferentiated marker expression, and lineage marker expression under growth and 
differentiating conditions. Undifferentiated cultures are largely SOX2 and nestin positive, while 
differentiated cultures show development of distinct GFAP and 13111 tubulin-positive populations as 
expected. 
As expected, the cells under growth conditions primarily expand as a single population with high 
nestin and SOX2 expression. Following 2 weeks in differentiation media, the NSC markers nestin 
and SOX2 become down-regulated in a portion of the population and some cells begin to up-
regulate GFAP and Pill tubulin. A decrease in both forward and side scattering also indicates 
cells size and granularity decreases as t he cells undergo differentiation. It has been reported 
that neurons are characterized by a distinct, low scattering profile. In order to clarify which cell 
populations were responsible for the changes in scattering and marker expression observed 
here, a direct comparison of the differentiated populations as defined by the box gates, is 
shown in Figure 37. 
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Figure 35. Representative flow cytometry results for cells cu ltured on PEG-c(RGDfK) modified hydrogels 
showing scatter profile and marker expression profi les under growth and differentiating condit ions. Cells 
are primarily SOX2 and nestin positive under growth conditions and develop into distinct GFAP and ~Ill 
tubulin-positive populations upon differentiation. 
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Figure 36. Comparison of growth and differentiated cultures on laminin-coated TCPS. Histogram overlays 
show decreasing nest in and SOX2 expression and increasing bill Tubulin and GFAP expression upon 
differentiation as expected. Differentiated cultures also exhibit decreased forward and side scattering. 
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Figure 37. Comparison of neuronal and glial populations as gated from CTXOE03 cells differentiated for 2 
weeks on laminin-coated TCPS. Neuronal cells show decreased forward and side scattering as well as a 
decrease in SOX2 and nestin expression compared to the glial population defined here. 
Comparison of the neuronal and glial populations derived from CTXOE03 cells differentiated on 
laminin-coated TCPS confirms the development of distinct scattering populations. Specifically, 
neuronal cells were observed to have very low side scattering and forward scattering behavior 
as compared to the glial differentiated cells. It was also observed from this comparison that the 
two populations show significant differences in nestin and SOX2 expression, with neurons down-
regulating these markers as compared to the GFAP-positive glial cells. This data indicates that 
the neuronal population may be more terminally differentiated after 2 weeks than the glial 
population . It is recommended for future studies that longer time points be evaluated to 
observe ifthe glial population will similarly turn off these NSC markers. 
Quantification of the flow cytometry data between the hydrogel and TCPS culture conditions is 
shown in Figure 38. In agreement with immunocytochemical analysis, approximately 95% of 
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Figure 38. Flow cytometry analysis of cells cultured on laminin-coated TCPS vs. the PEG-c(RGDfK) modified 
hydrogel matrix. Under growth conditions (A), approximately 95% of cells were found to be both nestin 
and SOX2 positive for both substrates. Differentiation was not found to be significantly different between 
the two culture materials (B) with approximately 37% of cells following a glial fate and 10 to 15% of cells 
following a neuronal fate. p < 0.05 
the cells cultured in growth media on either substrate were found to be positive for the 
undifferentiated NSC markers, SOX2 and nestin. Assessment of the differentiated cultures 
found that with the gated populations as defined here, approximately 37% of the differentiated 
cells have committed to a glial lineage, while between 11 and 17% of cells have committed to a 
neuronal fate. No significant difference was observed between cells differentiated on the 
laminin-coated TCPS vs. the PEG-c(RGDfK) hydrogel. It can therefore be concluded that the 
hydrogel material with 0.3 mM c(RGDfK) can provide an equivalent substrate for the growth and 
differentiation of the CTXOE03 cell line. 
In addition to the surface seeded cultures, flow cytometry analysis was similarly used to 
characterize the encapsulated cell populations. However, due to limitations on the size of the 
encapsulated cell cultures as well as poor cell recovery following hydrogel degradation at the 
end of the culture period, only a single, pooled sample was able to be evaluated for growth and 
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differentiated conditions. The flow cytometry data presented in Figure 39 for encapsulated the 
populations should therefore be considered only as an example, which may not be 
representative of the actual cell response. 
One notable characteristic of the encapsulated growth condition sample as compared to surface 
seeded cells was the significantly higher and more variable GFAP expression across the 
population. In vivo, the type B neural stem cells are known to express GFAP, however in vitro 
cultured neural stem cells and NSC lines rarely express this marker. Up-regulation of GFAP under 
encapsulated growth conditions may indicate that either that the cells were starting to undergo 
glial directed differentiation, or that they may have taken on a more in vivo-like expression 
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Figure 39. Flow cytometry results for cells encapsulated within c(RGDfK) modified degradable hydrogels. 
Scatter profile and marker expression under growth and differentiating condit ions are shown. It should be 
noted that only a single pooled sample was evaluate for each media condition and results may not be 
representative. 
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profile. Both possibilities are intriguing and warrant further investigation with larger sample 
groups and additional time points. Encapsulated cells that had been differentiated for 2 weeks 
were found to develop into both neural and glial populations within the range found for surface 
seeded samples. There does appear, however to be fewer cells "in limbo" between the two 
possible differentiated states defined here, with over 61% of the total cell population falling into 
either the neuronal or glial cell gates. It is possible, as suggested from analysis of the growth 
condition group, that the encapsulated cells were more driven towards a differentiated state 
than when cultured on a 2D surface. An additional observation from the differentiated scatter 
plot was the presence of a third cell cluster with low ~Ill tubulin and intermediate GFAP 
expression levels. larger sample groups and analysis of additional lineage makers would be 
required to identify this population; however these cells may indicate that a portion of the 
encapsulated culture was directed towards a third lineage, for example towards an 
oligodendrocyte fate. 
2.5 Conclusions 
This work presents the development and characterization of a synthetic hydrogel scaffold with 
ideal properties for probing the response of neural stem cells in vitro. The CTXOE03 cell line used 
here was generated for clinical use in humans and thus provided a relevant cell model for 
demonstrating the utility of the scaffold. An initial evaluation of the behavior of surface seeded 
cultures identified a cyclic, RGD containing peptide, c(RGDfK), as a potent mediator of cell 
adhesion and spreading. Further comparison of this c(RGDfK)-modified surface with the 
traditional culture substrate of the NSC line showed that it supported an equivalent rate of cell 
proliferation and maintained proper undifferentiated phenotype based on expression of 
recognized NSC markers. 
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Since the ultimate goal of neural tissue engineering is to repair or regenerate damaged neural 
cells and tissue, it was critical that the NSCs retained their abili~ to differentiate along the 
appropriate lineages when cultured on the artificial matrix. THe multi-lineage potential of 
CTXOE03 cells was confirmed by immunostaining against conserv~d markers of the committed 
neuronal and glial lineages following a two week differentiation period. It was demonstrated 
that both surfaces maintained NSC potential and permitted development of the expected 
differentiated cell types. In addition, the apparent morphology and organization of the cells 
following differentiation was indistinguishable between the two oulture surfaces. Finally, flow 
cytometry was presented here as a powerful tool for quantitative analysis and comparison of 
the resulting cell populations across all substrates and culture condi~ions. 
Ultimately, a key benefit of the bioactive hydrogel scaffold over traditional substrates such as 
TCPS is its ability to support encapsulated culture of the cells. Growth and differentiating culture 
conditions were similarly evaluated with CTXOE03 cells encapsulated in the bulk of degradable 
hydrogel scaffolds. It was confirmed that the material maintain!ed appropriate NSC marker 
expression under permissive conditions, and that the material suJI>ported the development of 
both neuronal and glial lineages following growth factor withdrawal. Furthermore, both culture 
conditions were observed to develop into extensive, three dimensibnal cell networks indicating 
cell-mediated degradation and remodeling of the scaffold has occurred. 
It is well accepted that cell behavior can be markedly different in a three dimensional 
environment as opposed to two dimensional culture. When embedded in the hydrogel matrix, 
the neural stem cells are provided with a more natural microenvirolnment that is reminiscent of 
the NSC niche. It is subsequently hypothesized that the behavior of 30 cultures will be more 
representative of true neural stem cells in vivo. 
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Only a single adhesive and degradable peptide sequence was fully investigated here, however 
the hydrogel scaffold presents a versatile environment in which any number of bioactive signals 
could be incorporated. Future studies could additionally make use of the light-based tethering of 
signaling molecules to generate 20 or 3D patterned substrates for investigation with the cells. 
Spatially controlled ligand presentation may, for example, be utilized to generate 
microenvironments within the scaffold with distinct patterns of laminin and fibronectin 
availability that mimic the organization in the niche. In all it is proposed that the synthetic 
hydrogel matrix will be a valuable tool for future investigations of neural stem cell behavior and 
the pathways that regulate NSC fate. 
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3 Immobilized Growth Factors for Spatial Control of NSC Behavior 
3.1 Introduction 
3.1.1 Soluble Signals in NSC Regulation and Lineage Determination 
Many components of the neural stem cell niche, such as the vasculature and the specialized 
basal lamina, are likely to impose their effect on the NSC through soluble signals.48•74 Two 
growth factors in particular, epidermal growth factor (EGF) and FGF-2, are now considered 
standard components of isolation and expansion protocols for NSCs.3•6•13•102•103 These well-known 
mitogens both promote the proliferation of NSCs, and in addition FGF-2 maintains neurogenic 
potential.3'13'72 As mentioned above, the fractones maintain a unique affinity for the neurogenic 
mitogen, FGF-2.74 One experiment in which labeled FGF-2 was introduced into the ventricles 
showed that the bulbs of the fractones were even able to sequester the growth factor from the 
cerebral spinal fluid (CSF).74 Fractones positive for N-sulfate heparin sulfate proteoglycan 
showed the greatest FGF-2 binding and were associated with a higher number of proliferating 
NSCs.74 
Besides these two mitogens, a large number of factors have now been characterized for their 
effects on NSCs. Figure 40 reviews the primary downstream effects for a number of these 
soluble and bound signaling interactions in the context of neural stem cell fate.11 In addition to 
FGF, several other soluble signals associated with the vasculature are included in the diagram 
b h . fl lib h . . . d" th ... h 6454872104 and have een s own to 1n uence stem ce e av1or m v1tro an 1n em v1vo me e.' ' ' ' 
These include Leukemia inhibitory factor {LIF), platelet derived growth factor (PDGF), and 
vascular endothelial growth factor (VEGF).6A8'102'104 Longer range signaling may occur via 
neurotransmitter release from axons that extend into the niche from other regions of the 
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Figure 40. Diagram of the various signaling inputs and their influence on neural stem cell fate. 11 Soluble 
and insoluble signals from the extracellular microenvironment can interact to result in a variety of 
downstream cell responses. Green highlighted text indicates up-regulation, while red highlighted text 
indicates down-regulation of the specified cell response. Figure from Basak et al. 2009. 
brain.48'72 The neurotransmitter, GABA, for example, has been shown to promote neuro~al 
differentiation and maturation, contrary to its typical inhibitory action outside the niche.48 
Although missing from this diagram, NGF or nerve growth factor is another well studied 
regulator of cell behavior within the central nervous system.105 Previous investigations have 
shown that neurosphere-forming cells express NGF receptors.105 This factor has been found to 
promote neural differentiation of precursor cells, encourage maturation of neurons, and also 
induce a neuroprotective effect in vivo.105 Its effect on the primitive neural stem cell, however, is 
not yet fully understood. One complication in the study of many of these growth factors is that 
the response of stem cells can vary widely based on other biochemical components in the 
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microenvironment, previous mitogen exposure, and the developmental stage from which they 
were originally harvested (e.g. embryonic vs. adult).16•20 Providing a defined system to 
investigate the factors that govern NSC fate and especially neurogenic differentiation would 
help to unravel these regulatory pathways and may ultimately lead to the development of an 
improved cell therapy.3'16 
For this work, two contrasting growth factors were chosen for investigation within the synthetic 
scaffold. To demonstrate control of stem cell proliferation, CTXOE03 response to FGF was 
evaluated with the growth factor presented both in solution as well as tethered to a hydrogel 
substrate. To demonstrate control of neuronal differentiation, NGF was similarly evaluated in 
solution and tethered to the matrix for its ability to promote neurite extension by the model, 
PC-12 progenitor line. 
3.1.2 Strategies for Growth Factor Immobilization 
A variety of methods have been developed for immobilization of whole proteins. For temporary 
applications, a non-covalent approach may be appropriate. Some examples include physical 
entrapment, simple adsorption of the protein to a substrate, binding of a His6-tagged protein to 
chelated Nickel ions, or specific binding of the protein by immobilized antibodies.106 These non-
covalent methods, however, may be susceptible to disruption by environmental factors such as 
pH, salt concentration, and displacement by other proteins in solution. As such, they provide 
limited utility under conditions suitable for long term cell culture and were not considered for 
this work. 
Covalent tethering approaches can be generally categorized by the functional group targeted for 
coupling. Nucleophiles such as a thiols (cysteine residues) and primary amines (lysine residues 
and the amino terminus) are common targets. Although thiol linkage can be achieved with the 
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Michael's reaction (Figure 41-B}, naturally occurring cysteine residues are often inaccessible or 
located within the active site of the protein leading to disrupted activity after 
bioconjugation.62'106' 107 Deliberate modification of the protein sequence to include an additional 
cysteine residue specifically for the purpose of conjugation is one possible solution, but this 
approach can be considerably time consuming. A much more convenient and rapid technique 
involves the reaction of a succinimide group with the primary amines on a protein (Figure 41-A}. 
Maintaining the pH of this reaction at 8.5 allows specificity for primary amines over other 
nucleophil ic groups which may be present. Primary amines can be found at the amino terminus 
as well as on lysine residues and frequently may be located on the solvent accessible surface of 
a natively folded protein. Additionally, succinimide to amine chemistry is well established and 
has been widely used for the attachment of PEG chains to proteins and other biological 
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Figure 41. Commonly used reaction schemes for covalent conjugation to proteins or peptides.107 
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Immobilization of vascular endothelial growth factor, platelet derived growth factor, and 
fibroblast growth factor are just some examples published in the literature using this reaction 
scheme.67'68'109 Another, relatively new approach for bioconjugation is referred to as 11click 
chemistry" (Figure 41-C).11° For this method, an azide is reacted with an alkyne to form the 
conjugated biomolecule.106'111 This approach can also be adapted for site-specific conjugation. 
Example applications of click chemistry include surface immobilization of biotin, covalent 
labeling of oligonucleotides, and functionalization of the surface of viral particles. 112 
3.2 Objectives 
The ability of the hydrogel system to present tethered growth factors to NSCs was 
demonstrated here using FGF and NGF, two proteins with well characterized effects on neural 
progenitor proliferation and differentiation, respectively. The proteins were first conjugated to 
mono-acrylate PEG linkers via succinimide chemistry and characterized for conjugation 
efficiency. The pegylated growth factors were then analyzed for retention of bioactivity 
following conjugation and finally investigated as tethered signals in the hydrogel matrix for their 
influence on neural progenitor behavior in vitro. 
3.3 Materials and Methods 
All materials were purchased from Sigma unless otherwise noted. 
3.3.1 Cell Culture 
Rat pheochromocytoma cells (PC-12, passage 6-12, ATCC) were used in addition the CTXOE03 
cell line since they are an established model for studying the activity of nerve growth factor. PC-
12 cells were cultured as non-adherent clusters in RPMI media supplemented with 10% heat-
inactivated horse serum, 5% fetal bovine serum (FBS, Atlanta Biologicals), 2 mM L-glutamine, 
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100 U/ml penicillin, and 100 ~g/ml streptomycin at 37° C in 5% C02 environment. Media was 
exchanged every other day by centrifuging the cell suspension for 5 min at 300xg and then 
resuspending the cell pellet in fresh media. Cell clusters were disrupted by pipette aspiration 
and subcultivated at a 1:5 ratio once per week or when the cells reached a concentration of 
approximately 2x106 cells/mi. 
3.3.2 Synthesis of PEG-Protein Conjugates 
To generate PEG-protein conjugates, recombinant human FGF basic (FGF, R&D Systems) and 
nerve growth factor basic (NGF, R&D Systems) were first dissolved at 100 ~ml in ice-cold, 
filter-sterilized HEPBS buffer (20 mM N-(2-Hydroxyethyl)piperazine-N'(4-butanesulfonic acid) 
and 100 mM NaCI, pH 8.7). Acryloyi-PEG-succinimidyl valerate (acryi-PEG-SVA MW 3400 Da, 
laysan Bio) was separately dissolved in ice cold HEPBS buffer at 2 mg/ml and immediately 
sterilized via filtration (0.2 ~m). For conjugation to FGF, protein solution and acryi-PEG-SVA 
solution were combined to achieve final reaction concentrations of 40 ~ml protein and 15:1 
molar ratio of PEG to protein. For conjugation to NGF, final reaction conditions of 40 ~ml 
protein and either 2:1, 5:1, or 10:1 ratio of PEG to protein were tested. All reactions were 
vortexed at 4 oc overnight and stored in undiluted aliquots at -80°C. 
3.3.3 Western Blot Determination of Conjugation Efficiency 
To determine efficiency of the conjugation reaction, a Western blot was performed on the 
protein and PEG-protein conjugates. Samples were loaded at 125 ng protein per lane and run at 
80V for 2 h on a 4-15% Tris-HCL polyacrylamide gel (ReadyGel, Biorad). Bands were then 
transferred to a nitrocellulose membrane, blocked in 5% milk block, and stained with 1:300 
dilution of rabbit anti-FGF primary antibody (Abeam) for PEG-FGF samples or rabbit anti-NGF 
primary antibody (R&D Systems) for PEG-NGF samples. Secondary antibody incubation (goat 
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anti-rabbit HRP conjugate, Santa Cruz Bio) at 1:SOO dilution was followed by visualization with 
an ECL chemiluminescent Western blotting analysis system (GE Healthcare). Stained blots were 
imaged with an LAS 4000 (FujiFilm) and images analyzed in lmageJ software. 
3.3.4 Analysis of PEG-Protein Bioactivity in Solution 
Fibroblast growth factor is expected to promote neural stem cell proliferation. To assess 
bioactivity of the PEG conjugates, the Ce11Titer96 proliferation assay (Promega) was used. 
Briefly, CTXOE03 cells were seeded at 1S,OOO cells/cm2 in differentiating media lacking growth 
factors (EGF, FGF, 4-0HT) in a 96 well plate. Media was supplemented with FGF or PEG-FGF at 
final concentrations of 40, 10, 2.S, 0.62S or 0 ng/ml. After 72 h in culture, 20 ~I Ce11Titer96 
reagent was added to each well according to the manufacturer's protocol and absorbance was 
read 490 nm after a subsequent 4 h incubation at 37 oc. 
Two methods for determining nerve growth factor bioactivity were performed. For 
quantification of neurite extension, PC-12 cells were seeded at 20,000 cells/cm2 in a laminin-
coated 48 well plate. Media was supplemented with NGF or one of the PEG-NGF conjugates at a 
final concentration of 100, SO, 10, 1, or 0 ng/ml. Cells were cultured for 1 week with fresh media 
and growth factor added every other day. Finally cells were imaged by phase contrast 
microscopy (Zeiss Axiovert 13S) and lmageJ software was used to quantify total neurite length 
per view field. 
Due to tendency of PC-12 cells to form clusters in culture, an alternative protocol was used to 
allow quantification of the percent of neurite positive cells in response to NGF or PEG-NGF 
exposure. Cells were first primed for three days in SO ng/ml NGF supplemented media in a 
laminin-coated flask. Next, the cells were passaged and seeded at 20,000 cells/cm 2 in a laminin-
coated 48 well plate. Media was supplement with 0 or 40 ng/ml of NGF or PEG-NGF and cells 
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were cultured for 72 h. Finally, samples were fixed for 1 h in 4% PFA, permeabilized for 10 min in 
0.5% tritonX-100, and stained with 1 11M DAPI in PBS for 1 h. Images were taken by phase 
contrast and fluorescent microscopy (Zeiss Axiovert 135) and analyzed in lmageJ. 
3.3.5 Analysis of PEG-Protein Incorporation into the Hydrogel Matrix 
The efficiency of PEG-protein incorporation into the hydrogel matrix was determined by 
measuring protein diffusion from the scaffold over time. The amount of protein released into 
solution was quantified with a CBQCA Protein quantification assay (Life Technologies) in which 
the CBQCA reagent becomes highly fluorescent upon reaction with primary amines in the 
presence of potassium cyanide. Since this assay quantifies primary amines, the Eosin Y + TEOA 
photoinitiator system was replaced by 2-2-dimethoxy-2-phenylacetophenone (lrgacure 651) to 
avoid interference from the buffer solution. Polymer precursor solution (10% 10 kDa PEGDA in 
PBS with 10 lll/ml of a 300 mg/ml acetophenone in NVP stock solution) was prepared with 0 or 
20 ~ml PEG-FGF or 2:1 PEG-NGF. Non-immobilized hydrogel disks (10 Ill volume, 3 per group) 
were synthesized with a 3 min exposure under UV light (Dolan-Jenner) and incubated in 100 Ill 
PBS on a rocker at RT for 24 or 48 h. For each time point, soak solution was removed and stored 
at -80 °C. Solution protein concentration was determined according to manufacturer's protocol. 
Briefly, a 90 Ill volume from each thawed sample was transferred to a black bottom 96 well 
microplate. To each well was added 40 Ill of a 2.5 mM potassium cyanide (KCN) stock solution 
and 20 Ill of a 0.5 mM CBQCA stock solution both of which were prepared in 0.1 M sodium 
borate buffer, pH 9.3. The samples were allowed to react on a rocker at RT for 1 h before 
reading on a fluorescent plate reader (SPEX Fluorolog-3 Spectrofluorometer) with excitation at 
465 nm and emission at 550 nm. Concentrations were compared to a similarly made standard 
curve of 0 to 111g/ml PEG-FGF or PEG-NGF solution in PBS. 
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3.3.6 Analysis of Tethered PEG-Protein Bioactivity 
Soluble factors may require internalization to initiate downstream signaling and cell response. 
For this reason, retention of bioactivity was next evaluated with the PEG-conjugated proteins 
tethered into the hydrogel matrix. For fibroblast growth factor, sterile-filtered polymer 
precursor solution (10% 10 kDa PEGDA in HBS with 1.5% TEOA, 3.4 tJ.I/ml NVP 10 !J.M eosin Y, 
and 0.3 mM PEG-c(RGDfK)) was prepared both with and without 11l8fml PEG-FGF. Immobilized 
hydrogels (10 !J.I volume, 3 per group) were synthesized as described in section 2.3.7 and 
incubated in 1 ml HBSS at RT for 24 h. CTXOE03 cells were seeded at 10,000 cells/cm2 in 
differentiating media lacking FGF, EGF, and 4-0HT and incubated at 37 oc for 48 h. Following 
incubation, samples were fixed for 1 h in 4% PFA, permeabilized for 15 min with 0.5% Triton X-
100, and blocked overnight at 4°C with 5% BSA. Samples were then incubated in primary 
antibody (rabbit anti Ki-67, 1:200, Vector Labs) at 4 oc overnight in PBS with 0.5% BSA, followed 
by 4 X 1 ml PBS rinses and secondary antibody incubation (Donkey anti-rabbit Alexa Fluor 555) 
at 4 oc overnight in PBS with 0.5% BSA . Final PBS rinses and DAPI staining (2 !J.M DAPI in PBS for 
1 h) were all performed at RT. Samples were imaged by phase contrast and fluorescent 
microscopy (Zeiss Axiovert 135) and analyzed in lmageJ to determine cell density and percent of 
cells positive for the proliferative, Ki-67 marker. 
Bioactivity of tethered NGF was assessed with the PC-12 cell line. Filter-sterilized polymer 
precursor solution (10% 10 kDa PEGDA in HBS with 1.5% TEOA, 3.4 !J.I/ml NVP 10 !J.M eosin Y, 
and 3 mM PEG-c(RGDfK)) was prepared containing 0, 0.5, 5, and 20 tJ.g/ml of the 2:1 reacted 
PEG-NGF. Immobilized hydrogels (10 Ill volume, 3 per group) were synthesized according to the 
protocol described in section 2.3.7, and incubated in 1 ml HBSS at RT for 24 h. PC-12 cells 
(primed for 3 days in media with 50 ng/ml NGF) were seeded on the hydrogel surface at 20,000 
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cells/cm2 and incubated at 37 oc for 72 h. Samples were then fixed, stained with DAPI, and 
analyzed for percent of neurite positive cells in the same manner as described for solution NGF 
bioactivity in section 3.3.4. 
3.3. 7 Statistical Analysis 
Significance was determined via unpaired, two-tailed t-test when p < 0.05. Error bars in figures 
depict standard deviations for the data sets. 
3.4 Results and Discussion 
The purpose of this work is to demonstrate the ability of the hydrogel system to present 
immobilized signals to neural stem cells in vitro. Two growth factors, fibroblast growth factor 
and nerve growth factor, were chosen for their contrasting effects on NSC behavior. Cell 
response to each of these factors has been well characterized and as such they present ideal 
models for initial evaluation of the system. For the first step, the proteins must be conjugated to 
a PEG linker. Due to the sensitivity of proteins to organic solvents, the reaction was performed 
in aqueous buffer with acryi-PEG-SVA, a more water-stable variant of the PEG-SCM reagent used 
previously in section 2.3.4. For FGF, the reaction ratio of PEG to protein was chosen based on 
the number of available primary amines in the recombinant protein sequence. For NGF, multiple 
ratios were tested as previous literature has shown that PEG conjugation can reduce 
bioactivity .108 
3.4.1 Western Blot Analysis of PEG Conjugates 
A Western blot was performed on the unmodified protein and PEG-SVA-reacted protein to 
assess the conjugation efficiency of the reaction. In this technique, PEG-conjugated protein will 
appear as a higher molecular weight smear due to single or multiple PEG chain additions. As 
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seen in Figure 42, the recombinant FGF protein appears as a dark band at the expected 
molecular weight of 17 kDa . A fainter band at approximately 34 kDa suggests some protein was 
present as a dimer. For the PEG-FGF conjugate, a faint 17 kDa band is observed in addition to a 
smear of higher molecular weight components. These results indicate that successful 
conjugation of the growth factor to the PEG linker has occurred. 
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Figure 42. Western blot analysis of PEG conjugated FGF and NGF proteins. Higher molecular weight smear 
ind icates presence of the PEG bound protein. For FGF, a conjugation efficiency of approximately 85% was 
observed based on lightening of the 17 kDa band from the unconjugated control. For NGF, conjugation 
eff iciencies of 95, 98, and 100% were observed for 2:1, 5:1, and 10:1 reaction ratios of PEG to protein, 
respectively. 
Comparison of the 17 kDa band intensity between FGF and PEG-FGF samples showed a reaction 
efficiency of approximately 85% at the 15 to 1 ratio of PEG-SVA to FGF protein. Previous 
literature has demonstrated successful conjugation of FGF to PEG hydrogels in order to direct 
the migration of fibroblast cells in vitro. Comparison t o the published study found that the 
efficiency of the reaction presented here was lower than previously observed.67 This discrepancy 
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is likely due to the variation in reactivity and aqueous half-life of the bi-functional PEG-SVA vs. 
the previously available PEG-NHS reagent, which was supplied by a different manufacturer. 
For conjugation to nerve growth factor, three reaction ratios of PEG to protein were evaluated. 
Although a higher ratio can improve conjugation efficiency, it may also result in reduced protein 
bioactivity if the polymer reacts to a region of the protein involved in receptor binding. By 
testing three ratios, one can optimize the retention of protein bioactivity vs. completeness of 
the conjugation reaction. By Western blot analysis (see Figure 42), all three reaction conditions 
resulted in successful conjugation based on the presence of the higher molecular weight smears. 
Comparison of the density of the unconjugated NGF band (13 kDa predicted MW) across the 
samples showed a conjugation efficiency of 95, 98, and 100% for ratios of 2:1, 5:1, and 10:1 
PEG-SVA to NGF. 
3.4.2 PEG-Protein Bioactivity in Solution 
Conjugation of PEG chains to a protein may impact the ability of the protein to bind and activate 
target receptors on the cell surface. It is therefore important to determine the effect of the PEG 
reaction on the bioactivity of the FGF and NGF proteins. FGF is recognized as a primary mitogen 
for neural progenitors. The Ce11Titer96 Assay was therefore chosen as a simple means to 
quantify proliferation of CTXOE03 cells in response to FGF or PEG-FGF supplemented media. 
With this assay, a linear relationship can be observed between the cell concentration and media 
absorbance due to metabolic conversion of an MTS reagent into a formazan product with peak 
absorption at 490 nm. CTXOE03 cells were seeded at equal density and cultured in varying 
concentrations of FGF or PEG-FGF for three days before comparison of the final cell 
concentration using the Ce11Titer96 assay. Note that concentrations are given based on FGF 
protein in solution, thus molarity of the growth factor is equivalent for these comparisons. The 
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results of this assay (Figure 43} showed that cell proliferation in response to FGF and PEG-FGF 
was equivalent for the 10 ng/ml and 40 ng/ml concentrations. At lower concentrations (0.625 
and 2.5 ng/ml) the FGF performed slightly better than the conjugated growth factor however 
this difference was only statistically significant for the 2.5 ng/ml concentration. Previously 
published work investigated only a single concentration (SO ng/ml) of pegylated protein to 
assess the effect of the conjugation reaction on FGF bioactivity.67 The data presented here 
indicates that the PEG modification may have a very slight impact on the bioactivity of the 
growth factor; however at higher concentrations this difference is not significant. 
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Figure 43. Ce11Titer96 assay of CTXOE03 proli feration in response to varying concentrations of FGF or PEG-
FGF supplemented media after three days in culture. Proliferation was found to be equivalent between 
the unmodified and PEG conjugated factor for all but the 2.5 ng/ml concentration. * p < 0.05 
The model PC-12 cell line was used for investigation of the bioactivity of nerve growth factor in 
solution . Upon exposure to NGF, this cell line is known to undergo differentiation and extension 
of neurites. Two criteria were used to quantify the cell response for these studies: total neurite 
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length, and percent of the cell population that underwent differentiation. Neurite extension was 
quantified from phase contrast images using the NeuronJ plugin to trace and measure the total 
length per view field. Representative images of the cell response after one week exposure to the 
growth factors are shown in Figure 44 along with the quantification of this response in Figure 
45. From these results, one can see that unmodified NGF induced robust neurite extension from 
Figure 44. Representative Images of PC-12 neurite extension in response to NGF or PEG-NGF in solution. 
Neurites were traced in the NeuronJ plugin for lmageJ to allow quantification and are shown here in 
fuchsia. It can be observed that neurite extension is greatest for the unmodified NGF protein. Increasing 
ratio of PEG to NGF used during the conjugation reaction results in reduced bioactivity as shown here. 
Scale bars represent 100 11m. 
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Figure 45. Quantification of neurite extension by PC-12 cells after 1 week exposure to NGF or PEG-NGF in 
solution . Response to 100 ng/ml concentration shows statistically significant difference between all 
sample groups with bioactivity inversely related to the ratio of PEG to NGF used during the conjugation 
reaction. * p < 0.05 
the cultured cells in a dose dependent manner. PEG conjugated growth factor was also able to 
induce neurite extension, however bioactivity was significantly reduced. Additionally, an inverse 
relationship can be observed between the neurogenic response and the ratio of PEG to NGF 
used in the coupling reaction. 
Similar results are obtained when quantifying the percent of neurite positive cells (Figure 46}. 
For this study, a shorter exposure time and DAPI counterstaining aided in the analysis of the 
individual cell response. Again the bioactivity of the growth factor was reduced as the ratio of 
PEG to protein was increased. This suggests that the coupling of a greater number of PEG chains 
per protein results in greater disruption of the interaction between NGF and the cell surface 
receptor. 
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Figure 46. Quantification of the percent of neurite extending PC-12 cells after 72 h exposure to soluble 
NGF. Decreased bioactivity is observed with increasing ratio of PEG to NGF. All values are significantly 
different from each other with p < 0.05. 
The structure of the folded NGF protein and its TrkA receptor complex are presented in Figure 
47. Lysine residues along the protein backbone are identified in blue and present possible sites 
for PEG-SVA coupling in addition to the N terminus. The TrkA receptor primarily binds to the 
saddle-like depression in center of the NGF homodimer as shown in Figure 47-8.113 Although the 
N terminus and C terminal lysine are solvent accessible and readily available for coupling, 
reaction of PEG-SVA to the lysine residues at position 32 and 34 may be responsible for the 
reduction in bioactivity observed, especially at higher ratios of PEG to protein. The results 
observed here were found to be consistent with those published in the literature. Previous 
studies have reported approximately 100 to 200 fold reduction in bioactivity when the growth 
factor was tagged using succinimide chemistry with a PEG-linked fluorophore at a 10 molar 
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Figure 47. Folded structure of nerve growth factor (A, produced in Jmol) with lysine residues labeled in 
blue. The portion of the N terminus not visible in the crystal structure has been added in cyan .114 Binding 
of the growth factor with the TrkA receptor (B) on PC-12 cells promotes survival and neurite extension.113 
Figure from Wehrman eta/. 2007. 
excess.108 By comparison, the 2:1 PEG-NGF synthesized here showed approximately 5-fold 
reduction in bioactivity and thus presents a significant improvement. It was therefore chosen for 
all tethered studies within the hydrogel system. 
3.4.3 Analysis of PEG-Protein Incorporation into the Hydrogel Matrix 
Efficiency of PEG-protein incorporation into the hydrogel matrix was determined by using the 
commercially available CBQCA assay to quantify the amount of protein which diffuses out of the 
hydrogel and into a soak solution. The CBQCA reagent reacts with primary amines on proteins 
and peptides in the presence of cyanide to produce a highly fluorescent product. The TEOA 
component of the Eosin Y-initiated polymer solution contains a primary amine and would likely 
oversaturate the assay, preventing accurate quantification of the protein concentration. 
Furthermore, the Eosin Y photoinitiator has significant autofluorescence within the same range 
as the CBQCA reagent. To avoid interference from these compounds, a different photoinitiator 
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system was used to generate the hydrogels for the assay. lrgacure 651 is a UV activated 
photoinitiator that shows minimal autof luorescence at 465 nm excitation. Hydrogel disks were 
synthesized with an extended exposure time of 3 min to ensure complete crosslinking. It is 
proposed that protein incorporation w ill be comparable between the photoinitiator systems 
when the crosslinking reaction is taken to completion in both cases. As shown in Figure 48, by 
the 48 h t ime point it was found that no significant reduction of incorporated PEG-FGF was 
observed, however approximately 36% of the PEG-NGF had diffused from the hydrogel. The 
lower incorporation by PEG-NGF was not surprising based on the likelihood that fewer PEG 
linker chains are present on each molecule of protein due to the lower ratio of the PEG to NGF 
used for the conjugation reaction (2:1 vs. 15:1 for FGF). 
120 
• PEG -FGF 
• PEG -NGF 
100 
~ 
\!) 
!: 
0.0 so 
!: 
·= 
'" E 
~ 
0:: 60 !: 
~ 
0 
ct 
0 
UJ 40 0. 
c: 
~ 
v 
... 
~ 
0. 
20 
0 
24 h 4811 
Figure 48. Analysis of PEG-FGF and PEG-NGF incorporation in t he hydrogel matrix. Approximately 64% of 
t he PEG-NGF remained incorporat ed after the 48 h incubation period. * p < 0.05 compared to 24 h time 
point. 
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3.4.4 Tethered PEG-Protein Bioactivity 
Investigation of tethered growth factor influence on surface-seeded neural stem cells was first 
eva luated for the fibroblast growth factor. PEG-FGF was incorporated in the bulk of immobilized 
hydrogel disks at a 1 ~g/ml concentration. During photo-initiated crosslinking, the acrlyl-
terminated PEG linker should allow covalent tethering of the protein to the hydrogel matrix. 
Cells were cultured on the surface of the hydrogels in differentiating media lacking FGF, EGF, 
and 4-0HT for three days prior to imaging and analysis of cell density. As shown in Figure 49, a 
signif icant increase in cell number was observed for the FGF-modified hydrogels as compared to 
control gels with 0 ~g/ml PEG-FGF. Representative brightfield images are also presented in the 
figure to demonstrate the apparent differences in cell density and distribution. Previous studies 
have shown that similarly immobilized FGF can induce oriented spreading of fibroblast cells67, 
however this is the f irst demonstration of PEG-FGF modified hydrogels for the control of neural 
stem cell proliferation. 
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Figure 49. Comparison of CTXOE03 proliferation on the surface of hydrogels containing 0 11g/ml {A) or 1 
llg/ml (B) of tethered PEG-FGF. A significant increase in cell number was observed for t he growth factor 
modified gels as compared to 0 ~g/ml cont rol (C) . * p < 0.05 
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A 
To study the bioactivity of immobilized nerve growth factor, the PC-12 line was again utilized. 
The cells were seeded on hydrogel disks containing 0 to 20 11g/ml 2:1 PEG-NGF incorporated in 
the bulk. After 72 h in culture, the samples were fixed and cell response was quantified by 
determining the percent of neurite positive cells. As shown in Figure 50, a significant increase in 
neurite positive cells was observed for hydrogels containing 5 and 20 11g/ml PEG-NGF. 
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Figure SO. Quantification of the percent of neurite positive cells after 72 h culture on hydrogel disks with 
immobilized PEG-NGF (A). A significant response was observed for the 5 and 20 11g/ml concentrations as 
compared to control gels without growth factor. Representative images of the 0 11g/ml (B) and 20 11g/ml 
(C) samples are also shown. * p < 0.05 as compared to 0 11g/ml control 
The overall cell response, however, was significantly lower when compared to solution 
bioactivity results. For example, at a concentration of 100 ng/ml in solution, the PEG-NGF 
induced neurite outgrowth in approximately 15% of the cell population. For the immobilized 
protein, a 20 11g/ml concentration resulted in only about 5% of the population responding 
despite the 200-fold increase in signal concentration . 
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Multiple factors may be responsible for this difference between solution and tethered 
bioactivity. First, when cells are grown in 2D on a modified surface, they will only interact with 
signal they are directly contacting and thus the spread area of the cell can dictate the amount of 
signal that is received. Another consideration is the mechanism by which a receptor triggers a 
downstream signaling response. For some pathways, internalization of the receptor-ligand 
complex may be required to initiate a response.115 In the case of NGF, however, primary signally 
pathways do not require internalization.113 Finally, the ability of the growth factor to initially 
bind and activate the receptor may be physically restricted by the PEG tether. As was shown in 
Figure 47, the NGF protein interacts in a deep pocket of the TrkA receptor. The 3400 MW PEG 
linker may simply be too short to allow proper assembly of this receptor-ligand complex. It is 
recommended for future studies that a variety of PEG linker lengths should be investigated to 
determine if this is the mechanism for the reduced bioactivity observed here. 
3.5 Conclusions 
This work demonstrates the capacity of the hydrogel matrix to present covalently tethered 
proteins to neural stem cell cultures in vitro. Two well characterized and contrasting growth 
factors, fibroblast growth factor and nerve growth factor, were chosen to show control over NSC 
proliferation and differentiation respectively. Successful conjugation was verified by an increase 
in the protein molecular weight as measured by western blot analysis. Furthermore, retention of 
bioactivity was confirmed for both factors in solution. For PEG-FGF, bioactivity remained 
comparable to the unmodified protein. For NGF, PEG conjugation resulted in reduced 
bioactivity, which may be caused by the presence of potential coupling sites near the active 
binding domain of the native protein. Finally, each growth factor was immobilized in the 
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hydrogel scaffold and re-evaluated to confirm its ability to influence the behavior of surface 
seeded neural progenitors. 
In addition to the two growth factors presented here, a wide array of PEG-linked protein signals 
could be developed for immobilization using this approach. Furthermore, the photo-initiated 
crosslinking system provides the capacity for light-based patterning of incorporated signals in 
both 2 and 3 dimensions. This technique could therefore be used to generate patterns of growth 
factor availability within a hydrogel matrix that, for example, are reminiscent of the fractone-
sequestered FGF reservoirs in the in vivo niche. Taken together, this work presents significant 
potential for developing a bioactive hydrogel matrix that mimics the complexity and biochemical 
organization of the in vivo NSC niche. 
Another possible application for this technology could be for in vivo drug delivery or 
development of advanced cell-based constructs for neural tissue engineering. The ability of the 
hydrogel system with incorporated factors to promote a response in vivo has been previously 
demonstrated in the study of angiogenic factors using the cornea micropocket assay.71 In the 
CNS, multiple factors have been identified with the capacity to activate endogenous repair 
systems. It is suggested that future work could investigate immobilization of these niche-
stimulating or neuroprotective factors in order to develop more advanced therapeutic strategies 
for the treatment of CNS damage and disease. 
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4 Investigation of the Angiogenic Potential of Neural Stem Cells 
4.1 Introduction 
4.1.1 Cell-Cell Signaling in the Niche 
A variety of important cell-cell interactions are expected to occur in the NSC niche based on the 
highly extended and interconnected morphology of the type B neural stem cells. These include 
interactions with endothelial cells of the vasculature, ependymal cells lining the ventricles, 
neurons through their axonal extensions, and perivascular astrocytes that contribute to fractone 
formation.45'51'104 Other astrocytes, macrophages, and fibroblasts found in the niche may also 
play a role through growth factor secretion or ECM interactions.45•51•72 In one example, 
astrocytes were found to promote the proliferation of NSCs and direct their differentiation 
toward a neuronal phenotype during in vitro co-cultures.116 Doetsh eta/. have even implicated 
the mechanical action of the ciliated ependymal cells in generating growth factor gradients to 
direct NSC migration.48 In addition to paracrine affects, neighboring cells can also promote their 
influence through direct cell-cell contact. Components of adherens junctions including cadherins 
and ~-catenin have been identified in the niche and are thought to influence NSC behavior.5 In 
one study, for example, ~-catenin over-expression was found to enhance neural progenitor 
proliferation in vivo leading to enlarged lateral ventricles in the rodent model.117 Direct cell-cell 
connections through gap junctions are another way to allow rapid, long distance signal 
transmission and have been observed between niche astrocytes as well as among the 
ependymal cells.22'48'72 
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4.1.2 The Neurovascular Niche 
Several groups have observed that within both proliferative zones of the CNS, neural stem cells 
are found in close proximity to microvasculature.5•6•45•48•118 Within the SGZ specifically, 
proliferating NSCs migrate towards and cluster at capillary ends or branch points.119 These areas 
of the vasculature are traditionally associated with active angiogenesis, suggesting a link 
between NSC expansion and the formation of new blood vessels.118' 119 Contrasting theories still 
exist as to whether the vascular compartment or the neural stem cells provide the first signals 
initiating this interaction and cell clustering events.119 Known stimulators of angiogenesis such as 
exercise, hypoxia, and testosterone have also been shown to increase neuroblast production 
and migration, further supporting a link between the two processes.3•8•72•118 One key player that 
has been identified is vascular endothelial growth factor, or VEGF.120 As shown in Figure 51, a 
positive feedback loop is established in which the endothelial cells and neural stem cells both 
secrete, and respond to the growth factor. As a result, both endothelial sprouting and NSC 
expansion and neuronal differentiation are stimulated. The newly formed neuroblasts have 
additionally been observed to use the network of blood vessels as a scaffold both during normal 
migration towards the olfactory bulb, and following stroke to reach areas of ischemic 
damage. 6,us,121 
Although the basic role of the vasculature is to transport oxygen and nutrients to the tissues, it 
can also interact through the surrounding extracellular matrix, secreted soluble factors, 
transported endocrine factors, and direct cell-cell contact.118 To investigate some of these 
interactions, in vitro experiments have studied the behavior of endothelial cell co-cultures with 
the NSCs.104 These experiments showed increased proliferation and neurogenesis of the NSCs 
when in the presence of endothelial cells.45'48'104'122 Additionally, the endothelial cells are also 
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Figure 51. Graphical representation of the process of spatiotemporal coordination between neurogenesis 
and angiogenesis in the neural stem cell niche.120 Both direct signals from the NSCs and indirect signals 
from other cellular components in the region are capable of stimulating endothelial sprouting. A positive 
feedback loop is then established between the two cell populations via secretion of VEGF and other 
soluble signals. 12° Figure from Ruiz de Almodovar eta/. 2009. 
stimulated under these conditions, leading to increased tubulogenesis.104 Beyond a few 
identified proteins such as VEGF and brain-derived neurotrophic factor (BDNF), the full signaling 
interactions involved are still under debate.104 It is clear however, that the vasculature of the 
niche plays a critical role and should be considered during the design of any tissue engineered 
construct.45.48' 104 
4.1.3 Vascular Lineage for Neural Stem Cell Differentiation 
The theory of coordinated neurogenesis and angiogenesis described above is well accepted and 
widely studied in the literature. Another, much more controversial idea however, is that neural 
stem cells themselves retain the capacity to differentiate along vascular lineages. In 2000, Tsai et 
a/. observed that rat cortical neural stem cells differentiated at varying culture densities 
developed into vastly different populations.123 Although the typical neuronal, astrocyte, and 
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oligodendrocyte lineages were formed from high density cultures, very low density cultures 
showed almost complete absence of theses cell types. Instead, a population of almost 
exclusively alpha-smooth muscle actin (a-SMA) positive cells was observed.123 In a subsequent 
study, these a-SMA positive cells were confirmed to express other markers of smooth muscle 
cells such as calponin and SM22, and were shown to contract in response to a variety of 
stimuli.124 The combination of multiple, cell type-specific markers and a contractile phenotype 
indicated the cells had differentiated along a mural lineage. 
More recently, Oishi eta/. demonstrated the expression of endothelial markers such as PECAM-
1 and VE-cadherin in a subpopulation of neural stem cells differentiated at low density in the 
presence of 10% fetal bovine serum. Isolation and expansion of this population found that they 
were capable of organizing into tubule-like networks when cultured in three-dimensional 
collagen gels. Taken together, the possibility for both mural and endothelial cells lineages to 
develop from a single population of embryonic neural stem cells presents an intriguing 
possibility for the generation of vascularized constructs in neural tissue engineering. 
4.2 Objectives 
The ability of the hydrogel scaffold to simulate the physical ECM and soluble signals of the in 
vivo niche has been demonstrated in previous sections. For this work, the cellular and 
specifically microvascular component of the niche is considered for its influence on neural stem 
cell behavior. Initial characterization of the angiogenic potential of the CTXOE03 cell line was 
performed, followed by investigation of a co-culture encapsulation of NSCs and primary 
endothelial cells within the degradable hydrogel matrix. Finally, a commercially available neural 
stem cell line transfected to constitutively express green fluorescent protein (GFP) was 
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investigated for its angiogenic potential in vivo using the cornea micropocket angiogenesis 
assay. Growth of the limbic vessels at the edge of the cornea toward cell-laden, degradable 
hydrogel disks with no added growth factors was used as an indicator of NSC-induced 
angiogenesis. 
4.3 Materials and Methods 
All materials were purchased from Sigma unless otherwise noted. 
4.3.1 Cell Culture 
Primary human umbilical vein endothelial cells (HUVECs passage 2 to 6, Lonza) were cultured at 
37 oc in a 5% C02 environment in endothelial basal medium (EBM-2, Lonza) supplemented with 
the endothelial growth media bullet kit (EGM-2, Lonza). Media was exchanged every other day 
and subcultivation was performed at a ratio of 1:6 once the cells reached 85% confluency. 
Human cortical neural stem cells (CTXOE03) were cultured as described in section 2.3.1. Murine 
neuroepithelial cells transfected to express green fluorescent protein (NE-GFP-4C passage 3 to 
6, ATCC} were cultured on TCPS that had been treated with 15 ~g/ml poly-L-Iysine in PBS for 2 h 
at RT. The NE-GFP-4C cells were cultured in Eagle's minimum essential medium (EMEM, ATCC} 
supplemented with 4 mM L-glutamine and 10% FBS and incubated at 37 oc in a 5% C02 
environment. Media was exchanged every other day and subcultivation was performed at a 
ratio of 1:10 once the cells reached 90% confluency. 
4.3.2 Characterization of NSC Pro-Angiogenic Features 
CTXOE03 cells were seeded at high (100,000 cell/cm2) and low (10,000 cells/cm2) densities and 
cultured in differentiating media lacking EGF, FGF, and 4-0HT for 2 weeks on laminin-coated 24-
well plates (protocol section 2.3.1). Additional wells were also seeded at 20,000 cells/cm2 in 
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complete growth media and cultured for 3 days. Following this culture period, select wells were 
passaged with Accutase and reseeded at 10,000 cell/cm2 to allow observation of individual cell 
morphology. To assess marker expression, a portion of the cells were fixed and stained with 
primary antibodies against smooth muscle alpha-actin (mouse anti-a-SMA, 1:200) and neuronal 
13111 Tubulin (rabbit anti-13111 Tubulin, 1:500, Abeam) followed by secondary antibodies (donkey 
anti-rabbit Alexa Fluor 488 and donkey anti-mouse Alexa Fluor 555, 1:500, Invitrogen) according 
to the immunostaining protocol in section 2.3.10. Images were acquired by phase contrast and 
fluorescence microscopy (Zeiss Axiovert 135). 
To assess production of vascular endothelial growth factor (VEGF), 3 wells per group were 
exchanged with 0.5 ml fresh media at the final time point and incubated at 37 oc and 5% C02 for 
an additional 48 h. After the incubation period, the media was sampled and stored at -80 oc and 
the cells were passaged and counted by hemacytometer to determine final cell number per 
well. The amount of VEGF produced by the cell cultures was determined by analyzing the 
thawed media samples with a Quantikine human VEGF ELISA kit (R&D Systems) using VEGF 
standards according to manufacturer's protocol. 
4.3.3 NSC Co-culture with Endothelial Cells In Vitro 
HUVECs and CTXOE03 were passaged and separately resuspended in degradable polymer 
precursor solution (sterile-filtered 5% PEG-PQ-PEG in HBS with 0.3 mM PEG-c(RGDfK), 1.5% 
TEOA, 3.4 lll/ml NVP, and 5 11M eosin Y) at 30x106 cells/mi. Immobilized hydrogel disks of 10 111 
volume were then generated according to the method described in section 2.3.7 as either a 
HUVEC monoculture, or a 4:1 mix of the HUVEC and CTXOE03 cell suspensions. For select 
samples, the two cell suspensions were pipetted adjacent to each other prior to gelation to 
provide a direct interface between the monoculture and co-culture conditions. The 
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encapsulated cell samples were cultured in 1 ml of HUVEC media for 7 days at 37 oc with media 
exchanges every other day. Samples were then fixed and immunostained with primary 
antibodies at 1:200 dilution (goat anti-CD31 (Santa Cruz Bio), mouse anti-a-SMA, and rabbit 
anti-nestin) followed by secondary antibodies at 1:500 dilution (donkey anti-goat, mouse, and 
rabbit conjugated to Alexa Fluor 488, 555, and 647 respectively, Invitrogen). Samples were 
imaged by confocal microscopy (Zeiss LiveS DuoScan) and analyzed in lmageJ. 
4.3.4 Cornea Micropocket Assay of NSC-Induced Angiogenesis 
The fluorescently-labeled NE-GFP-4C line was used to investigate the angiogenic potential of 
neural stem cells in vivo. The cells were passaged and resuspended at 15x106 cells/ml in sterile 
polymer solution (10% PEG-PQ-PEG in HBS with 3 mM PEG-RGDS, 1.5% TEOA, 3.4 111/ml NVP, 
and 5 llM eosin Y). Non-immobilized hydrogel disks 127 11m thick, 500 11m diameter were 
prepared using a slight modification to the standard protocol. Specifically, a 127 11m spacer was 
used in place of the 380 11m spacer and gels were punched with a 500 11m biopsy punch after 
gelation. Blank hydrogel disks without cells were prepared in a similar manner. Viability of the 
encapsulated cells was determined with a Live/Dead staining kit (Invitrogen) as previously 
described in section 2.3.12. 
The hydrogel disks were implanted in the cornea of Flkl-myr::mCherry transgenic mice125 in a 
modified version of the cornea micropocket angiogenesis assay as described by Poche et a/.126 
Briefly, a partial thickness incision was made in the cornea and the corneal layers were 
separated using a Von Graefe knife to create a micropocket approximately 700 11m in length and 
300 to 400 11m from the limbic vasculature. Blank or cell-encapsulated hydrogel disks were then 
inserted and the pocket was allowed to seal closed naturally. Non-implanted gels from each 
group were also maintained in NE-GFP-4C media in vitro and imaged after 3 days by brightfield 
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(Zeiss Axiovert 135) and confocal microscopy (Zeiss LSM 510 META). After 3 and 7 days, mice 
were euthanized and the corneas were removed and fixed in 4% PFA prior to flat-mounting and 
imaging on a confocal microscope (Zeiss LSM 510 META). All animals were used under a protocol 
approved by the American Association of Laboratory Animal Science and the Institutional Animal 
Care and Use Committee at Baylor College of Medicine. 
4.3.5 Statistical Analysis 
Significance was determined via unpaired, two-tailed t-test when p < 0.05. Error bars in figures 
depict standard deviations for the data sets. 
4.4 Results and Discussion 
The primary goal of this work is to characterize the CTXOE03 cell line with regards to its 
angiogenic potential, and to demonstrate the utility of the hydrogel scaffold for investigation of 
NSC-induced angiogenesis both in vitro and in vivo. For initial cell characterization, the CTXOE03 
line was investigated as cultures on laminin-coated TCPS. 
4.4.1 Characterization of NSC Pro-Angiogenic Features 
It has been previously claimed that neural stem cells are capable of transdifferentiation to adopt 
a smooth muscle or pericyte fate.123'124 Studies investigating this phenomenon reported that low 
cell density is one way to drive this differentiation pathway.123 To test if the CTXOE03 cell line 
can develop smooth muscle cell characteristics, the cells were seeded at high and low densities 
on laminin coated TCPS and cultured in differentiating media. Following the differentiation 
period, the cells were assessed for morphology, angiogenic growth factor expression, and 
expression of smooth muscle alpha-actin. Figure 52-A and B shows the representative 
morphology of cells that had undergone either high or low density differentiation. A marked 
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Figure 52. Representative phase contrast images show elongated, neuronal-like morphology of the 
CTXOE03 cells after high density differentiation (A) compared to the larger, spread cell morphology 
observed following low density different iation (B). Normalized VEGF expression from the two 
differentiated cell cultures compared to cells in growth media show dramatically higher VEGF expression 
from the low density differentiated cells. All groups are significantly different from each other with p < 
0.05. 
difference is observed between the two conditions. Specifically, the high density differentiated 
culture primarily appears as small, highly elongated cells with a neuronal-like extensions and 
morphology. The low density differentiated culture, in contrast, generally showed much larger, 
spread morphology on the laminin-coated surface w ith lamellipodia-like projections along the 
cell edge. Such a dramatic difference in cell morphology provides strong evidence that the cells 
have differentiated along distinct lineages. An ELISA assay allowed comparison of secreted VEGF 
by the cell cultures from each cond ition and is quantified in Figure 52, C. It was found that when 
cult ured in expansion media, CTXOE03 cells produce approximately 17 pg VEGF/103 cells over a 
period of 48 h. Following high density differentiation, the production of this angiogenic growth 
factor is significantly reduced to about 7 pg VEGF/103 cells. Low density differentiation, 
however, more t han doubles the growt h factor production. An increase in VEGF production 
suggests that these low density derived cultures are more inclined to interact with the 
vasculature and endothelial cells for example in an in vivo setting. 
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A final analysis of these two differentiated cultures was achieved by immunostaining against a 
marker of smooth muscle cells, a-SMA. In Figure 53-A and B, representative phase contrast 
images again show the difference in cell morphology. A small percentage of cells in the high 
density group are observed to express the a-SMA marker (Figure 53-C) . For the low density 
group, however, the majority of the cell population was found to strongly express this 
cytoskeletal protein (Figure 53-D) . 
Seeded at 100,000 cells/cm2 Seeded at 10,000 cells/cm2 
Figure 53. Representative phase contrast (A, B) and fluorescent images (C, D) of CTXOE03 cells 
differentiated at high density (A, C) or low density (B, D). lmmunostaining was performed against 
neuronal ~Ill Tubulin (green) and a-SMA (red) with a nuclear counterstain (DAPI, blue). Low density 
differentiation was found to drive a large portion of the cell population towards a spread, a-SMA positive 
phenotype. 
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Although identification of a-SMA protein by immunostaining does not confirm smooth muscle 
or pericyte differentiation, it does provide additional evidence that CTXOE03 cells differentiated 
at low density are driven towards a much different phenotype than the elongated, neuronal and 
glial populations resulting from higher seeding densities. Furthermore, the cell-density 
dependent results observed here are in agreement with previously published literature 
concerning the possibility of a smooth muscle fate from cortical neural stem cells.123 
It is important to remember that in vitro culture conditions (2D surface, monoculture 
interactions) are vastly different from the environment in which a neural stem cell would reside 
in the body. It is possible that the artificial conditions created here have resulted in aberrant 
differentiation of the cells which would not naturally occur otherwise. This work indicates only 
that the neural stem cells may retain the capacity to develop along an a-SMA-positive, VEGF 
secreting lineage, however further work would be required to investigate if this behavior is 
observed for NSCs in vivo. 
4.4.2 NSC Co-culture with Endothelial Cells 
It has been previously shown that co-cultures of pericyte precursors cells and endothelial cells 
can organize into a primitive vascular plexus.71 Furthermore, endothelial cells co-cultured with 
neural stem cells have also be observed to self-organize in vitro and in vivo to a greater extent 
than the endothelial monoculture.127'128 The bioactive hydrogel scaffold developed in this work 
provides an excellent environment for studying the angiogenic properties of the CTXOE03 neural 
stem cell line in a functional co-culture with endothelial cells. Importantly, the hydrogel provides 
minimal intrinsic bioactivity, which could interfere or confound the results. 
To study this interaction, primary endothelial cells (HUVECs) were encapsulated alone, or in a 4 
to 1 ratio with neural stem cells and maintained in HUVEC media for one week before fixation 
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and staining against cell-specific markers: CD-31 for endothelial cells and nestin for neural stem 
cells. Staining against a-SMA was also performed to determine if any of the neural stem cells 
expressed this smooth muscle cell marker. Confocal z-projections of the immunostained 
samples are shown in Figure 54. It can be observed that little or no organization occurred for the 
HUVEC monocultures. In contrast, co-cultured samples show development of a robust, 
interconnected network. Occasional a-SMA-positive cells were identified primarily along nestin-
positive cell clusters as shown in Figure 54-B. The interface between these two conditions was 
also investigated by placing the monoculture and coculture hydrogel solutions in direct contact 
prior to gelation (Figure 55}. Again, minimal spreading is visible on the HUVEC- only side of the 
dual-hydrogel construct, while the coculture region shows extensive spreading and organization. 
Figure 54. Confocal z-projections of an encapsulated HUVEC monoculture (A) and a 4:1 coculture of 
HUVECs and CTXOE03 neural stem cells (B). Minimal organization and cell elongation was observed for the 
encapsulated endothelial cells after 1 week in culture in the 3D hydrogel environment. The coculture with 
neural stem cells, however, showed extensive spreading and network formation, with occasional cells 
expressing a-SMA marker. 
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Figure 55. Confocal z-projection of the interface between a monoculture encapsulation of HUVECs and a 
4:1 coculture with neural stem cells. M inimal organization is observed for endothelial cells alone; however 
co-encapsulation with neural stem cells resulted in the formation of an extensive 30 cellular network. 
One unexpected finding apparent in all of these samples was the low frequency of CD31 positive 
cells in the coculture at the end of the incubation period. Observation of CD31 positive cells in 
the monoculture side of the dual-hydrogel sample (Figure 55) indicates that this loss of CD31 is a 
result of direct cell contact or short acting signals and not a secreted factor in the media of the 
culture. Additional studies are needed to determine if this observation is a result of down-
regulation of the CD31 protein, or reduced viability of the endothelial population. It is proposed 
that time-lapse imaging or analysis of the cultures at earlier time points would be especially 
helpful in understanding the interactions within this complex system. 
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Although the CD31 marker is not prevalent in the coculture system, the tubule-like organization 
of the cells is similar to the primitive vascular networks formed by endothelial cells in 3D culture. 
Furthermore, spreading of a-SMA positive cells along these tubule networks is comparable to 
the arrangement of mural cells in vivo, where they extend along and stabilize the vasculature. 
Further investigation to verify the presence of a lumen in the cocultures structures are 
recommended in order to confirm vasculogenesis has occurred. Substitution of HUVECs with 
brain derived endothelial cells is also recommended for future studies in order to provide a 
more relevant coculture interaction similar to what would be found in the in vivo NSC niche. 
Although significant work remains, these preliminary studies demonstrate the utility of the 
hydrogel scaffold for investigating the interactions between endothelial cells and neural stem 
cells in vitro. 
4.4.3 Cornea Micropocket Assay of NSC-Induced Angiogenesis 
To investigate the angiogenic nature of NSCs in an in vivo, the cornea micropocket angiogenesis 
assay was employed. This assay is well established for the study of soluble signals that may 
promote or inhibit a vascular response in the animal model. For this technique, the factor of 
interest is typically loaded into a Hydron pellet and implanted into a small pocket that has been 
surgically generated between the outer layers of the cornea.129 Diffusion of an angiogenic 
growth factor such as VEGF from the implanted device induces the limbic vessels at the base of 
the eye to sprout and grow in the direction of the growth factor gradient. As the cornea is 
normally an avascular tissue, the relative strength of this angiogenic response can be easily 
measured against a neutral background. 
Recently, a modification of this protocol has been published in which the Hydron pellet was 
replaced with a PEGDA based hydrogel as the source of the angiogenic factors. 126 For this thesis 
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work, the hydrogel was investigated as a platform for the delivery of pro-angiogenic signals from 
encapsulated NSC cultures in the absence of exogenous signaling proteins. 
To aid in the identification of the neura l stem cells following implantation, the CTXOE03 cell line 
was replaced with a commercially available NSC line, NE-GFP-4C. These cells are derived from 
embryonic mice and have been transfected to constitutively express GFP. Lower risk of an 
immunogenic response is another expected benefit of the NE-GFP-4C cell line as compared to 
the xenogeneic, human-derived CTXOE03 line. An initial, proof of concept study was conducted 
to verify that the cells could be encapsulated in appropriately sized hydrogel disks for in vivo 
implantation with minimal impact on cell viability. The small dimensions of the corneal pocket 
as generated in the mouse model restricts the size of the construct to approximately a 500 11m 
diameter by 200 11m thick disk. The standard protocol for hydrogel synthesis was thus modified 
by using 127 11m thick PDMS spacers and punching with a 500 11m diameter biopsy punch after 
gelation. As shown in Figure 56-A and B, this process was successful in producing appropriately 
sized hydrogel constructs while maintaining high viability of the encapsulated NE-GFP-4C cells. 
After 3 days culture in vitro, the cells were observed to develop into dense, neurosphere-like 
Figure 56. Brightfield (A) and brightfield/fluorescent overlay (B) of an encapsulated NE-GFP-4C culture 
stained with calcein AM (live, green) and ethidium homodimer (red, dead) to show cell viability. 
Representative Brightfield image of the encapsulated cells after 3 days in culture in vitro (C) shows 
development of neurosphere-like clusters indicating that the cells are proliferat ing within the hydrogel 
scaffold. 
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clusters as shown by the brightfield image in Figure 56-C. The formation of these aggregates 
indicates that the cells survived the encapsulation process and are proliferating within the 
hydrogel scaffold. Confocal images from several of these clusters confirm GFP expression by the 
encapsulated cells {Figure 57-A, B, and C). It was also noted that expression of the fluorescent 
protein varied both between cell clusters and among individual cells within a single cluster. 
Variation in gene expression is a common challenge with transfected cell lines. For the purposes 
of this experiment it should be considered that not all implanted cells will be traceable in vivo. 
Figure 57. Confocal images from three different NE-GFP-4C clusters (A, B, and C) formed after 3 days in 
vitro in the hydrogel scaffold . Varying levels of GFP expression were observed between the individual 
cells. 
A preliminary study in which these encapsulated cell constructs were implanted in the cornea 
micro pocket assay resulted in similar development of the neurosphere-like clusters after 3 days 
in vivo {Figure 58) . Fluorescent imaging of a fixed and flat-mounted sample identified many of 
these clusters as GFP positive {Figure 58-B, C), showing that the implanted cells continue to 
express the label and can therefore be distinguished from the host tissue. 
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Figure 58. Brightfield (A), fluorescent (B), and overlay image (C) of hydrogel-encapsulated NE-GFP-4C cells 
3 days after implantation in the mouse cornea. Cells were observed to form neurosphere-like clusters 
indicating cells survived and proliferated in the in vivo environment. Fluorescent image shows 
heterogeneous expression of the GFP label by the implanted cells at this time point. 
At 7 days post-implantation, a portion of the encapsulated cell constructs were observed to 
have stimulated an angiogenic response from the limbic vessels in the animal model based on 
visualization of mCherry-labeled blood vessels extending toward the implant (Figure 59). For 
hydrogels implanted without encapsulated cells, no angiogenic response was observed. The 
growth of vessels toward the cell-laden hydrogel is similar, though not quite as extensive, as 
observed in previously published work with hydrogels releasing an angiogenic growth factor 
such as VEGF.71 Additionally in these samples, GFP-positive neural stem cells were no longer 
isolated to the cell clusters but had migrated outward across the region covered by the 
implanted hydrogel. Figure 59-A shows a low magnification image of the edge of a hydrogel 
construct where one can see the spreading GFP-posit ive cell population as well as the in-
growing vascular network. Higher magnification of the interaction between these host vessels 
and the implanted neural stem cells is provided in Figure 59-B. This close interaction, as well as 
the overall induction of vessel in-growth, provides evidence that soluble, angiogenic signals 
were secreted by the implanted cells. Further studies are recommended to identify which 
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factors are involved in promoting this response and to discover whether the NE-GFP-4C cells are 
differentiating in the in vivo microenvironment. 
Figure 59. Low magnification (A) and high magnification (B) fluorescent and brightfield overlay images of a 
hydrogel disk with encapsulated NE-GFP-4C cells 7 days after implantation in the mouse cornea . At this 
time point, GFP-Iabeled NSCs (green) were observed to have escaped the dense cell clusters and are 
spread across the area of the hydrogel. Z-projection of the mCherry channel (red) shows an influx of host 
vasculature has occurred from the limbic region and is intimately associated with the NE-GFP-4C 
population . 
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4.5 Conclusions 
Overall, the work presented in this chapter provides preliminary evidence of the pro-angiogenic 
nature of neural stem cells. The CTXOE03 cell line was confirmed to express VEGF under growth 
conditions and more strongly when the cells were differentiated in low density conditions. The 
low density differentiated cultures may also present the possibility of pericyte or smooth muscle 
lineage commitment based on up-regulation of a-SMA. Smooth muscle and endothelial cell 
types have both been reported previously from differentiated neural stem cells, suggesting the 
potential for NSCs to play a direct role in the formation of new vasculature. A more rigorous 
analysis of the culture generated here, however, is required to fully identify and characterize the 
low density differentiated population. 
Although co-culture interactions between neural stem cells and endothelial cells have been 
investigated previously in the literature, these studies were primarily limited to 2D substrates or 
difficult-to-control, natural matrices. It was demonstrated here with a coculture of human NSCs 
and primary endothelial cells, that the bioactive hydrogel scaffold can provide a suitable 3D 
environment with precisely controlled biochemical properties for more elegant investigation of 
these complex, cell-cell interactions. After 7 days in vitro, the coculture encapsulations 
underwent dramatic organization to form an interconnected cell network, while little or no 
organization occurred for the monoculture of endothelial cells. Further characterization of this 
network is recommended to determine if any of the structures had luminized, as would be 
expected in a primitive vascular plexus. Spatial control of the encapsulated cell populations was 
also demonstrated in a simple, binary hydrogel. For more advanced patterning experiments and 
control of cell-cell interactions, mask-based or confocal patterning may be employed.130'131 
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The ability to induce vessel growth in vivo is ultimately the most relevant test for determining 
the pro-angiogenic characteristics of a growth factor or cell population. In the preliminary 
studies presented here, the cornea micropocket angiogenesis assay was therefore used to 
observe the vascular response to hydrogel-encapsulated neural stem cells in a rodent model. It 
was found that the hydrogel scaffold successfully supported the delivery and proliferation of 
GFP-Iabeled NSCs over a period of 7 days after implantation. Furthermore, a portion of the 
constructs facilitated both vessel in-growth and outward migration of the neural stem cells from 
the scaffold. The observation of a vascular response for implanted cell constructs that had not 
been augmented with any exogenous growth factor provides strong evidence that the NSC 
themselves are a source of pro-angiogenic signals. 
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5 Development of a Microencapsulation Technique for NSC 
Delivery 
Much of the work in this section was published in: Franco CL et a/. "Development and 
optimization of a dual-photoinitiator, emulsion-based technique for rapid generation of cell-
laden hydrogel microspheres." Acta Biomaterialia. 2011; 7(9)3267-76. 
5.1 Introduction 
5.1.1 Neural Stem Cell Therapies 
Current clinical trials involving neural stem cell delivery are promising27'28'40'80'132'133, however cell 
survival and engraftment is still limited27A1'134, possibly reducing the potential therapeutic 
effects. These approaches generally involve the injection of a cell suspension directly into the 
target location. Cell survival is impacted by both mechanical injury during the injection process, 
and also the cellular microenvironment of the implantation site, which may not be ideal for 
maintaining viability due to the extent of tissue disease or injury, or simply because the cells are 
introduced to a non-native environment. Active clearance of implanted cells by the host 
immune response is another concern especially when a non-autologous cell source is used. 
Encapsulating cell therapies within a supporting matrix can provide valuable protection during 
delivery, physically restrict cells to the target site, and isolate cells from a potentially hostile 
immune response. Additionally, this approach provides a means to control the 
microenvironment to which an implanted cell is initially exposed. Controlling the biochemical 
environment may be critical for improving the success of NSC therapies since these cells are 
naturally supported by a highly specialized niche as discussed in detail in Chapter 1.4'5'47•135•136 
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Another consideration for neural tissue engineering is that any kind of cell-scaffold construct 
must be deliverable via injection in order to limit damage to the surrounding brain tissue.137 Two 
main approaches for injectable systems have so far been investigated in the literature. One 
strategy employs a hydrogel scaffold that, while liquid during injection, forms a suitable matrix 
once in the body. Thermoresponsive hydrogels are designed to transition from a liquid at RT to a 
more solid like construct at physiological temperatures.75'137'138 Following injection into the 
damaged tissue, the material mixed with cells slowly sets, encapsulating the cells in a soft matrix 
in situ.138 Thermoresponsive materials used for neural tissue engineering have so far been 
exclusively naturally derived, and include cellulose-based, chitosan-based, and collagen-
hyaluronan based matrices.75'137'138 Promising compatibility with neural stem cells has been 
shown in vitro, however it has not yet been demonstrated if these systems will succeed in an 
animal model.139 In addition, a bulk encapsulation approach such as this may lead to cell death 
and necrosis at the core of the construct if its dimensions are larger than the oxygen and 
nutrient diffusion limit.140 The other approach for brain tissue engineering involves 
microencapsulation of cells within small particles of a cross-linked matrix prior to 
implantation.139 The size and shape of the material is controlled such that injectable delivery can 
be maintained. 
5.1.2 Strategies for Microencapsulation 
Historically, cell microencapsulation has been primarily studied as a method for 
immunoisolation.141-149 By far the most common technique involves alginate-based materials 
that are cross-linked by ionic interactions as droplets come into contact with a cationic 
I t . 146-148,150-152 Wh th It" h . I . ft so u 10n. en e u •mate t erapeut1c goa IS engra ment of the encapsulated 
cells, however, these alginate systems are not ideal since they do not degrade in a controlled 
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manner. 140 Additional concerns include batch to batch variability for naturally derived materials 
and possible toxicity from the polycations used during crosslinking, which may induce an 
inflammatory response following implantation.146' 149 Several alternative materials for cell 
encapsulation have also been investigated, including synthetic polymers such as PEG diacrylate 
and polyvinylalcohol.146' 147' 153' 154 These can offer benefits such as reduced immunogenicity and 
greater control over mechanical stability and degradation.146 
The benefits of providing a physical support when attempting to repair and regenerate neural 
tissue was demonstrated by Park et at. in 2002.155 The researchers had previously observed that 
suspensions of NSCs injected into a region of the brain damaged by hypoxic ischemia could 
engraft and survive only along the edges of the infarct zone.155 According to their hypothesis, 
the central area of damage is primarily a liquid-filled cavity and does not maintain enough 
physical structure to support the cells. When the neural stem cells were seeded onto the surface 
of small polyglycolic acid (PGA} scaffolds, they could be implanted into the defect by glass 
micropipette.155 The polymer provided artificial support, termed a bio-bridge, which provided 
both implanted and host cells a structure for growth and migration (Figure 60}.155 
Figure 60. Comparison of different treatment groups in a stroke injured rat brain model.155 Injection of 
cell suspension alone (A) showed extensive engraftment (dark staining) at the edges of the infarct region 
(arrow) but no new tissue formation . Non-treated brain (B) showed no new tissue filling the infarct region 
(arrow). Implantation of PGA with encapsulated NSCs (C) filled region of infarct and improved survival of 
engrafted cells. 155 Figure from Park eta/. 2002. 
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Histology showed extensive neuronal differentiation from the implanted NSCs, however it was 
not demonstrated whether the resulting cells were functional or integrated with the existing 
circuitry.155 In 2009, Modo eta/. showed that similar, poly(lactic acid-co-glycolic acid) (PLGA}-
based particles could be used as microcarriers for NSC therapy in rats, however functional 
improvement was not measured.156 It is important to note that both PGA and PLGA materials 
degrade hydrolytically into acidic products with potentially detrimental effects on implanted 
cells and surrounding host tissue. A more biocompatible scaffold, for example poly(ethylene 
glycol} hydrogels, could provide a better alternative for delivery and support of implanted cells 
in this type of approach. 
5.2 Objectives 
As demonstrated in previous sections, the biochemical properties and degradation of PEG-based 
scaffolds can be precisely controlled to support encapsulated NSCs in vitro. The hydrogel 
material itself, however, had been synthesized in a form unsuitable for injectable delivery. In 
preparation for therapeutic applications, a simple but highly tunable method was thus 
developed for emulsion-based generation of PEG microspheres. Rapid crosslinking of suspended 
polymer droplets was achieved through the use of a unique combination of photoinitiators 
added to both phases of the system. Compatibility with cell encapsulation was demonstrated 
with three relevant cell lines in vitro. NIH-3T3 fibroblasts, MHP36 neural stem cells, and bEnd.3 
brain endothelial cells provided varying morphologies, adhesion preferences, and matrix-
metalloproteinase expression to fully explore the potential of the encapsulation system. Finally, 
through collaboration with researchers at King's College, london, the hydrogel microspheres 
were demonstrated to successfully deliver a cell-based therapy in a model of ischemic stroke. 
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5.3 Materials and Methods 
All materials were purchased from Sigma unless otherwise noted. 
5.3.1 Cell Culture 
Conditionally immortalized neural stem cells (MHP36 line34•157 passage 56 to 62), were 
generously donated from the lab of Dr. Jack Price. The cells were cultured on fibronectin-coated 
TCPS flasks, which were prepared by applying 0.07 ml per cm2 of a 0.01 mg/ml solution of 
fibronectin to the surface for 15 min at RT. Cells were cultured in DMEM/F12 supplemented 
with 0.03% BSA, 94 I!Wml apo-transferrin, 15.3 l-lg/ml putrescine dihydrochloride, 4.7 I!Wml 
insulin, 380 ng/ml l-thyroxine, 317 ng/ml tri-iodo-l-thyronine, 1.9 mM l-Giutamine, 58 ng/ml 
progesterone, 38 ng/ml sodium selenite, 9.4 units/ml heparin sodium salt, 10 ng/ml basic-FGF, 
1.2 ng/ml interferon, 100 U/ml penicillin, and 100 I!Wml streptomycin. The cells were incubated 
at 33 oc in a 5% C02 environment. Murine brain microvascular endothelial cells (bEnd.3, ATCC, 
passage 25 to 30) were cultured in High Glucose DMEM (Invitrogen) with 2 mM l-glutamine, 
10% FBS, 100 U/ml penicillin, and 100 ~/ml streptomycin at 37 oc in a 5% C02 environment. 
NIH-3T3 fibroblasts (ATCC, passage 128 to 135) were cultured in High Glucose DMEM, with 2mM 
l-glutamine, 10% bovine calf serum, 100 U/ml penicillin, and 100 ~/ml streptomycin at 37° C in 
5% C02 environment. 
5.3.2 Characterization of Cellular MMP Expression 
Relative collagen-specific MMP expression was determined by gelatin zymography of the cell 
culture supernatants. Cells were seeded in 48 well TCPS plates with 400 l-11 media per well. 
Seeding densities were chosen such that the cell cultures remained subconfluent after a 48 h 
incubation period. MHP36 and 3T3 cells were seeded at 20,000 cells/cm2, and bEnd.3 cells were 
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seeded at 5,000 cells/cm2• Appropriate media and culture conditions (as described above) were 
used for each cell type. After 48 h incubation, the media was collected and stored at -20 oc, and 
the cells trypsinized and counted by hemacytometer. Zymography was performed using a 10% 
gelatin precast Ready Gel (BioRad) according to manufacturer's protocol. Briefly, media samples 
were diluted 1:1 with loading buffer (125 mM Tris-HCI, pH 6.8, 20% glycerol, 4% SDS, 0.005% 
Bromophenol Blue) and run at 100 V for 2 h. The gel was then soaked for 30 min each in 
renaturing buffer (2.5% Triton X-100 in MilliQ H20) and then developing buffer (10mM Tris base, 
40mM Tris-HCI, 0.2M NaCI, 5mM CaCI2, 0.02% Brij 35) at RT. Fresh developing buffer was then 
added and the gel incubated at 37 oc overnight with gentle agitation. The gel was stained with 
Coomassie blue (Sigma) for 1 h at RT and destained with Coomassie destain solution 
(Methanoi:Acetic acid:Water (5:1:4)) for 30 min before imaging (LAS4000 Imager, Fujifilm) and 
analysis in lmageJ. Band intensity was normalized to the cell count at the 48 h time point. 
5.3.3 Development of Emulsion-based Microsphere Synthesis 
A consistent protocol for attempting emulsion-based microsphere synthesis was maintained for 
all studies. In this approach, 20 Ill of a hydrogel precursor solution was added to 1 ml of mineral 
oil in a glass test tube (13 mm by 75 mm), vortexed (Vortex Genie2, VWR) at full speed for 3 s, 
and exposed to light from a metal halide lamp (Dolan-Jenner) for 25 s. The lamp was modified 
with heat-absorbing and UV-blocking optical filters (Edmund Optics) to define an excitation 
range of 365 to 700 nm light. Light exposure was limited to 25 s since microdroplets settle out of 
solution rapidly and can result in phase separation beyond this time period. Cross-linked 
hydrogel particles were then separated from the mineral oil by addition of 500 Ill of PBS and 
centrifugation at 300 xg for 2 min. The oil layer was removed by aspiration, and the wash step 
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was repeated with an additional 500 Ill PBS. Finally, the re-suspended microspheres were 
transferred to a multiwell plate for imaging and further characterization. 
The synthesis protocol was first investigated with a single photoinitiator added only to the 
hydrogel precursor solution {10% 10 kOa PEGOA in HBS). For testing of 2-2-dimethoxy-2-phenyl 
acetophenone {also known as lrgacure 651, 1651) initiated cross-linking, an 1651 stock solution 
{300 mg/ml in NVP) was added at 10 (ll/ml to the precursor solution. For testing of eosin Y 
initiated cross-linking, the precursor solution was supplemented with 3.4 (ll/ml NVP, 1.5% TEOA, 
and 10 llM eosin Y. Microsphere synthesis was attempted according to protocol and the product 
analyzed for the presence of cross-linked particles. To investigate the effects of a dual 
combination of photoinitiators, the polymer solution was supplemented with 3.4 (ll/ml NVP, 
1.5% TEOA, and 10 llM eosin Y, while additionally the oil phase was supplemented with 3 (ll/ml 
of 1651 stock solution. Finally, in order to isolate the effect of the oil phase photoinitiator, the 
synthesis protocol was conducted with 3 (ll/ml of 1651 stock solution added to the oil phase and 
no photoinitiator in the precursor solution. All samples were imaged under brightfield 
microscopy with a ProgRes C5 {Jenoptik) ceo camera mounted to a Zeiss Axiovert 135 inverted 
microscope. For improved visualization, 0.04% trypan blue solution158 was added and samples 
incubated for a minimum of 4 h before imaging on a dissecting microscope affixed with the ceo 
camera. 
The dual photoinitiator combination for microsphere synthesis was further investigated by 
varying initiator concentrations and adding a cell-compatible surfactant, pluronic F68.159 
Hydrogel precursor solution was formed by mixing 10% 10 kOa PEGOA {refer to Chapter 2 for 
synthesis of this compound) in HBS containing 3.4 (ll/ml NVP and 1.5% TEOA both with and 
without 0.1% pluronic F68. Eosin Y photoinitiator was added to the solutions at final 
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concentrations of 0, 5, 10, or 15 IJM. Separately, sterile light mineral oil was supplemented with 
0, 1, 3, or 5 ~-tl/ml of 1651 stock solution. For all combinations of initiator concentrations with and 
without the surfactant, microspheres were generated and collected in multiwell plates 
according to the described protocol. To determine particle yield and size distribution, all 
samples were stained with 0.04% trypan blue and imaged on a dissecting microscope affixed 
with the ProgRes C5 CCD camera. lmageJ software was used to threshold, watershed, and finally 
analyze the stained-particle images to produce a particle count per view field and histogram of 
particle diameters. For analysis of particle diameter distribution, three fields of view (>900 
individual microspheres) were analyzed for each group. 
5.3.4 Microspheres as Surface Seeded Carriers 
The ability of the hydrogel microspheres to function as microcarriers for surface-seeded cell 
culture was evaluated by incorporating the fibronectin-derived RGDS adhesive peptide 
sequence. Non-degradable polymer solution (HBS with 10% PEGDA, 1.5% TEOA, 3.4 ~-tl/ml NVP, 
and 10 llM eosin Y) was prepared both with and without 0.1% pluronic F68. To an aliquot of 
each solution, PEG-RGDS (refer to Chapter 2 for synthesis of this compound) was added at 3 mM 
and all solutions were sterilized via filtration through and 0.2 ~-tm membrane. To form bulk 
hydrogel disks, a 10 Ill droplet was sandwiched between sterile glass slides separated by 380 ~-tm 
polydimethyl siloxane (PDMS) spacers. After exposure to 25 s of white light, the hydrogel disk 
was transferred to the well of a 24 well plate containing 500 Ill sterile PBS. This process was 
repeated to prepare an N of 3 for each solution. Microspheres were also formed from each of 
the precursor solutions using the previously described emulsion-based protocol (section 5.3.3) 
and mineral oil containing 3 ~-tl/ml 1651 stock solution. Particles were washed with PBS and 
transferred to a 24 well plate. The disks and microspheres were incubated overnight at 37 oc 
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and finally the PBS was replaced with NIH-3T3 culture media. 3T3 fibroblast cells were passaged 
and seeded onto hydrogels at 3,000 cells/cm2 for bulk disks or 3,000 cells per Ill of 
microspheres. After 24 h, the cultures were imaged under brightfield microscopy (Zeiss Axiovert 
135}. Percent cell attachment was quantified across three fields of view for the seeded 
m icrospheres. 
5.3.5 Microencapsulation and In Vitro Cell Culture 
NIH-3T3 fibroblasts, MHP36 neural stem cells, and bEnd.3 endothelial cells were each tested 
independently with the microencapsulation protocol to observe the effect of encapsulation 
conditions on cell viability. Appropriate media and culture conditions were used for each cell 
type as described previously in section 5.3.1. For encapsulation, cells were trypsinized and 
resuspended at a final concentration of 30 x 106 cells per ml in sterile-filtered, non-degradable 
polymer solution (HBS with 10% PEGDA, 1.5% TEOA, 3.4 lll/ml NVP, and 0.1% pluronic F68} 
containing either 5, 10, or 15 llM eosin Y. Microsphere synthesis, using mineral oil containing 
either 1, 3, or 5 lll/ml 1651 stock solution, was performed according to protocol with the 
exception that the 500 Ill PBS washes were replaced with 1 ml media washes. Resultant 
microspheres with encapsulated cells were maintained as a suspension culture in multiwell 
plates for 24 h at 37 °C. To observe viability and distribution of encapsulated cells, samples were 
incubated for 30 min at RT in PBS containing 2 llM calcein AM and 4 llM ethidium homodimer 
(Live/Dead Kit, Invitrogen) and imaged by fluorescence microscopy (Zeiss Axiovert 135} or 
confocal microscopy (Zeiss LiveS DuoScan). For assessment of microencapsulation efficiency, an 
additional encapsulation of NIH-3T3 cells was similarly performed at 15 x 106 cells/ml using the 
10 llM eosin Y concentration and 3 1-11/ml 1651 stock solution. Cells within microspheres were 
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permeabilized for 5 min in 0.5% Triton X, stained with 4 11M ethidium homodimer, and imaged 
to quantify total number of encapsulated cells. 
For long term encapsulation studies, the nondegradable PEGDA was replaced with MMP-
sensitive PEG-PQ-PEG polymer (refer to Chapter 2 for synthesis of this compound) and PEG-
RGDS to allow cell spreading and migration within the artificial matrix. The three cell types were 
resuspended separately at 30 x 106 cells/ml in filter-sterilized polymer solution (HBS with 10% 
PEG-PQ-PEG, 1.5% TEOA, 3.4 111/ml NVP, and 10 11M eosin Y) containing 3 mM PEG-RGDS and 
0.1% pluronic F68. Microspheres were generated using 3 lll/ml1651 stock solution in the mineral 
oil and purified with media washes according to the described protocol. The resulting samples 
were cultured in their respective media type for one week with media exchanges every 2 days. 
After 3 and 7 days, samples were fixed for nuclear and actin staining or immunostaining to allow 
morphological analysis and phenotypic characterization. Briefly, the cells were fixed for 30 min 
in 4% PFA, permeabilized for 15 min with 0.5% Triton X-100, and blocked for 2 h with 5% BSA. A 
portion of the samples was then stained for 2 h at RT in PBS with 5 U/ml rhodamine-phalloidin 
(Invitrogen) and 2 11M DAPI to allow visualization of actin and nuclei. All steps were performed 
at RT with reagents diluted in PBS and PBS rinses following each step. For immunostaining, 
blocked samples were incubated overnight at 4°C in primary antibodies in PBS with 0.5% BSA, 
rinsed in thoroughly in PBS, incubated with secondary antibodies overnight at 4°C in PBS with 
0.5% BSA, rinsed in PBS, and finally stained for 1 h at RT in 2 11M DAPI. Primary antibodies 
included rabbit anti-nestin (1:200, Abeam) and rat anti-CD31 (1:200, BD Biosciences). Secondary 
antibodies included Alexa Fluor 488 conjugated donkey anti-rabbit (1:500, Invitrogen), and Alexa 
Fluor 594 conjugated donkey anti-rat (1:500, Invitrogen). After staining was completed, all 
samples were imaged by confocal microscopy (Zeiss LIVE 5 DuoScan). 
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5.3.6 Microspheres for Cell Delivery in a Rodent Model for Stroke 
All procedures complied with the UK Animals Scientific Procedures Act (1986) and the Ethical 
Review Process of the King's College London. After a week of acclimatization, twenty-two 
Sprague-Dawley rats (250-270g on arrival, Harlan, UK) underwent middle cerebral artery 
occlusion (MCAo) as previously described.43 Briefly, a 0.3 mm diameter polypropylene filament 
(Doccol) was advanced through the internal carotid to the ostium of the MCA in the circle of 
Willis for a transient 60 min occlusion. At the end of the occlusion period, rats were assessed for 
forelimb flexion and contralateral circling to confirm ischemia. The filament was then removed 
to allow reperfusion of the MCA and the neck incision was sutured. 
High resolution, T2-weighted MR images (TR=4200ms, TE=10 ms, NE=8, Matrix=192x192, 
FOV=35x35mm, 50 slices in total by 0.5mm each, Gap=O, Scan Time= 54 min) were taken 10 
days following MCAO to allow an accurate assessment of lesion volume and to determine 
transplantation coordinates. This T2-weighted MRI scan was acquired as a baseline measure as 
well as 1 week following transplantation to provide a direct measure of the effect of 
experimental intervention on lesion volume (expressed as% change between baseline and 1 
week lesion volumes). Baseline MRI lesion volumes were also used to balance animals into 
equivalent treatment groups prior to transplantation: MCAo only (n=6), MCAo treated with 
empty hydrogel beads (n=5), or MCAo treated with microencapsulated bEnd.3 and MHP36 cells 
(n=5). Animals with no lesion or a purely cortical lesion by MRI were not included in subsequent 
experiments. 
Treatment groups were prepared and implanted two weeks following MCAo. To allow 
immunohistochemical detection of grafts, cells were incubated in vitro with 10 JlM 5-bromo-2-
deoxyuridine (BrdU) for 3 days prior to microencapsulation and transplantation. Polymer 
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solution was prepared as 12.5% PEG-PQ-PEG in 10 mM HBS containing 3 mM PEG-RGDS, 10 11M 
eosin Y, 3.4 111/ml NVP, and 1.5% v/v TEOA. For the microencapsulated treatment group, MHP36 
and bEnd.3 cells were separately passaged and resuspended in the polymer at a final 
concentration of 50x106 cells/mi. Microspheres were generated by adding 20 Ill of polymer only 
or cell-polymer solution to 1 ml of sterile light mineral oil containing 3 Ill of 1651 in NVP (300 
mg/ml). The mixture was vortexed and exposed to a combination of UV and white light (Dolan-
Jenner) for 30 seconds. The resulting microspheres containing each between 5-10 cells were 
transferred to media by centrifugation and filtered through a 100 11m cell strainer (Millipore). 
After overnight incubation, microspheres were re-suspended at a concentration of 200 
microparticles/~-tl for MHP36 cells and 1000 microparticles/~-tl for endothelial cells in 0.1 mM N-
acetyl-cysteine (NAC, Sigma, UK) in HBSS for implantation. Calcein AM and ethidium homodimer 
staining (Live/Dead Stain Kit, Invitrogen) was used to determine cell viability (ranging from 70-
90% following encapsulation). For each animal, a 20 Ill volume of HBSS with 0.1 mM NAC and 
one of the grafts was injected at a speed of 1~-tl/min via stereotactic injection into the center of 
the lesion as determined by MRI coordinates. Approximately 20,000 MHP36 and 200,000 bEnd.3 
cells were transplanted per animal for the microencapsulated treatment group. 
One week following transplantation, T2-weighted MR imaging was again performed and animals 
were sacrificed for histology. Brain tissue was isolated, fixed in 4% PFA overnight, and 
cryoprotected in 30% sucrose with 0.05% sodium azide prior to cryostat (Lecia) sectioning at a 
50 11m thickness. Hematoxylin and eosin (H&E) staining was performed on the tissue sections. 
Grafted cells were visualized by immunofluorescent staining of the BrdU label. Briefly, sections 
were exposed to 50% formamide (Fisher Scientific) for 2 h at 65°C, rinsed in Tris-buffered 
solution (TBS, Sigma), and blocked in 10% goat serum (Vector) in 0.3% TBS-TritonX for 1 h at RT. 
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Overnight incubation with primary biotinylated antibodies against BrdU (sheep polyclonal or 
mouse monoclonal anti-BrdU, 1:250, Abeam) was performed at 4°C followed by TBS rinse, 
repeated blocking step, and finally incubation in secondary antibody (anti-mouse or sheep 
streptavidin Alexa Fluor 488 conjugated antibody, 1:500, Invitrogen) for 2 h at RT. Stained 
sections were rinsed in TBS and mounted on coverslips in Vectashield with DAPI (Vector). 
Additional primary antibodies (polyclonal rabbit anti-nestin (1:100, Abeam) and monoclonal rat 
anti-CD31 (1:100, Abeam)) and Alexa Fluor-conjugated secondary antibodies (all at 1:500, 
Invitrogen) were similarly used to distinguish implanted cells. 
5.3.7 Statistical Analysis 
Significance was determined via unpaired, two-tailed t-test when p < 0.05. Error bars in figures 
depict standard deviations for the data sets. 
5.4 Results and Discussion 
5.4.1 Development and Optimization of the Emulsion-based System 
During development of the emulsion based encapsulation technique, cytocompatibility of 
photoinitiators, cell sensitivity to vortex derived shear forces, and photoinitiator solubility must 
all be considered. For example, emulsion-based microsphere synthesis requires rapid and 
complete polymer cross-linking before droplets have time to coalescence or phase separation 
can occur. It was anticipated that a balance would need to be achieved between higher 
photoinitiator concentrations required for rapid cross-linking and the cytocompatibility of these 
concentrations. 
For initial investigations, photoinitiator was added solely to the polymer precursor solution. It 
was found, however, that the emulsion-based approach yielded few or no microspheres with 
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only a single photoinitiator present at concentrations suitable for cell encapsulation.160•161 For a 
hydrophobic photoinitiator with low water solubility such as 1651, poor microsphere yield may 
be due to rapid diffusion of the initiator into the much larger oil phase before polymerization 
can occur. To limit photoinitiator diffusion, the hydrophilic eosin Y photoinitiator was tested. A 
small number of particles were generated when eosin Y was used as the sole initiator; however 
these were neither consistently spherical nor fully cross-linked as shown in Figure 61-A. 
Specifically, a halo of diffuse material was visible around each bead suggesting lower cross-
linking density at the surface. 
Dual Photoinitiators 1651 Only 
Figure 61. Representative images of microspheres formed with: (A and D) 10 11M eosin Y in polymer 
phase; (B and E) 10 11M eosin Y in the polymer phase with 3 111 per ml 1651 stock solution in the oil phase; 
and (C and F) 3 Ill per ml1651 stock solution in the oil phase only. Arrow indicates particle which had burst 
and was leaking internal contents. Dual combination of initiators (B and E) provides uniform spherical 
particles with smooth surface. 
Trypan blue, a stain commonly used to assess cell viability, has also been shown in the literature 
. b. . I . I d. PEG b d h d I 1s8' 162' 163 For th"1s to be useful in staining vanous 1omatena s mc u mg - ase y rage s. 
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work the dye was found to aid in the visualization of the microspheres. In Figure 61-D, the 
uncross-linked outer halo on the particles was visua lized as an area of lighter Trypan blue 
staining. Based on these observations, a dual-photoinitiator system was conceived that 
maintained the hydrophilic eosin Y in the aqueous phase but additionally utilized the 
hydrophobic initiator, 1651, in the surrounding oil phase to facilitate cross-linking of the particle 
surface. A diagram of this unique system is shown in Figure 62. 
Polymer Solution 
+ hydrophilic 
photoinitiator 
, 
,' Mineral Oil 
, , ' + hydrophobic 
,' photoinitiator 
Vortex 
+ Light 
Add Media 
Centrifuge 
Figure 62. Diagram of vortex-induced emulsion encapsulation method. A polymer precursor solution 
conta ining cells (green), adhesive ligands (red), and degradable polymer (blue) is combined with mineral 
oil in a glass test tube. The solution is vortexed briefly during exposure to a crosslinking light source. A 
dual-i nitiator system with a hydrophilic photoinitiator in the aqueous phase and a hydrophobic initiator in 
the oil phase was found to be ideal for consistent particle formation . Cross-linked microspheres were 
purified by addition of buffer or media followed by centrifugation and aspiration of the oil layer. 
Representative images of the particles formed from the dual-initiator system are shown in 
Figure 61-B and E. The particles appea r highly spherical, have crisp, clear borders, and stain 
uniformly with the trypan blue dye. Removal of eosin Y from the system was observed to 
generate particles with a cross-linked shell but seemingly liquid or uncross-linked core as shown 
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in Figure 61-C. The trypan blue staining of this sample (Figure 61-F) confirmed the idea of a 
liquid core when some of the particles were compromised under the weight of a coverslip and 
began leaking (arrow). This indicates that, as predicted, the presence of the photoinitiator in the 
mineral oil primarily aids in rapid polymerization of the outer shell of the beads. From these 
results it was concluded that the combination of a hydrophilic initiator in the aqueous phase 
with a hydrophobic initiator in the oil phase provide dramatically improved particle synthesis 
and cross-linking. 
5.4.2 Controlling Particle Size and Yield 
Due to the nature of the vortex-based system, a highly heterogeneous mix of particle sizes is 
produced. To assess this, trypan blue stained samples made with various initiator 
concentrations in both the oil and aqueous phases were imaged and analyzed to generate a 
histogram of the particle diameters. As shown by the blue bars in Figure 63, a combination of 10 
11M eosin Y in the polymer phase and 3 111 1651 stock solution in the oil phase produces 
microspheres ranging from less than 50 11m to over 500 11m in diameter. Larger diameter 
particles may be more difficult to inject or could be subject to diffusional limitations and 
reduced cell viability at their core. Therefore, it is desirable to control or limit the size range of 
microspheres that are produced. This can be accomplished by mechanical filtration of the final 
particle suspension, or through addition of stabilizing surfactants during synthesis. Pluronic F68 
is a PEG-based, cell-compatible surfactant that is frequently used in bioreactors as a shear 
protectant.159 It was found that addition of a low concentration (0.1% pluronic F68) to the 
polymer solution significantly reduced the average particle size (Figure 63, red bars). 
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Figure 63. Comparison of particle size distribution for microspheres formed with 10 IJ.M eosin Y in the 
polymer phase and 3 !J.I 1651 stock solution in the oil phase with and without 0.1% pluronic F68. The 
presence of the surfactant shifts the particle diameters to the left such that average size was reduced 
from 280 to 95 !J.m diameter. 
In addition to reducing particle diameter, the surfactant also significantly increased the number 
of microspheres produced for all encapsulations in which the oil phase photoinitiator was 
present. See Figure 64 for quantification of particle yield without (A) and with (B) the surfactant 
included. Both of these observations are likely caused by the stabilizing effect of the surfactant 
on the emulsion, which first allows smaller microspheres to be formed within the same shear 
environment, and then reduces the likelihood that particles will coalesce before cross-linking 
can occur. Figure 64 additionally shows that with surfactant present, yield generally increased as 
the photoinitiator concentration in either the polymer or oil phase was increased. This follows 
expectations since higher concentrations would lead to faster cross-linking and less time for 
polymer droplets to settle out of solution. 
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Figure 64. Quantification of particle yield across a range of eosin Y and 1651 concentrations both (A) 
without and (B) with 0.1% pluronic F68 added to the polymer phase. In general, increasing particle yield 
was observed with increasing photoinitiator concentrations. In addition, a significant increase in particle 
yield occurred upon addition of 0.1% pluronic F68 surfactant for all conditions in which 1651 was present. 
5.4.3 Hydrogel Microspheres as Surface Seeded Carriers 
To determine if the microsphere formulation provides an equivalent matrix to traditionally 
formed hydrogels, the particles were first evaluated with surface seeded cultures of the 
fibroblast control cell line. Unmodif ied PEGDA hydrogels naturally resist protein adsorption and 
therefore do not support cell attachment.63'164'165 Incorporation of adhesive peptide sequences 
into the matrix, however, can provide attachment sites and allow seeded cells to spread on the 
materia1.63•66•68.71•164. 167 The fibronectin-derived RGDS peptide sequence is known to bind cell 
surface integrins, stimulating adhesion and spreading on synthetic scaffolds such as PEG-based 
hydrogels.63•164•166•167 In this work, the RGDS peptide was covalently linked to an acrylated PEG 
spacer so that it could be cross-linked into the hydrogel matrix. Bulk hydrogel disks and hydrogel 
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Figure 65. NIH-3T3 fibroblasts seeded on the surface of (A) a bulk hydrogel disk and (B) hydrogel 
microspheres containing 3 mM PEG-RGDS adhesive ligand. Microsphere formulation was observed to 
maintain bioactivity comparable with that of the traditionally formed hydrogel. Cells seeded on hydrogel 
surface or beads with 0 mM PEG-RGDS remained rounded in suspension and did not associate with the 
polymer surface (not shown). 
microspheres were generated from non-degradable precursor material containing 0 or 3 mM 
PEG-RGDS. NIH-3T3 fibroblasts were then seeded and incubated for 24 h to allow time for the 
cells to interact with the scaffold. As seen in Figure 65, both the bulk and microsphere form of 
the RGDS-containing hydrogel behaved similarly by supporting cell attachment and spreading. 
No cell attachment was observed for samples which did not contain RGDS. Quantification of 
these images confirmed 0% of cells attached to microspheres lacking PEG-RGDS, while 83% of 
cells were adherent on microspheres wit h 3 mM PEG-RGDS incorporated. These results confirm 
that the emulsion-based synthesis did not affect the bioactivity of the scaffold, and shows the 
feasibility of using this technique for the generation of microcarriers. 
5.4.4 Microencapsulation Cytocompatibility and Efficiency 
Photoinitiator sensitivity is known to vary across cell types.161 Therefore, by optimizing the 
encapsulation system across multiple single cell line, it was expected that the chosen 
concentrations woud be more useful for a wider range of applications. Encapsulations were 
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performed across all combinations of a high, medium, and low concentration of 1651 and eosin 
Y. Calcein AM and ethidium homodimer staining then allowed direct observation of cell viability 
and distribution. Ultimately, the ideal conditions will minimize cytotoxicity while maximizing 
microsphere yield. 
As previously shown in Figure 64, higher eosin Y and 1651 concentrations generate a larger 
number of microspheres. Figure 66 however, reveals significantly reduced viability in nearly all 
cases when 1651 initiator concentration in the oil phase was increased. Although the lowest 
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Figure 66. Viability analysis for (A) NIH-3T3, (B) MHP36 and (C) bEnd.3 cell lines following 
microencapsulation. Eosin Y photoinitiator concentration in the polymer phase was varied from 5 to 15 
11M, while 1651 stock solution added to the oil phase was varied from 1 to 5 111 per mi. A representative 
brightfield and fluorescence overlay of microencapsulated MHP36 cells stained with calcein AM (green, 
live) and ethidium homodimer (red, dead) is shown in (D). Variations in photoinitiator sensitivity can be 
observed across the three cell lines. 
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1651 concentration (1111 stock solution per ml oil) produced the highest cell viability, it generally 
resulted in the formation of fewer, larger microspheres or misshapen particles. Higher 
concentrations of eosin Y generally did not impact cell viability for the cell lines tested, however 
it may be expected that other cell types for which the encapsulation might be used could be 
more sensitive. For these reasons, an intermediate level of 10 11M eosin Y in the polymer phase 
and 3 111/ml 1651 stock solution in the oil phase was chosen as the standard conditions for cell 
encapsulation in subsequent experiments. In Figure 66-D, a representative image is shown of 
MHP36 cells that had been encapsulated under these conditions and then labeled with calcein 
AM and ethidium homodimer. The results indicated that the cells are well dispersed within the 
spheres and quantification confirmed viability of greater than 80%. Finally, the efficiency of the 
encapsulation technique was assessed with NIH/3T3 cells using the standard cell encapsulation 
conditions. For these conditions, microencapsulation efficiency was quantified at 85% of the 
starting cell number. 
5.4.5 Characterization of Cellular MMP Expression 
In contrast to a 2D environment, a cell's ability to spread or migrate following encapsulation 
within the 3D hydrogel matrix will be influenced not only by integrin activation, but additionally 
its ability to degrade the material through secretion of proteolytic enzymes 168'169• This is a result 
of the small pore sizes which physically restrict cell spreading when a nondegradable polymer is 
used 169• MMP-2 and 9 expression levels were therefore characterized across the three cell 
lines, since encapsulation will ultimately be tested with an MMP-sensitive hydrogel material. 
Gelatin zymography was used to determine the relative amounts of collagen-specific MMP 
expressed by the three cell lines. For this assay, protease activity appears as clear bands against 
a dark background corresponding to MMP-2 at 62 kDa and MMP-9 and at 92 kDa. Figure 67-A 
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and 6-B show the zymogram results and quantified band intensity adjusted according to the 
final cell number for each cell type and normalized to 3T3 MMP-2 expression. MMP-2 and g 
expression was clearly identified in the endothelial and fibroblast cell cultures. 
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Figure 67. Gelatin zymogram and (B) quantif ied expression after normalization, showing varying levels of 
MMP expression across three cell lines: MHP36, negligible expression; 3T3, low expression; bEnd.3, high 
expression. 
The bEnd.3 cell line, known for its enhanced proteolytic activity 170, showed over 5 times higher 
expression compared to the 3T3 cells. MHP36 neural stem cells, in contrast, had no detectable 
collagenase activity using this assay. This data shows that the chosen cell lines provide a broad 
range of collagenase activity and will likely vary in their response when encapsulated within the 
MMP-sensitive hydrogel used in this work. 
5.4.6 In Vitro Analysis of Microencapsulated Cultures 
For cell spreading to occur following 3D encapsulation within PEG hydrogels, the surrounding 
matrix must both support cell adhesion and be capable of degrading to make room for the 
advancing filopodia .168 Thus, for long term microencapsulated culture, the MMP-sensitive PEG-
PQ-PEG polymer, in combination with PEG-RGDS additive, was used to provide a convincing 
128 
extracellular mimic in which encapsulated cells can spread and migrate in 3D.69•70 Individual 
microencapsulated cultures of these three cell lines were assessed by DAPI and rhodamine-
phalloidin staining after 7 days for visualization of actin and nuclei (Figure 68, D-F). The 
autofluorescence from residual eosin Y photoinitiator was additionally used to visualize the 
location of the hydrogel material surrounding the cells (Figure 68, A-C). 
As expected, the cell lines varied in their observed ability to degrade and spread in the hydrogel. 
For MHP36 cells, the combination of negligible collagenase expression and a high rate of 
proliferation contributed to the formation of neurosphere-like clusters of cells over time. It was 
further indicated that these cell clusters were displacing rather than degrading the surrounding 
matrix based on observations of stretching and distortion of the hydrogel in the eosin Y 
fluorescence channel (Figure 68-A). In encapsulated 3T3 cultures, phalloidin staining revealed 
fine process extensions on most cells and in some cases clear spreading of cells within the 
matrix. This response was expected based on their moderate level of MMP expression as 
observed by zymography. The bEnd.3 cell line, in contrast, showed dramatic process extension 
by all encapsulated cells and extensive spreading within the 3D scaffold, which is consistent with 
their high expression levels of MMP-2 and 9. By maintaining viable cultures of all three cell lines 
to the 7 day time point, we have demonstrated the ability of the degradable hydrogel 
microspheres to provide a conducive, 3D culture environment for a variety of cell types. 
Microspheres were also found to be compatible with traditional immunohistochemical analysis 
of encapsulated cells. As shown in Figure 69-A and B, monocultures of MHP36 or bEnd.3 were 
fixed and stained for cell-specific markers following 3 days of in vitro culture. MHP36 cells were 
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MHP36 Cells 
Figure 68. Representative confocal projections of (A and D) MHP36, (B and E) 3T3 and (C and F) b.End3 
microencapsulated cultures at the 7-day time point, showing relative cell spreading and process extension 
in the 3D matrix. (A)-(C) show autofluorescence signal from t he hydrogel matrix, while (D)-(F) show DAPI 
(nuclei, blue) and phalloidin (actin, red) staining. Cell spreading within the collagenase degradable 
hydrogel was more extensive for cells with higher MMP expression levels. Scale bar represents 100 ~m . 
found to strongly express the NSC marker nestin, and to be negative for the endothelial marker, 
CD31. bEnd.3 cells, in contrast, showed robust CD31 expression, and in addition expressed lower 
amounts of nestin protein. Following co-encapsulation of the two cell types within a single 
microsphere culture, these differences in marker expression could be utilized to distinguish the 
two cell types. In Figure 69-C, one can identify proliferative MHP36 clusters (white arrows) 
based on nestin positive staining, as well as larger, CD31 positive bEnd.3 cells. Demonstrating 
the compatibility of the microspheres with traditional cell characterization techniques is an 
important step towards developing the system for further in vitro and in vivo studies. 
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C 1:1 Co-culture of MHP36 and bEnd.3 cells 
Figure 69. Immunofluorescent staining of MHP36 and bEnd.3 cells encapsulated within the microsphere 
system following 3 days in culture. Monocult ure of MHP36 cells was found to be strongly positive for the 
NSC marker, nestin (a) while brain endothelial cells showed CD31 as well as moderate nestin expression 
(b). Differential marker expression allowed identification of MHP36 cell clusters (C, arrows) following co-
encapsulation and culture with the bEnd.3 cells. 
5.4.7 Delivery of Encapsulated Cells in a Model of Ischemic Stroke 
Collaborators at the King's College, London, have previously reported on the ability of MHP36 
cell transplantation to promote functional recovery in a rodent model of ischemic stroke.43 Low 
cell survival and engraftment, however, suggest the possibility for further improving the 
therapeutic effect of this treatment. Microencapsulation of the cell therapy within a hydrogel 
matrix may be one solution to provide both physical protection and a more supportive 
microenvironment following delivery. In a preliminary study, the ability of the microspheres to 
deliver viable encapsulated cells to the lesion site was evaluated. Transplantation was 
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performed with a combination of MHP36 cells and bEnd.3 endothelial cells separately 
encapsulated within the microspheres. Cooperative signaling between endothelial and neural 
stem cells has been previously reported to promote both neurogenic and angiogenic responses 
in the brain and in vitro. Promoting revascularization at the lesion site in addition to neural 
differentiation may be one avenue to regenerate the lost tissue. Towards this end, viable 
delivery of both cell types was evaluated within this proof-of-concept study. 
A diagram of the experimental timeline is presented in Figure 70-A. Ten days following MCAo, 
animals were evaluated with T2-weighted MR imaging to determine the extent and location of 
ischemic tissue damage. Two weeks after MCAo, encapsulated cell therapy or control 
treatments (hydrogel only or vehicle only) were administered by stereotactic injection to the 
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Figure 70. Investigation of encapsulated MHP36 therapy in a rodent model for stroke. (a) Diagram of 
study time-line. (b) T-2 weighted MRI images showing area of ischemic damage (arrow) and quantification 
of lesion volume changes one week following treatment. 
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central coordinates of the lesion. One week following treatment, animals were re-evaluated by 
MRI and sacrificed for histology. Comparison of baseline and post-MR images allowed 
evaluation of the percent change in lesion volume one week following therapy (Figure 70-B). 
Limited group sizes were such that none of the differences between treatment groups showed 
statistical significance, however a 4-fold reduction in the size of affected tissue was observed 
when encapsulated cells were administered compared to vehicle-only treatment group. It is 
recommended for future studies that larger group sizes and multiple time points be employed in 
order to fully investigate this promising trend. 
During histological analysis of the sectioned tissues, hematoxylin and eosin was found to 
provide clear contrast between the implanted hydrogel and surrounding brain. As shown in 
Figure 71, polymer was successfully delivered and retained in the lesion site and injection tract 
for the hydrogel-only control group. Similar, reddish brown staining was not present in the 
vehicle only control tissue. At this t ime-point, microspheres of the material were not 
Figure 11. Hematoxylin and Eosin staining of fixed tissue sections clearly identified hydrogel material 
(reddish brown) within the lesion cavity and injection tract of the hydrogel-only group. Vehicle-only 
control did not show a similar staining pattern. 
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distinguishable, possibly suggesting degradation of the scaffold following implantation. 
The successful delivery and support of viable MHP36 and bEnd.3 cells out to one week in vivo 
was additionally observed through immunohistochemical staining. As shown in Figure 72, BrdU 
positive MHP36 and bEnd.3 cells could both be clearly identified within the lesion site. The two 
delivered cell types were delineated by contrasting CD31 expression . Infiltration of host vascular 
cells (BrdU-, CD31+) suggests possible angiogenic response, however further studies are 
required to confirm and investigate these findings. Overall, this study provided excellent proof-
of-concept that a cell-based 
therapy could be micro-
encapsulated and delivered via 
injection into the injured 
rodent brain. Larger group sizes 
and additional controls will 
ultimately be required for 
future experiments in order to 
determine the effects of 
encapsulation on behavioral 
improvement in the rodent 
model. 
5.5 Conclusion 
Figure 72. Immunofluorescent image at the site of the implanted cell 
therapy. MHP36 cells are identified by BrdU+, CD31- staining pattern 
(1), while implanted endothelial cells are distinguished by BrdU+, 
CD31+ staining (2). Host vascular cells were also observed to 
infiltrate the area based on BrdU-, CD31+ staining (3) . 
This work presents a novel method for simple, rapid, microencapsulation of cells using 
universally available laboratory equipment. In comparison to the commonly used calcium-
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alginate microencapsulation system, the method presented here allows for more fine-tuned 
control over the physical and biochemical properties of the material. Furthermore, since the 
system employs a bulk encapsulation approach it is potentially scalable with few additional 
modifications. One drawback to the vortex-based emulsion generation is the heterogeneous mix 
of particle sizes that is produced. Although surfactant addition and filtration can be used to 
select a desired particle size range, further improvement of the technique could be 
accomplished through the use of a more controlled shear environment during emulsion 
generation. 
The work herein has demonstrated that this system can be applied to a variety of cell types and 
that the material can be modified for both cell adhesion and enzyme-mediated degradation. 
Although the integrin-binding RGDS peptide and the collagenase-sensitive PQ peptide were 
employed in these studies, the system is highly modular, and thus any combination of adhesive 
and protease cleavable components could be utilized in order to tune the polymer scaffold for a 
specific application. As shown in previous sections, whole proteins can additionally be tethered 
to the matrix. It is thus theorized that growth factor or cytokine integration into the 
microspheres could provide more sophisticated control over the behavior of the encapsulated 
cells or could alternatively be used as a method for local drug delivery following in vivo 
implantation. 
To prepare for future, therapeutic applications, these microspheres were lastly evaluated as 
carriers to deliver a cell-based therapy in a rodent model for stroke. Histological analysis at a 
one week time point confirmed successful delivery and prolonged survival of both encapsulated 
cell types. Furthermore, MR imaging of the stroke-damaged brain before and after treatment 
revealed a trend of decreasing lesion volume following delivery of the microencapsulated cell 
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therapy as compared to control groups. Further investigations are needed, however to 
determine whether the hydrogel carriers provide a statistically significant benefit over the 
traditional approach of injecting a free cell suspension. 
Overall, the flexibility and ease of microsphere synthesis as presented in this work indicates 
potential both for in vitro studies and in vivo cell delivery. It is expected that this approach will 
serve as an additional, highly useful tool for the rapid generation and study of tissue engineered 
constructs for a wide variety of applications. 
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6 Summary of Conclusions and Implications 
6.1 Development of a Synthetic Niche for NSC Investigations In Vitro 
A bioactive, PEG-based scaffold is presented here as an ideal system for the study of neural stem 
cell behavior in vitro. The cyclic RGD-modified surface was confirmed to support equivalent NSC 
proliferation and differentiation to that of the traditional laminin-coated TCPS substrate. 
Substitution of a whole ECM protein, such as laminin, with a small peptide provides several 
advantages including reduced cost, reduction of batch-to-batch variability, and greater control 
over ligand concentration and presentation to the cells. Another significant benefit of the 
hydrogel system is the ability to support true, three-dimensional cultures. Replacing PEGDA with 
polymer chains containing a protease-cleavable peptide permitted cell-mediated degradation 
and remodeling following encapsulation. In this environment, the neural stem cells were 
capable of both self renewal and differentiation and were observed to organize into complex, 
interconnecting 3D networks. In contrast to naturally derived 3D culture substrates such as 
matrigel, the PEG-based scaffold provides greater control over which bioactive factors are 
presented to the cells. Though not tested here, broad control over the mechanical properties of 
the hydrogel could also be achieved with minimal impact on biochemical characteristics by 
simply varying the molecular weight or weight percent of the polymer in solution. 
6.2 Control of NSC Behavior with Tethered Factors 
In addition to adhesive and degradable sequences, it was also shown that whole proteins such 
as growth factors could be covalently linked to the hydrogel. In vivo, growth factors are often 
sequestered by components of the extracellular matrix. Sequestering of factors can permit 
localized signaling and is especially important since a single growth factor may have very 
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different downstream effects depending on the cell type or tissue it reaches. Two common 
growth factors in the CNS were investigated here as tethered signals in the synthetic scaffold, 
fibroblast growth factor and nerve growth factor. With these immobilized proteins, the ability of 
the scaffold to influence the proliferation and neuronal differentiation of surface seeded 
cultures was demonstrated. In addition to the two signals shown here, a vast array of proteins 
with possible influence over neural stem cell fate have been identified. Systematic investigation 
of these proteins against a neutral background, such as that provided by the hydrogel scaffold, 
could greatly enhance the general knowledge in this field. 
6.3 Investigation of the Angiogenic Potential of NSCs 
Neighboring cells in the niche are another source for both soluble and direct signaling to the 
NSCs. These interactions are often highly complex and bi-directional as presented herein with 
the interplay between neural stem cells and the endothelial cells of the vasculature. In a 
preliminary study, this work demonstrated that the hydrogel matrix can permit observation of 
this coculture interaction in a well-defined, in vitro setting. Evidence of angiogenic signaling 
from the neural stem cells to the endothelial cells was observed both in the coculture, and in a 
more relevant, in vivo setting through the use of the cornea micropocket assay. Evidence was 
also shown of a more direct role for NSCs in angiogenesis via the possibility of differentiation 
along vascular lineages. Future studies employing time-lapse imaging would provide critical data 
towards unraveling this complex system. 
6.4 Microencapsulation Approach for Injectable Cell Constructs 
For the final portion of this thesis work, the hydrogel scaffold was produced in a form that could 
be delivered via minimally invasive injection. Generation of hydrogel microspheres was 
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achieved using a dual combination of photoinitiators to rapidly crosslink the polymer droplets 
within a water-in-oil emulsion. Extensive optimization of this process was conducted to improve 
microsphere yield, provide control over particle diameter, and to maximize cell viability at the 
end of the process. Overall the technique provides multiple key advantages over previously 
published microencapsulation systems. For example, the use of common laboratory equipment 
means this method is simple and affordable to set up. In addition, because the microspheres are 
produced in bulk, large quantities can be generated rapidly and the overall method is much 
easier to scale-up compared to droplet or microfluidic approaches. Based on the data shown 
here, a variety of cell types can tolerate the emulsion-based microencapsulation process and 
can be studied in vitro as encapsulated suspensions. Finally, the microspheres were shown to 
successfully support the delivery of neural stem cells in vivo. 
6.5 Future Directions 
By screening of a variety of hydrogel configurations using the techniques presented here, 
specific combinations of physical and biochemical characteristics could be identified that 
promote a desired cellular behavior, such as the differentiation of NSCs along a neuronal 
lineage. Identifying which matrix, protein, and cellular components drive a particular fate may in 
turn provide valuable clues as to the role these components likely play in the in vivo neural stem 
cell niche. In addition, the ideal polymer compositions for particular applications could be 
investigated for clinical use in the field of neural tissue engineering. For example, in the next 
generation of tissue engineered therapeutics for stroke treatment, an optimized hydrogel 
material could be employed to support and direct the microencapsulated neural stem therapy, 
driving the formation of new neurons to restore and repair the damaged tissue. 
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The potential of the hydrogel microsphere formulation on its own to improve in vivo delivery is 
already being shown beyond the applications described in this work. Olabisi et a/. in 2010 
employed the method to provide immunoprotection and physically restrict a cell-based drug 
delivery system in a model of heterotopic ossification.171 For this study, the microencapsulated 
cells showed improved survival and provided nearly twice the bone-forming capacity as 
compared to an injection of a free cell suspension.171 Other applications for the micro-
encapsulation technique could include delivery of stem cells to repair non-neuronal tissues such 
as damaged heart muscle from myocardial infarction, or delivery and protection of pancreatic 
islet cells for insulin therapy. 
Overall, the versatility of the hydrogel material combined with this rapid, scalable technique for 
microencapsulation provides a powerful tool for the generation of customized, cell-based 
therapeutics for nearly any tissue engineering application. 
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